A murine monoclonal antibody (OC125) has been developed that reacts with each of six epithelial ovarian carcinoma cell lines and with cryopreserved tumor tissue from 12 of 20 ovarian cancer patients. By contrast, the antibody does not bind to a variety of nonmalignant tissues, including adult and fetal ovary. OC125 reacts with only 1 of 14 cell lines derived from nonovarian neoplasms and has failed to react with cryostat sections from 12 nonovarian carcinomas.
R C Bast Jr, M Feeney, H Lazarus, L M Nadler, R B Colvin, R C Knapp
Year: | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | 1998 | 1997 | 1996 | 1995 | 1994 | 1993 | 1992 | 1991 | 1990 | 1989 | 1988 | 1987 | 1986 | 1985 | 1984 | 1983 | 1982 | 1969 | Total |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Citations: | 8 | 15 | 19 | 21 | 29 | 23 | 29 | 28 | 24 | 31 | 31 | 36 | 45 | 29 | 65 | 35 | 24 | 27 | 31 | 22 | 20 | 13 | 17 | 16 | 13 | 19 | 14 | 21 | 23 | 22 | 21 | 38 | 43 | 49 | 42 | 54 | 59 | 47 | 48 | 25 | 21 | 11 | 6 | 5 | 1 | 1220 |
Title and authors | Publication | Year |
---|---|---|
Plasma proteomes and metabolism with genome-wide association data for causal effect identification in ovarian cancer
Qi L, Zhang C, Liu Y, Li W, Ren J, Zhao M |
Discover Oncology | 2025 |
Cancer Antigen 125 Levels at Time of Ovarian Cancer Diagnosis by Race and Ethnicity
Smith AJ, Gleason E, Kadiyala S, Wang X, Howell EA, McCarthy AM |
JAMA Network Open | 2025 |
Modern Emerging Biosensing Methodologies for the Early Diagnosis and Screening of Ovarian Cancer
Abul Rub F, Moursy N, Alhedeithy N, Mohamed J, Ifthikar Z, Elahi MA, Mir TA, Rehman MU, Tariq S, Alabudahash M, Chinnappan R, Yaqinuddin A |
Biosensors | 2025 |
miR-203 Alleviates Myocardial Damage Caused by Acute Coronary Syndrome by Inhibiting CA125.
Guo Y, Li J, Zhang L |
Biochemical genetics | 2025 |
Mapping the Binding Sites of CA125-Specific Antibodies on a Revised Molecular Model of MUC16
Wang CW, Srivastava A, Hanson EK, McEntee CR, Nair T, March JC, Whelan RJ |
Cancers | 2025 |
FLOT1 Is a Novel Serum Biomarker of Ovarian Cancer Targeted by N6‐methyladenosine Modification Inhibition
Guan B, Lu Q, Chen J, Fang J, Liu Z, Li W, Zhang L, Xu G |
Cell Biology International | 2025 |
Comparative Analysis of Salivary Tumor Marker CA-125 Among Oral Squamous Cell Carcinoma Patients and Healthy Individuals
Mohammed R, El Sheikh M, Hashim NT, Chaitanya NC, Suleiman A |
Dentistry Journal | 2025 |
A Dual Immunosensor Based on Optical Weak Value Amplification for Simultaneous Detection of CA125 and HE4
Wang B, Liang G, Meng L, Li H, Song Z, Xu Y, He Y, Duan D, Shi Q, Guan T, Gong Y |
Sensors (Basel, Switzerland) | 2025 |
Autoantibodies, antigen-autoantibody complexes and antigens complement CA125 for early detection of ovarian cancer.
Young Han C, Bedia JS, Yang WL, Hawley SJ, Bergan L, Hopper M, Celestino J, Guo J, Gornet TG, Soosaipillai A, Yang H, Doskocil SD, Lokshin AE, Handy BC, Diamandis EP, Moore RG, Lu KH, Lu Z, Anderson KS, Drescher CW, Skates SJ, Bast RC Jr |
British Journal of Cancer | 2024 |
A Revised Molecular Model of Ovarian Cancer Biomarker CA125 (MUC16) Enabled by Long-read Sequencing.
Wang CW, Weaver SD, Boonpattrawong N, Schuster-Little N, Patankar M, Whelan RJ |
2024 | |
Diagnostic biomarkers in ovarian cancer: advances beyond CA125 and HE4.
Ghose A, McCann L, Makker S, Mukherjee U, Gullapalli SVN, Erekkath J, Shih S, Mahajan I, Sanchez E, Uccello M, Moschetta M, Adeleke S, Boussios S |
Therapeutic advances in medical oncology | 2024 |
Current strategies for early epithelial ovarian cancer detection using miRNA as a potential tool
Bhadra M, Sachan M, Nara S |
Frontiers in Molecular Biosciences | 2024 |
Tumor biomarkers for diagnosis, prognosis and targeted therapy
Zhou Y, Tao L, Qiu J, Xu J, Yang X, Zhang Y, Tian X, Guan X, Cen X, Zhao Y |
Signal Transduction and Targeted Therapy | 2024 |
Clinical characteristics and status of treatment of small-cell carcinoma of the ovary, hypercalcemic type in the Chinese population: a meta-analysis
Zheng K, Gao Y, Xu C, Kang Y |
Journal of Gynecologic Oncology | 2024 |
Emerging role of mucins in antibody drug conjugates for ovarian cancer therapy.
Malik S, Sikander M, Bell N, Zubieta D, Bell MC, Yallapu MM, Chauhan SC |
Journal of Ovarian Research | 2024 |
Identification of a novel histone acetylation-related long non-coding RNA model combined with qRT-PCR experiments for prognosis and therapy in gastric cancer.
Wu Z, Yang X, Yuan Z, Guo Y, Wang X, Qu L |
Heliyon | 2024 |
Preclinical evaluation and pilot clinical study of [(68)Ga]Ga-NOTA-H006 for non-invasive PET imaging of 5T4 oncofetal antigen.
He Y, Tian R, Xu D, Wu Y, Rina S, Chen T, Guan Y, Xie T, Ying T, Xie F, Han J |
European journal of nuclear medicine and molecular imaging | 2024 |
Radiomics Signatures Based on Computed Tomography for Noninvasive Prediction of CXCL10 Expression and Prognosis in Ovarian Cancer
Wang X, Xing Y, Zhou X, Wang C, Han S, Zhao S |
Cancer Reports | 2024 |
Single-cell analysis of matrisome-related genes in breast invasive carcinoma: new avenues for molecular subtyping and risk estimation
Su L, Wang Z, Cai M, Wang Q, Wang M, Yang W, Gong Y, Fang F, Xu L |
Frontiers in Immunology | 2024 |
Glycosylation editing: an innovative therapeutic opportunity in precision oncology.
Dai XF, Yang YX, Yang BZ |
Molecular and cellular biochemistry | 2024 |
Structural Basis for Multivalent MUC16 Recognition and Robust Anti-Pancreatic Cancer Activity of Humanized Antibody AR9.6
Aguilar EN, Sagar S, Murray BR, Rajesh C, Lei EK, Michaud SA, Goodlett DR, Caffrey TC, Grandgenett PM, Swanson B, Brooks TM, Black AR, van Faassen H, Hussack G, Henry KA, Hollingsworth MA, Brooks CL, Radhakrishnan P |
Molecular cancer therapeutics | 2024 |
Serum NLR combined with CA125 and HE4 improves the diagnostic and prognostic efficiency in patients with ovarian cancer
Tian Y, Li X, Zhang H, Wang Y, Li H, Qin Q |
Frontiers in Oncology | 2024 |
Evolving Landscape of Detection and Targeting miRNA/Epigenetics for Therapeutic Strategies in Ovarian Cancer
Bhowmik AD, Shaw P, Pillai MS, Rao G, Dwivedi SK |
Cancer letters | 2024 |
MUC16 and TP53 family co-regulate tumor-stromal heterogeneity in pancreatic adenocarcinoma
Chirravuri-Venkata R, Dam V, Nimmakayala RK, Alsafwani ZW, Bhyravbhatla N, Lakshmanan I, Ponnusamy MP, Kumar S, Jain M, Ghersi D, Batra SK |
Frontiers in Oncology | 2023 |
An Overview of Ovarian Cancer: The Role of Cancer Stem Cells in Chemoresistance and a Precision Medicine Approach Targeting the Wnt Pathway with the Antagonist sFRP4
Varier L, Sundaram SM, Gamit N, Warrier S |
Cancers | 2023 |
Through the Looking Glass: Updated Insights on Ovarian Cancer Diagnostics
Chakraborty S, Shenoy PS, Mehrotra M, Phadte P, Singh P, Rekhi B, Ray P |
Diagnostics | 2023 |
Stearoyl-CoA desaturase 1 expression in early ovarian cancer alters free fatty acid level in serum
Kanoko Katoh, Yuki Katoh, Akiko Kubo, Miho Iida, Yuji Ikeda, Takashi Iwata, Hiroshi Nishio, Masaki Sugawara, Daiki Kato, Makoto Suematsu, Shuichi Hirai, Kei Kawana |
Cancer Research Communications | 2023 |
High ATP6V1B1 expression is associated with poor prognosis and platinum‑based chemotherapy resistance in epithelial ovarian cancer
Han GH, Yun H, Chung JY, Kim JH, Cho H |
Oncology reports | 2023 |
Treatment for ovarian clear cell carcinoma with combined inhibition of WEE1 and ATR
Chien W, Tyner JW, Gery S, Zheng Y, Li LY, Gopinatha Pillai MS, Nam C, Bhowmick NA, Lin DC, Koeffler HP |
Journal of Ovarian Research | 2023 |
Successful treatment of breast metastasis from primary transverse colon cancer: A case report
Jiao X, Xing FZ, Zhai MM, Sun P |
World journal of clinical cases | 2023 |
Evaluation of the Potential Diagnostic Utility of the Determination of Selected Immunological and Molecular Parameters in Patients with Ovarian Cancer.
Englisz A, Smycz-Kubańska M, Mielczarek-Palacz A |
2023 | |
Comparison of the diagnostic accuracy of HE4 with CA125 and validation of the ROMA index in differentiating malignant and benign epithelial ovarian tumours among patients in Lagos, Nigeria
Shittu KA, Rabiu KA, Akinola OI, Ahmed SB, Adewunmi AA |
ecancermedicalscience | 2023 |
Serum leucine‐rich α2‐glycoprotein as a possible marker for inflammatory status in endometriosis
Kobayashi M, Nakamura O, Kitahara Y, Inoue N, Tsukui Y, Hasegawa Y, Hiraishi H, Yabuki A, Muraoka A, Osuka S, Iwase A |
Reproductive Medicine and Biology | 2023 |
The CA125 level postoperative change rule and its prognostic significance in patients with resectable pancreatic cancer.
Luo X, Lin X, Lin R, Yang Y, Wang C, Fang H, Huang H, Lu F |
BMC Cancer | 2023 |
Diagnostic value of CA125, HE4, and systemic immune-inflammation index in the preoperative investigation of ovarian masses.
Song L, Qi J, Zhao J, Bai S, Wu Q, Xu R |
Medicine | 2023 |
Development and Validation of Tumor Marker Indices in Advanced Gastric Cancer Patients
Zhang J, Yin X, Wang H, Fang T, Gao J, Zhu Z, Li C, Wang Y, Wang X, Lu Z, Wu J, Wang Y, Zhang Y, Xue Y |
Cancer control : journal of the Moffitt Cancer Center | 2023 |
Mortality impact, risks, and benefits of general population screening for ovarian cancer: the UKCTOCS randomised controlled trial.
Menon U, Gentry-Maharaj A, Burnell M, Ryan A, Kalsi JK, Singh N, Dawnay A, Fallowfield L, McGuire AJ, Campbell S, Skates SJ, Parmar M, Jacobs IJ |
2023 | |
Aptamers as Potential Therapeutic Tools for Ovarian Cancer: Advancements and Challenges
Szymanowski W, Szymanowska A, Bielawska A, Lopez-Berestein G, Rodriguez-Aguayo C, Amero P |
Cancers | 2023 |
Unlocking the power of nanomedicine: the future of nutraceuticals in oncology treatment.
Singla M, Smriti, Gupta S, Behal P, Singh SK, Preetam S, Rustagi S, Bora J, Mittal P, Malik S, Slama P |
Frontiers in Nutrition | 2023 |
Machine learning-based models for the prediction of breast cancer recurrence risk.
Zuo D, Yang L, Jin Y, Qi H, Liu Y, Ren L |
BMC medical informatics and decision making | 2023 |
Stem Cell Theory of Cancer: Clinical Implications of Epigenomic versus Genomic Biomarkers in Cancer Care
Tu SM, Chen JZ, Singh SR, Aydin AM, Gokden N, Tam NN, Leung YK, Langford T, Ho SM |
Cancers | 2023 |
Comparison of International Ovarian Tumor Analysis ADNEX model and Ovarian-Adnexal Reporting and Data System with final histological diagnosis in adnexal masses: a retrospective study
Filiz AA, Kahyaoglu S, Atalay CR |
Obstetrics & Gynecology Science | 2023 |
Plasma circRNA microarray profiling identifies novel circRNA biomarkers for the diagnosis of ovarian cancer
L Ge, Y Sun, Y Shi, G Liu, F Teng, Z Geng, X Chen, H Xu, J Xu, X Jia |
Journal of Ovarian Research | 2022 |
Application of a novel microscopic technique for quantifying CA125 binding to circulating mononuclear cells in longitudinal specimens during treatment for ovarian cancer
K Lakatos, G González, J Hoballah, J Brooker, S Jeong, C Evans, P Krauledat, W Hansen, K Elias, M Patankar, V Fülöp, P Konstantinopoulos, D Cramer |
Journal of Ovarian Research | 2022 |
Circulating tumor cells in the early detection of human cancers
Feng Z, Wu J, Lu Y, Chan YT, Zhang C, Wang D, Luo D, Huang Y, Feng Y, Wang N |
International journal of biological sciences | 2022 |
Applications of Proteomics in Ovarian Cancer: Dawn of a New Era
Ghose A, Gullapalli SV, Chohan N, Bolina A, Moschetta M, Rassy E, Boussios S |
Proteomes | 2022 |
Crystal structure of a human MUC16 SEA domain reveals insight into the nature of the CA125 tumor marker.
White B, Patterson M, Karnwal S, Brooks CL |
Proteins | 2022 |
International Society of Paediatric Surgical Oncology (IPSO) Surgical Practice Guidelines.
de Campos Vieira Abib S, Chui CH, Cox S, Abdelhafeez AH, Fernandez-Pineda I, Elgendy A, Karpelowsky J, Lobos P, Wijnen M, Fuchs J, Hayes A, Gerstle JT |
ecancermedicalscience | 2022 |
Association between Rheumatoid Arthritis Disease Activity and Risk of Ovarian Malignancy in Middle-Aged and Elderly Women.
Huang Z, Tan L, Ling Y, Huang F, Ma W |
BioMed Research International | 2022 |
Elevated preoperative CA125 is associated with poor survival in patients with metastatic colorectal cancer undergoing primary tumor resection: a retrospective cohort study.
Huang JH, Liu HS, Hu T, Zhang ZJ, He XW, Mo TW, Wen XF, Lan P, Lian L, Wu XR |
Gastroenterology Report | 2022 |
Current and Emerging Methods for Ovarian Cancer Screening and Diagnostics: A Comprehensive Review.
Liberto JM, Chen SY, Shih IM, Wang TH, Wang TL, Pisanic TR 2nd |
Cancers | 2022 |
CA-125 monitoring in gynecologic cancer patients with COVID-19: A case series.
Folsom SM, Mumford B, Lemon L, Taylor S |
Gynecologic Oncology Reports | 2022 |
Oncofetal reprogramming in tumour development and progression.
Sharma A, Blériot C, Currenti J, Ginhoux F |
Nature reviews. Cancer | 2022 |
Circulating Exosomal miR-1290 for Diagnosis of Epithelial Ovarian Cancer.
Jeon H, Seo SM, Kim TW, Ryu J, Kong H, Jang SH, Jang YS, Kim KS, Kim JH, Ryu S, Jeon S |
Current issues in molecular biology | 2022 |
[MUC16: The Novel Target for Tumor Therapy].
Gao R, Lou N, Han X, Shi Y |
Zhongguo fei ai za zhi = Chinese journal of lung cancer | 2022 |
Carbonic anhydrase XII as biomarker and therapeutic target in ovarian carcinomas.
Hiepp L, Mayr D, Gärtner K, Schmoeckel E, Klauschen F, Burges A, Mahner S, Zeidler R, Czogalla B |
PloS one | 2022 |
Machine Learning analysis of high-grade serous ovarian cancer proteomic dataset reveals novel candidate biomarkers.
Farinella F, Merone M, Bacco L, Capirchio A, Ciccozzi M, Caligiore D |
Scientific Reports | 2022 |
Bidirectional Relationship Between Cancer and Heart Failure: Insights on Circulating Biomarkers.
Chianca M, Panichella G, Fabiani I, Giannoni A, L'Abbate S, Aimo A, Del Franco A, Vergaro G, Grigoratos C, Castiglione V, Cipolla CM, Fedele A, Passino C, Emdin M, Cardinale DM |
Frontiers in Cardiovascular Medicine | 2022 |
Molecular Management of High-Grade Serous Ovarian Carcinoma
Punzón-Jiménez P, Lago V, Domingo S, Simón C, Mas A |
International journal of molecular sciences | 2022 |
Diagnostics of Ovarian Tumors in Postmenopausal Patients.
Mustafin C, Vesnin S, Turnbull A, Dixon M, Goltsov A, Goryanin I |
2022 | |
ROMA Index Is an Effective Predictor for Advanced Endometrial Cancer before Surgery
Wang J, Xu P, Zou G, Yin M, Mao X, Zhang X |
Disease Markers | 2022 |
A review of recent advances on single use of antibody-drug conjugates or combination with tumor immunology therapy for gynecologic cancer
Wang AJ, Gao Y, Shi YY, Dai MY, Cai HB |
Frontiers in pharmacology | 2022 |
Circulating and non-circulating proteins and nucleic acids as biomarkers and therapeutic molecules in ovarian cancer.
Utkarsh K, Kumar A, Aditi, Khan A, Nayyar A, Haque S, Iqbal S |
Genes & Diseases | 2022 |
A Review of Principal Studies on the Development and Treatment of Epithelial Ovarian Cancer in the Laying Hen Gallus gallus
P Pal, KN Starkweather, KH Hales, DB Hales |
Comparative medicine | 2021 |
Characterization of Cell-Bound CA125 on Immune Cell Subtypes of Ovarian Cancer Patients Using a Novel Imaging Platform
G González, K Lakatos, J Hoballah, R Fritz-Klaus, L Al-Johani, J Brooker, S Jeong, CL Evans, P Krauledat, DW Cramer, RA Hoffman, WP Hansen, MS Patankar |
Cancers | 2021 |
Altered glycosylation in cancer: A promising target for biomarkers and therapeutics
D Thomas, AK Rathinavel, P Radhakrishnan |
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer | 2021 |
Aptamers for Medical Applications: From Diagnosis to Therapeutics
Y Dong |
2021 | |
Quantitative Mass Spectrometry-Based Proteomics for Biomarker Development in Ovarian Cancer
J Ryu, SN Thomas |
Molecules (Basel, Switzerland) | 2021 |
MAPK Signaling Is Required for Generation of Tunneling Nanotube-Like Structures in Ovarian Cancer Cells
JM Cole, R Dahl, KD Dahl |
Cancers | 2021 |
Design Strategies for Electrochemical Aptasensors for Cancer Diagnostic Devices
K Malecka, E Mikuła, EE Ferapontova |
Sensors (Basel, Switzerland) | 2021 |
Targeting CA-125 Transcription by Development of a Conditionally Replicative Adenovirus for Ovarian Cancer Treatment
E Yue, G Yang, Y Yao, G Wang, A Mohanty, F Fan, L Zhao, Y Zhang, T Mirzapoiazova, TC Walser, L Rodriguez-Rodriguez, Y Fong, R Salgia, EW Wang |
Cancers | 2021 |
Roles of CA125 in diagnosis, prediction, and oncogenesis of ovarian cancer
M Zhang, S Cheng, Y Jin, Y Zhao, Y Wang |
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer | 2021 |
Toward improvement of screening through mass spectrometry-based proteomics: Ovarian cancer as a case study
GT Luu, LM Sanchez |
International Journal of Mass Spectrometry | 2021 |
The Search for Biomarkers in Endometriosis: a Long and Windy Road
M Králíčková, V Vetvicka, L Fiala, AS Laganà, S Garzon |
Reproductive sciences (Thousand Oaks, Calif.) | 2021 |
Next Generation Sequencing Technology in the Clinic and Its Challenges
LK Vestergaard, DN Oliveira, CK Høgdall, EV Høgdall |
Cancers | 2021 |
Comprehending the Proteomic Landscape of Ovarian Cancer: A Road to the Discovery of Disease Biomarkers
S Mukherjee, K Sundfeldt, CA Borrebaeck, ME Jakobsson |
Proteomes | 2021 |
Dynamic light scattering and fluorescence dual-signal sensing of cancer antigen-125 via recognition of the polymerase chain reaction product with gold nanoparticle probe
R Shen, J Zhang, W Huang, S Wu, G Li, S Zou, L Ling |
Analytica Chimica Acta | 2021 |
Automated Assay of a Four-Protein Biomarker Panel for Improved Detection of Ovarian Cancer
C Walker, TM Nguyen, S Jessel, AB Alvero, DA Silasi, T Rutherford, S Draghici, G Mor |
Cancers | 2021 |
Revisiting antibody-drug conjugates and their predictive biomarkers in platinum-resistant ovarian cancer
KE Bairi, OA Jarroudi, S Afqir |
Seminars in Cancer Biology | 2021 |
Clinical Molecular Diagnostics
S Pan, J Tang |
2021 | |
Contemporary Obstetrics and Gynecology for Developing Countries
F Okonofua, JA Balogun, K Odunsi, VN Chilaka |
2021 | |
Diagnostic utility of LDH, CA125 and CYFRA21-1 in tuberculosis pleural effusion
H Lin, L Ni |
Medicina Clínica | 2021 |
An aptamer biosensor for CA125 quantification in human serum based on upconversion luminescence resonance energy transfer
X Zhang, Y Wang, H Deng, X Xiong, H Zhang, T Liang, C Li |
Microchemical Journal | 2021 |
Cancer antigen 125 assessment using carbon quantum dots for optical biosensing for the early diagnosis of ovarian cancer
WE Omer, MF Abdelbar, NM El-Kemary, N Fukata, MA El-Kemary |
RSC Advances | 2021 |
An open-label phase I dose-escalation study of the safety and pharmacokinetics of DMUC4064A in patients with platinum-resistant ovarian cancer
J Liu, H Burris, JS Wang, L Barroilhet, M Gutierrez, Y Wang, A Vaze, R Commerford, S Royer-Joo, V Choeurng, E Humke, K Moore |
Gynecologic Oncology | 2021 |
State of the problem of early diagnosis and treatment of benign ovarian tumors in postmenopausal patients (literature review)
NM Podzolkova, RE Kuznetsov, OL Glazkova, LG Sozaeva, LB Tumgoeva |
Gynecology | 2021 |
Biomarkers in Ovarian Pathology: From Screening to Diagnosis. Review of the Literature
MÁ Elorriaga, JL Neyro, J Mieza, I Cristóbal, A Llueca |
Journal of Personalized Medicine | 2021 |
WFDC Protein: A Promising Diagnosis Biomarker of Ovarian Cancer
C Zhang, H Hu, X Wang, Y Zhu, M Jiang |
Journal of Cancer | 2021 |
Research Progress in Prognostic Factors and Biomarkers of Ovarian Cancer
S Liu, M Wu, F Wang |
Journal of Cancer | 2021 |
Predictive effects of preoperative serum CA125 and AFP levels on post‑hepatectomy survival in patients with hepatitis B‑related hepatocellular carcinoma
C Qin, Y Gao, J Li, C Huang, S He |
Oncology Letters | 2021 |
One-stop clinic for patients with suspected ovarian cancer: results from a retrospective outcome study of the referral pathway.
Ashmore AA, Gnanachandran C, Luqman I, Horrocks K |
BMC Women's Health | 2021 |
Cancer antigen 125 assessment using carbon quantum dots for optical biosensing for the early diagnosis of ovarian cancer.
Omer WE, Abdelbar MF, El-Kemary NM, Fukata N, El-Kemary MA |
RSC Advances | 2021 |
Epithelial Ovarian Cancer and the Immune System: Biology, Interactions, Challenges and Potential Advances for Immunotherapy
AM Macpherson, SC Barry, C Ricciardelli, MK Oehler |
Journal of Clinical Medicine | 2020 |
Randomized Phase II Trial of Nivolumab Versus Nivolumab and Ipilimumab for Recurrent or Persistent Ovarian Cancer: An NRG Oncology Study
D Zamarin, RA Burger, MW Sill, DJ Powell, HA Lankes, MD Feldman, O Zivanovic, C Gunderson, E Ko, C Mathews, S Sharma, AR Hagemann, S Khleif, C Aghajanian |
Journal of Clinical Oncology | 2020 |
ARID3A and ARID3B induce stem promoting pathways in ovarian cancer cells
P Dausinas, K Pulakanti, S Rao, JM Cole, R Dahl, KD Dahl |
Gene | 2020 |
Laboratory predictors of survival in ovarian cancer
MP Jammal, AM Filho, GH Bandeira, BM Murta, EF Murta, RS Nomelini |
Revista da Associação Médica Brasileira | 2020 |
Comparison of Risk of Ovarian Malignancy Algorithm and cancer antigen 125 to discriminate between benign ovarian tumor and early‑stage ovarian cancer according to imaging tumor subtypes
YJ Lee, YM Kim, JS Kang, SH Nam, DY Kim, YT Kim |
Oncology Letters | 2020 |
Genetically predicted circulating protein biomarkers and ovarian cancer risk
DP Considine, G Jia, X Shu, JM Schildkraut, PD Pharoah, W Zheng, SP Kar |
Gynecologic Oncology | 2020 |
'Essentials of Cancer Genomic, Computational Approaches and Precision Medicine
N Masood, SS Malik |
2020 | |
Raised CA125 – what we actually know…
T Howe, N Sokolovsky, A Sayasneh, K Omar, F Tahmasebi |
The Obstetrician & Gynaecologist | 2020 |
Highly Sensitive Detection of CA 125 Protein with the Use of an n-Type Nanowire Biosensor
KA Malsagova, TO Pleshakova, RA Galiullin, AF Kozlov, ID Shumov, VP Popov, FV Tikhonenko, AV Glukhov, VS Ziborov, OF Petrov, VE Fortov, AI Archakov, YD Ivanov |
Biosensors | 2020 |
Liquid biopsy in ovarian cancer: Catching the silent killer before it strikes
L Feeney, IJ Harley, WG McCluggage, PB Mullan, JP Beirne |
World journal of clinical oncology | 2020 |
Additive prognostic value of carbohydrate antigen‐125 over frailty in patients undergoing transcatheter aortic valve replacement
FJ Romeo, IM Seropian, JG Chiabrando, JV Raleigh, M Smietniansky, M Cal, M Falconi, V Kotowicz, CR Agatiello, DH Berrocal |
Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions | 2020 |
microRNA as Biomarker in Ovarian Cancer Management: Advantages and Challenges
V Kumar, S Gupta, K Varma, M Sachan |
DNA and Cell Biology | 2020 |
CA125 and Ovarian Cancer: A Comprehensive Review
P Charkhchi, C Cybulski, J Gronwald, FO Wong, SA Narod, MR Akbari |
Cancers | 2020 |
Radiopharmacologic screening of antibodies to the unshed ectodomain of MUC16 in ovarian cancer identifies a lead candidate for clinical translation
B Nemieboka, SK Sharma, TD Rao, KJ Edwards, S Yan, P Wang, A Ragupathi, A Piersigilli, DR Spriggs, JS Lewis |
Nuclear Medicine and Biology | 2020 |
E2F8 Induces Cell Proliferation and Invasion through the Epithelial–Mesenchymal Transition and Notch Signaling Pathways in Ovarian Cancer
KJ Eoh, HJ Kim, JW Lee, LK Kim, SA Park, HS Kim, YT Kim, PJ Koo |
International journal of molecular sciences | 2020 |
Association of genetic variants in the 3′‐untranslated region of the mesothelin ( MSLN ) gene with ovarian carcinoma
AM AbouElNaga, SM ElKhair, AZ Mahmoud, M Hamza, RM Elshazli |
Journal of Biochemical and Molecular Toxicology | 2020 |
Validation of IOTA-ADNEX Model in Discriminating Characteristics of Adnexal Masses: A Comparison with Subjective Assessment
SY Jeong, BK Park, YY Lee, TJ Kim |
Journal of Clinical Medicine | 2020 |
A biosensor for determination of the circulating biomarker CA125/MUC16 by Surface Plasmon Resonance Imaging
B Szymańska, Z Lukaszewski, K Hermanowicz-Szamatowicz, E Gorodkiewicz |
Talanta | 2020 |
Biomarker CA125 Feature Engineering and Class Imbalance Learning Improves Ovarian Cancer Prediction
X Yang, M Khushi, K Shaukat |
2020 | |
Controversial issues of clinical, laboratory and instrumental diagnostics of ovarian tumors of reproductive women (literature review)
NM Podzolkova, VB Osadchev, KV Babkov, NE Safonova |
Gynecology | 2020 |
Diagnostic Utility of Serum CA-125 Levels in Cases of Acute Appendicitis in Male Patients - A Hospital Based Study
MR Lingareddy, M Gajula, AK Vishwanath, SP R |
2020 | |
MUC16 affects the biological functions of ovarian cancer cells and induces an antitumor immune response by activating dendritic cells
Y Zhai, Q Lu, T Lou, G Cao, S Wang, Z Zhang |
Annals of translational medicine | 2020 |
Prognostic Significance of CA125 Dynamic Change for Progression Free Survival in Patients with Epithelial Ovarian Carcinoma
Z Li, H Yin, M Ren, Y Shen |
Medical science monitor : international medical journal of experimental and clinical research | 2020 |
Nanotechnology and Immunotherapy in Ovarian Cancer: Tracing New Landscapes
B Corradetti, S Pisano, RS Conlan, M Ferrari |
The Journal of pharmacology and experimental therapeutics | 2019 |
Untouchable genes in the human genome: Identifying ideal targets for cancer treatment
IP Gorlov, OY Gorlova, CI Amos |
Cancer Genetics | 2019 |
Tumour biomarkers—Tracing the molecular function and clinical implication
J Lin, L Ma, D Zhang, J Gao, Y Jin, Z Han, D Lin |
Cell Proliferation | 2019 |
Pseudo-pseudo Meigs’ syndrome presenting with a combination of polyserositis, elevated serum CA 125 in systemic lupus erythematosus: A case report
F Gao, YM Xu, GW Yang |
Medicine | 2019 |
Biomarkers and algorithms for diagnosis of ovarian cancer: CA125, HE4, RMI and ROMA, a review
V Dochez, H Caillon, E Vaucel, J Dimet, N Winer, G Ducarme |
Journal of Ovarian Research | 2019 |
Diagnostic performance of biomarkers for ovarian cancer: Protocol for an overview, evidence mapping, and adjusted indirect comparisons
J Hua, J Liu, M Hua, R Cai, M Li, J Wang, J Wang |
Medicine | 2019 |
Novel Approaches to Ovarian Cancer Screening
DR Nebgen, KH Lu, RC Bast |
Current Oncology Reports | 2019 |
Malignant ovarian lesion complicated by a rare entero-ovarian fistula
R Ravikanth, K Kamalasekar |
Gynecology and Minimally Invasive Therapy | 2019 |
Compatibility of the frozen section method in histopathological specimens for female pelvic masses with results for pathology and tumor markers
Parisa Mokhles, Amjad Ahmadi, Ramesh Rahehagh, Nasrin Soofizadeh, Ebrahim Ghaderi |
Medical journal of the Islamic Republic of Iran | 2019 |
Elevated Preoperative Serum CA125 Predicts Larger Tumor Diameter in Patients with Hepatocellular Carcinoma and Low AFP Levels
S Zhou, Z Wang, M Li, L Wu |
BioMed Research International | 2019 |
Ultrasensitive bioassay of epitope of Mucin-16 protein (CA 125) in human plasma samples using a novel immunoassay based on silver conductive nano-ink: A new platform in early stage diagnosis of ovarian cancer and efficient management
M Jafari, M Hasanzadeh, E Solhi, S Hassanpour, N Shadjou, A Mokhtarzadeh, A Jouyban, S Mahboob |
International Journal of Biological Macromolecules | 2019 |
A protein nanocontainer targeting epithelial cancers: rational engineering, biochemical characterization, drug loading and cell delivery
C Ladurantie, M Coustets, G Czaplicki, P Demange, S Mazères, S Dauvillier, J Teissié, MP Rols, A Milon, V Ecochard, G Gross, L Paquereau |
Nanoscale | 2019 |
Ovarian cancer and the evolution of subtype classifications using transcriptional profiling†
DP Cook, BC Vanderhyden |
Biology of reproduction | 2019 |
American Society of Anesthesiologists physical status score as a predictor of long-term outcome in women with endometrial cancer
AM Kolehmainen, A Pasanen, T Tuomi, R Koivisto-Korander, M Loukovaara, R Butzow |
International Journal of Gynecological Cancer | 2019 |
Gastric Cancer In The Precision Medicine Era: Diagnosis and Therapy
V Canzonieri, A Giordano |
2019 | |
Preventive Oncology for the Gynecologist
S Mehta, A Singla |
2019 | |
Biomarkers in Cancer Therapy: Liquid Biopsy Comes of Age
H Shimada |
2019 | |
Role of human epididymis protein 4 (HE4) in detecting recurrence in CA125 negative ovarian cancer patients
F Plotti, F Guzzo, T Schirò, C Terranova, CD Nardone, R Montera, D Luvero, G Scaletta, S Lopez, S Capriglione, PB Panici, R Angioli |
International Journal of Gynecological Cancer | 2019 |
The predictive role of CA-125 in the management of tubo-ovarian abscess. A retrospective study
G Levin, S Herzberg, UP Dior, A Shushan, R Gilad, A Benshushan, A Rottenstreich |
European journal of obstetrics, gynecology, and reproductive biology | 2019 |
Ovarian carcinomas express HE4 epitopes independently of each other
I Hellstrom, YY Yip, M Darvas, E Swisher, KE Hellstrom |
Cancer Treatment and Research Communications | 2019 |
The Translational Status of Cancer Liquid Biopsies
S Bratulic, F Gatto, J Nielsen |
Regenerative Engineering and Translational Medicine | 2019 |
Cox-LASSO Analysis Reveals a Ten-lncRNA Signature to Predict Outcomes in Patients with High-Grade Serous Ovarian Cancer
L Xu, Y Wu, X Che, J Zhao, F Wang, P Wang, X Qu, YP Liu, Z Li |
DNA and Cell Biology | 2019 |
Molecularly imprinted polymer SPE sensor for analysis of CA-125 on serum
TS Rebelo, R Costa, AT Brandão, AF Silva, MG Sales, CM Pereira |
Analytica Chimica Acta | 2019 |
Paper based immunosensing of ovarian cancer tumor protein CA 125 using novel nano-ink: A new platform for efficient diagnosis of cancer and biomedical analysis using microfluidic paper-based analytical devices (μPAD)
F Bahavarnia, A Saadati, S Hassanpour, M Hasanzadeh, N Shadjou, A Hassanzadeh |
International Journal of Biological Macromolecules | 2019 |
The predictive value of serum cancer antigen 125 (CA125) levels on pregnancy outcome in threatened miscarriages
MA Adeku, O Adegbola, GO Ajayi |
Journal of Perinatal Medicine | 2019 |
Photoimmunotherapy of Ovarian Cancer: A Unique Niche in the Management of Advanced Disease
S Nath, MA Saad, M Pigula, JW Swain, T Hasan |
Cancers | 2019 |
Short- and Long-Term Effects of CDK4/6 Inhibition on Early-Stage Breast Cancer
WB Kietzman, GT Graham, V Ory, GM Sharif, MH Kushner, GT Gallanis, B Kallakury, A Wellstein, AT Riegel |
Molecular cancer therapeutics | 2019 |
An Investigation of Survival following Ovarian Cancer
JH Karami, K Luo, T Fung, J Carter, Z Ding |
2019 | |
Clinical Epigenetics
LB Hesson, AL Pritchard |
Clinical Epigenetics | 2019 |
Natural Killer Cells Control Tumor Growth by Sensing a Growth Factor
AD Barrow, MA Edeling, V Trifonov, J Luo, P Goyal, B Bohl, JK Bando, AH Kim, J Walker, M Andahazy, M Bugatti, L Melocchi, W Vermi, DH Fremont, S Cox, M Cella, C Schmedt, M Colonna |
Cell | 2018 |
The Impact of Mesothelin in the Ovarian Cancer Tumor Microenvironment
T Hilliard |
Cancers | 2018 |
Identification of grade and origin specific cell populations in serous epithelial ovarian cancer by single cell RNA-seq
AJ Shih, A Menzin, J Whyte, J Lovecchio, A Liew, H Khalili, T Bhuiya, PK Gregersen, AT Lee, S Orsulic |
PloS one | 2018 |
MUC16 overexpression induced by gene mutations promotes lung cancer cell growth and invasion
M Kanwal, XJ Ding, X Song, GB Zhou, Y Cao |
Oncotarget | 2018 |
Development and characterization of carboxy-terminus specific monoclonal antibodies for understanding MUC16 cleavage in human ovarian cancer
A Aithal, WM Junker, P Kshirsagar, S Das, S Kaur, C Orzechowski, SK Gautam, R Jahan, YM Sheinin, I Lakshmanan, MP Ponnusamy, SK Batra, M Jain, SV Pizzo |
PloS one | 2018 |
Preparation and characterization of a high-affinity monoclonal antibody against human epididymis protein-4
Y Shen, Y Wang, X Jiang, L Lu, C Wang, W Luo, Y Zhang, P Li, Z Du, T Dai, C Wu, A Fang, Y Yao, Q Peng, J Yang |
Protein Expression and Purification | 2018 |
Sensitive on-chip detection of cancer antigen 125 using a DNA aptamer/carbon nanotube network platform
V Gedi, CK Song, GB Kim, JO Lee, E Oh, BS Shin, M Jung, J Shim, H Lee, YP Kim |
Sensors and actuators. B, Chemical | 2018 |
Recent advances in design of electrochemical affinity biosensors for low level detection of cancer protein biomarkers using nanomaterial-assisted signal enhancement strategies
L Farzin, M Shamsipur |
Journal of Pharmaceutical and Biomedical Analysis | 2018 |
MUC16 as a novel target for cancer therapy
A Aithal, S Rauth, P Kshirsagar, A Shah, I Lakshmanan, WM Junker, M Jain, MP Ponnusamy, SK Batra |
Expert Opinion on Therapeutic Targets | 2018 |
“Recurrent multiple cerebral infarctions related to the progression of adenomyosis: a case report”
Y Aso, R Chikazawa, Y Kimura, N Kimura, E Matsubara |
BMC neurology | 2018 |
Serum CA125 in combination with ferritin improves diagnostic accuracy for epithelial ovarian cancer
J Zhao, N Guo, L Zhang, L Wang |
British journal of biomedical science | 2018 |
Carbohydrate antigen 125: a promising tool for risk stratification in heart diseases
F Falcão, FR de Oliveira, MC da Silva, DC Filho |
Biomarkers in Medicine | 2018 |
Preoperative serum levels of cancer antigen 125 and carcinoembryonic antigen ratio can improve differentiation between mucinous ovarian carcinoma and other epithelial ovarian carcinomas
JH Choi, GS Sohn, DB Chay, HB Cho, JH Kim |
Obstetrics & Gynecology Science | 2018 |
Elevated CA 125 in a CASE of Leaking Endometrioma
S Rao, S Kapurubandara, A Anpalagan |
Case Reports in Obstetrics and Gynecology | 2018 |
Does the Risk of Ovarian Malignancy Algorithm Provide Better Diagnostic Performance Than HE4 and CA125 in the Presurgical Differentiation of Adnexal Tumors in Polish Women?
N Abdalla, R Piorkowski, M Bachanek, P Stanirowski, K Cendrowski, W Sawicki |
Disease Markers | 2018 |
Relationship Between Carbohydrate Antigen 125 and Coronary Artery Calcification in Patients without Known Coronary Artery Disease
K Fu, HD Liu, KB MaMuTi, DN Hu, P Hao |
Medical science monitor : international medical journal of experimental and clinical research | 2018 |
CA-125 in Disease Progression and Treatment of Lymphangioleiomyomatosis
CG Glasgow, G Pacheco-Rodriguez, WK Steagall, ME Haughey, PA Julien-Williams, MP Stylianou, BR Gochuico, J Moss |
Chest | 2018 |
CLIC1 and CLIC4 complement CA125 as a diagnostic biomarker panel for all subtypes of epithelial ovarian cancer
B Singha, SL Harper, AR Goldman, BG Bitler, KM Aird, ME Borowsky, MG Cadungog, Q Liu, R Zhang, S Jean, R Drapkin, DW Speicher |
Scientific Reports | 2018 |
Diagnostic utility of glycosyltransferase mRNA expression in gastric cancer
SA Bhat, MU Mir, S Majid, T Hassan, MU Rehman, S Kuchy |
Hematology/Oncology and Stem Cell Therapy | 2018 |
Optimisation of Cytoreductive Surgery in Relation to Ca 125 in Epithelial Ovarian Cancer
K Shobha, N Jayashree, UD Bafna |
Indian Journal of Gynecologic Oncology | 2018 |
Cell Biology of the Ovary
H Katabuchi, T Ohba, T Motohara |
2018 | |
Current advancement on diagnosis of ovarian cancer using biosensing of CA 125 biomarker: Analytical approaches
N Razmi, M Hasanzadeh |
Trends in analytical chemistry : TRAC | 2018 |
A case of autoimmune hepatitis diagnosed with elevated value of CA125, ascites, metrorrhagia
W Jomen, R Okutsu, T Masuda |
Kanzo | 2018 |
Liquid Crystals: A Novel Approach for Cancer Detection and Treatment
J Vallamkondu, E Corgiat, G Buchaiah, R Kandimalla, P Reddy |
Cancers | 2018 |
Cisplatin-induced immune modulation in ovarian cancer mouse models with distinct inflammation profiles
S Grabosch, M Bulatovic, F Zeng, T Ma, L Zhang, M Ross, J Brozick, YS Fang, G Tseng, E Kim, A Gambotto, E Elishaev, RP Edwards, AM Vlad |
Oncogene | 2018 |
Integrated Genomic, Epigenomic, and Expression Analyses of Ovarian Cancer Cell Lines
E Papp, D Hallberg, GE Konecny, DC Bruhm, V Adleff, M Noë, I Kagiampakis, D Palsgrove, D Conklin, Y Kinose, JR White, MF Press, R Drapkin, H Easwaran, SB Baylin, D Slamon, VE Velculescu, RB Scharpf |
Cell Reports | 2018 |
Ovarian Cancer - From Pathogenesis to Treatment
O Devaja, A Papadopoulos |
2018 | |
The contribution and perspectives of proteomics to uncover ovarian cancer tumor markers
VP de Carvalho, ML Grassi, C de Souza Palma, HH Carrara, VM Faça, FJ dos Reis, A Poersch |
Translational research : the journal of laboratory and clinical medicine | 2018 |
Induction of anti-VEGF therapy resistance by upregulated expression of microseminoprotein (MSMP)
T Mitamura, S Pradeep, M McGuire, SY Wu, S Ma, H Hatakeyama, YA Lyons, T Hisamatsu, K Noh, A Villar-Prados, X Chen, C Ivan, C Rodriguez-Aguayo, W Hu, G Lopez-Berestein, RL Coleman, AK Sood |
Oncogene | 2017 |
Transmembrane Mucins: Signaling Receptors at the Intersection of Inflammation and Cancer
JP van Putten, K Strijbis |
Journal of Innate Immunity | 2017 |
History, molecular features, and clinical importance of conventional serum biomarkers in lung cancer
H Nakamura, T Nishimura |
Surgery Today | 2017 |
Emerging biomarkers of lymphangioleiomyomatosis
J Nijmeh, S El-Chemaly, EP Henske |
Expert Review of Respiratory Medicine | 2017 |
Correlation of preoperative ROMA scores with clinical stage in epithelial ovarian cancer patients
QL Li, CJ Wang, P Qi, YX Zhang |
Clinical and Translational Oncology | 2017 |
A Perspective on Ovarian Cancer Biomarkers: Past, Present and Yet-To-Come
F Ueland |
Diagnostics | 2017 |
Precision diagnostics: moving towards protein biomarker signatures of clinical utility in cancer
CA Borrebaeck |
Nature Reviews Cancer | 2017 |
Serum carbohydrate antigen 125 is a significant prognostic marker in patients with unresectable advanced or recurrent gastric cancer
T Namikawa, Y Kawanishi, K Fujisawa, E Munekage, J Iwabu, M Munekage, H Maeda, H Kitagawa, M Kobayashi, K Hanazaki |
Surgery Today | 2017 |
A Resident’s Perspective of Ovarian Cancer
C Smith |
Diagnostics | 2017 |
Antibodies Against Specific MUC16 Glycosylation Sites Inhibit Ovarian Cancer Growth
TD Rao, A Fernández-Tejada, A Axelrod, N Rosales, X Yan, S Thapi, A Wang, KJ Park, B Nemieboka, J Xiang, JS Lewis, N Olvera, DA Levine, SJ Danishefsky, DR Spriggs |
ACS chemical biology | 2017 |
Peritoneal dissemination of ovarian cancer: role of MUC16-mesothelin interaction and implications for treatment
R Coelho, L Marcos-Silva, S Ricardo, F Ponte, A Costa, JM Lopes, L David |
Expert Review of Anticancer Therapy | 2017 |
The role of biomarkers in the management of epithelial ovarian cancer
WL Yang, Z Lu, RC Bast |
Expert Review of Molecular Diagnostics | 2017 |
Adjustment of serum HE4 to reduced glomerular filtration and its use in biomarker-based prediction of deep myometrial invasion in endometrial cancer
J Chovanec, I Selingerova, K Greplova, SL Antonsen, M Nalezinska, C Høgdall, E Høgdall, E Søgaard-Andersen, KM Jochumsen, P Fabian, D Valik, L Zdrazilova-Dubska |
Oncotarget | 2017 |
The Use of Human Epididymis 4 and Cancer Antigen 125 Tumor Markers in the Benign or Malignant Differential Diagnosis of Pelvic or Adnexal Masses
ZN Dolgun, C Kabaca, A Karateke, C İyibozkurt, C İnan, AS Altıntaş, C Karadağ |
BALK MED J | 2017 |
Prediction of lymphatic dissemination in endometrioid endometrial cancer: Comparison of three risk-stratification models in a single-institution cohort
T Tuomi, A Pasanen, A Leminen, R Bützow, M Loukovaara |
Gynecologic Oncology | 2017 |
Gastric Cancer Prewarning and Early Diagnosis System
D Cui |
2017 | |
Smartphone-based immunosensor for CA125 detection
O Hosu, A Ravalli, GM lo Piccolo, C Cristea, R Sandulescu, G Marrazza |
Talanta | 2017 |
Prediction of therapy response in ovarian cancer: Where are we now?
KE Bairi, M Amrani, AH Kandhro, S Afqir |
Critical Reviews in Clinical Laboratory Sciences | 2017 |
In Vivo Optical Detection and Spectral Triangulation of Carbon Nanotubes
CW Lin, H Yang, SR Sanchez, W Mao, L Pang, KM Beckingham, RC Bast, RB Weisman |
ACS Applied Materials & Interfaces | 2017 |
The prognostic value of perioperative, pre-systemic therapy CA125 levels in patients with high-grade serous ovarian cancer
T May, JM Stewart, MQ Bernardini, SE Ferguson, S Laframboise, H Jiang, B Rosen |
International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics | 2017 |
Treatment of peritoneal carcinomatosis with photodynamic therapy: Systematic review of current evidence
MQ Almerie, G Gossedge, KE Wright, DG Jayne |
Photodiagnosis and Photodynamic Therapy | 2017 |
Respective and simultaneous detection tumor markers CA125 and STIP1 using aptamer-based fluorescent and RLS sensors
F Chen, Y Liu, C Chen, H Gong, C Cai, X Chen |
Sensors and actuators. B, Chemical | 2017 |
Red Snappers and Red Herrings: Pelvic Tuberculosis Causing Elevated CA 125 and Mimicking Advanced Ovarian Cancer. A Case Report and Literature Review
Johnnie Alphonse Yates, Olivia Ann Collis, Thanasak Sueblinvong, Tarquin Kamakana Collis |
Hawai'i Journal of Medicine & Public Health | 2017 |
Analysis of CA125 antigen in normal human seminal plasma highlightsthe molecular heterogeneity of underlying glycosylated species
N MITIC, B MILUTINOVIC, M JANKOVIC |
TURK J BIOL | 2017 |
Leveraging immunotherapy for the treatment of gynecologic cancers in the era of precision medicine
D Zamarin, AA Jazaeri |
Gynecologic Oncology | 2016 |
Weekly vs. Every-3-Week Paclitaxel and Carboplatin for Ovarian Cancer
JK Chan, MF Brady, RT Penson, H Huang, MJ Birrer, JL Walker, PA DiSilvestro, SC Rubin, LP Martin, SA Davidson, WK Huh, DM OMalley, MP Boente, H Michael, BJ Monk |
New England Journal of Medicine | 2016 |
Major milestones in translational oncology
TA Dragani, A Castells, V Kulasingam, EP Diamandis, H Earl, WT Iams, CM Lovly, JP Sedelaar, JA Schalken |
BMC Medicine | 2016 |
PPARγ Modulation of Cytokine-Stimulated MUC16 (CA125) Expression in Breast and Ovarian Cancer-Derived Cells: PPARγ C ONTROL OF MUC16 E XPRESSION
M Morgado, DD Carson |
Journal of Cellular Biochemistry | 2016 |
The human fetoembryonic defense system hypothesis: Twenty years on
PC Pang, SM Haslam, A Dell, GF Clark |
Molecular Aspects of Medicine | 2016 |
Prédictibilité préopératoire de la malignité des tumeurs ovariennes à partir du score ADNEX et utilisation en pratique clinique
E Joyeux, T Miras, I Masquin, PE Duglet, K Astruc, S Douvier |
Gynécologie Obstétrique & Fertilité | 2016 |
High levels of pretreatment CA125 are associated to improved survival in high grade serous ovarian carcinoma
F Morales-Vásquez, E Pedernera, J Reynaga-Obregón, HN López-Basave, MJ Gómora, E Carlón, S Cárdenas, R Silva-Ayala, M Almaraz, C Méndez |
Journal of Ovarian Research | 2016 |
Establishment of anti-mesothelioma monoclonal antibodies
N Mizutani, M Abe, S Matsuoka, K Kajino, M Wakiya, N Ohtsuji, R Hatano, C Morimoto, O Hino |
BMC Research Notes | 2016 |
Long-term significance of urinary neopterin in ovarian cancer: a study by the Austrian Association for Gynecologic Oncology (AGO)
BM Volgger, GH Windbichler, AG Zeimet, AH Graf, G Bogner, L Angleitner-Boubenizek, M Rohde, U Denison, G Sliutz, LC Fuith, D Fuchs, C Marth |
Annals of Oncology | 2016 |
Total internal reflection plasmonic scattering-based fluorescence-free nanoimmunosensor probe for ultra-sensitive detection of cancer antigen 125
SK Chakkarapani, P Zhang, S Ahn, SH Kang |
Biosensors and Bioelectronics | 2016 |
Elevation of CA19-9-Related Novel Marker, Core 1 Sialyl Lewis A, in Sera of Adenocarcinoma Patients Verified by a SRM-Based Method
M Tanaka-Okamoto, M Yabu, M Mukai, H Takahashi, Y Fujiwara, M Ohue, Y Kamada, E Miyoshi, Y Miyamoto |
Journal of Proteome Research | 2016 |
External validation of non-imaging models for predicting distant metastasis in patients with endometrial cancer
M Koskas, J Uzan, A Vanderstraeten, I Vergote, F Amant |
Gynecologic Oncology | 2016 |
Ocular Surface Membrane-Associated Mucins
AF Ablamowicz, JJ Nichols |
The ocular surface | 2016 |
Validation of a Novel Biomarker Panel for the Detection of Ovarian Cancer
F Leung, MQ Bernardini, MD Brown, Y Zheng, R Molina, RC Bast, G Davis, S Serra, EP Diamandis, V Kulasingam |
Cancer epidemiology, biomarkers & prevention | 2016 |
Fucosylated Glycans in α1-Acid Glycoprotein for Monitoring Treatment Outcomes and Prognosis of Cancer Patients
S Yazawa, R Takahashi, T Yokobori, R Sano, A Mogi, AR Saniabadi, H Kuwano, T Asao, PK Singh |
PloS one | 2016 |
Evaluation and Management of Adnexal Masses:
C MacGregor, B Cronin |
Topics in Obstetrics & Gynecology | 2016 |
The cost-effectiveness and value of gynecological cancer biomarker screening in financially vulnerable female populations
R Hendricks-Sturrup |
Journal of Cancer Policy | 2016 |
Photonics immunotherapy — A novel strategy for cancer treatment
F Zhou, RE Nordquist, WR Chen |
Journal of Innovative Optical Health Sciences | 2016 |
Novel Immunogenic Epitopes in the NaPi-IIb Protein: Production of Monospecific Antibodies Using Synthetic Peptides Outlined on Isoform Specific Regions of the Type IIb Sodium-Dependent Phosphate Transporter (NaPi-IIb)
ÂA Megale, JM da Júnior, LB Rangel, MD Diz, MS Mano, PM Hoff, PH Lopes, RJ Arai, WD da Silva |
Journal of Cancer Therapy | 2016 |
Phase I study of safety and pharmacokinetics of the anti-MUC16 antibody–drug conjugate DMUC5754A in patients with platinum-resistant ovarian cancer or unresectable pancreatic cancer
JF Liu, KN Moore, MJ Birrer, S Berlin, UA Matulonis, JR Infante, B Wolpin, KA Poon, R Firestein, J Xu, R Kahn, Y Wang, K Wood, WC Darbonne, MR Lackner, SK Kelley, X Lu, YJ Choi, D Maslyar, EW Humke, HA Burris |
Annals of Oncology | 2016 |
Aptamer and 5-fluorouracil dual-loading Ag2S quantum dots used as a sensitive label-free probe for near-infrared photoluminescence turn-on detection of CA125 antigen
H Jin, R Gui, J Gong, W Huang |
Biosensors and Bioelectronics | 2016 |
Clinical Significance of Tissue Factor Pathway Inhibitor 2, a Serum Biomarker Candidate for Ovarian Clear Cell Carcinoma
N Arakawa, H Kobayashi, N Yonemoto, Y Masuishi, Y Ino, H Shigetomi, N Furukawa, N Ohtake, Y Miyagi, F Hirahara, H Hirano, E Miyagi, SK Batra |
PloS one | 2016 |
Encyclopedia of Signaling Molecules
S Choi |
Encyclopedia of Signaling Molecules | 2016 |
Holland-Frei Cancer Medicine
RC Bast, WN Hait, DW Kufe, RR Weichselbaum, JF Holland, CM Croce, M Piccart-Gebart, H Wang, WK Hong, RE Pollock |
Holland-Frei Cancer Medicine | 2016 |
NCCN Work Group Report: Designing Clinical Trials in the Era of Multiple Biomarkers and Targeted Therapies
Alan P. Venook, Maria E. Arcila, Al B. Benson, Donald A. Berry, David Ross Camidge, Robert W. Carlson, Toni K. Choueiri, Valerie Guild, Gregory P. Kalemkerian, Razelle Kurzrock, Christine M. Lovly, Amy E. McKee, Robert J. Morgan, Anthony J. Olszanski, Mary W. Redman, Vered Stearns, Joan McClure, Marian L. Birkeland |
Journal of the National Comprehensive Cancer Network : JNCCN | 2016 |
Exploratory Analysis of TP53 Mutations in Circulating Tumour DNA as Biomarkers of Treatment Response for Patients with Relapsed High-Grade Serous Ovarian Carcinoma: A Retrospective Study
CA Parkinson, D Gale, AM Piskorz, H Biggs, C Hodgkin, H Addley, S Freeman, P Moyle, E Sala, K Sayal, K Hosking, I Gounaris, M Jimenez-Linan, HM Earl, W Qian, N Rosenfeld, JD Brenton, ER Mardis |
PLoS Medicine | 2016 |
Serum CA125 concentration as a predictor of peritoneal dissemination of colorectal cancer in men and women:
CJ Huang, JK Jiang, SC Chang, JK Lin, SH Yang |
Medicine | 2016 |
M2 macrophages induce ovarian cancer cell proliferation via a heparin binding epidermal growth factor/matrix metalloproteinase 9 intercellular feedback loop
MJ Carroll, A Kapur, M Felder, MS Patankar, PK Kreeger |
Oncotarget | 2016 |
Discovery of biomarkers for endometrial cancer: current status and prospects
TL Rižner |
Expert Review of Molecular Diagnostics | 2016 |
Serum concentrations of the biomarkers CA125, CA15-3, PSA and PAPP-A in early pregnancy
M Stemp, P Roberts, A McClements, V Chapple, P Matson |
2016 | |
Very rare cause of hemoperitoneum: Ovarian fibroma
M Köse, F Çelik, SK Köse, DT Arıöz, BD Yavas |
Journal of Obstetrics & Gynaecology | 2016 |
Protein Glycosylation in Cancer
SR Stowell, T Ju, RD Cummings |
Annual review of pathology | 2015 |
Advances in Cancer Biomarkers
R Scatena |
2015 | |
Advances in Cancer Biomarkers
R Scatena |
2015 | |
Advances in Cancer Biomarkers
R Scatena |
2015 | |
Advances in Cancer Biomarkers
R Scatena |
2015 | |
High-grade serous ovarian cancer cell lines exhibit heterogeneous responses to growth factor stimulation
DL Bourgeois, KA Kabarowski, VL Porubsky, PK Kreeger |
Cancer Cell International | 2015 |
The Homeoprotein DLX4 Stimulates NF-κB Activation and CD44-Mediated Tumor–Mesothelial Cell Interactions in Ovarian Cancer
D Haria, BQ Trinh, SY Ko, N Barengo, J Liu, H Naora |
The American Journal of Pathology | 2015 |
ROMA, an algorithm for ovarian cancer
AM Chudecka-Głaz |
Clinica Chimica Acta | 2015 |
Risk-stratification of endometrial carcinomas revisited: A combined preoperative and intraoperative scoring system for a reliable prediction of an advanced disease
T Tuomi, A Pasanen, A Luomaranta, A Leminen, R Bützow, M Loukovaara |
Gynecologic Oncology | 2015 |
A phase I clinical trial of adoptive T cell therapy using IL-12 secreting MUC-16ecto directed chimeric antigen receptors for recurrent ovarian cancer
M Koneru, R O’Cearbhaill, S Pendharkar, DR Spriggs, RJ Brentjens |
Journal of Translational Medicine | 2015 |
Relationship of tumor marker CA125 and ovarian tumor stem cells: preliminary identification
H Zhang, Y Yang, Y Wang, X Gao, W Wang, H Liu, H He, Y Liang, K Pan, H Wu, J Shi, H Xue, L Liang, Z Cai, Y Fan, Y Zhang |
Journal of Ovarian Research | 2015 |
Validation of LRG1 as a Potential Biomarker for Detection of Epithelial Ovarian Cancer by a Blinded Study
J Wu, H Yin, J Zhu, RJ Buckanovich, JD Thorpe, J Dai, N Urban, DM Lubman, AW Lo |
PloS one | 2015 |
Postmenopausal Meigs' Syndrome in Elevated CA-125: A Case Report
JW Park, JW Bae |
Journal of Menopausal Medicine | 2015 |
Membrane proximal ectodomain cleavage of MUC16 occurs in the acidifying Golgi/post-Golgi compartments
S Das, PD Majhi, MH Al-Mugotir, S Rachagani, P Sorgen, SK Batra |
Scientific Reports | 2015 |
BAI1-Associated Protein 2-Like 1 (BAIAP2L1) Is a Potential Biomarker in Ovarian Cancer
A Chao, CL Tsai, SM Jung, WC Chuang, C Kao, A Hsu, SH Chen, CY Lin, YC Lee, YS Lee, TH Wang, HS Wang, CH Lai, DW Chan |
PloS one | 2015 |
ARID3B Directly Regulates Ovarian Cancer Promoting Genes
A Bobbs, K Gellerman, WM Hallas, S Joseph, C Yang, J Kurkewich, KD Dahl, J Zhang |
PloS one | 2015 |
Nutlin-3a: A Potential Therapeutic Opportunity for TP53 Wild-Type Ovarian Carcinomas
EK Crane, SY Kwan, DI Izaguirre, YT Tsang, LK Mullany, Z Zu, JA Richards, DM Gershenson, KK Wong, AN Cheung |
PloS one | 2015 |
Noninvasive Molecular Markers in Gynecologic Cancers
P Peitsidis |
Noninvasive Molecular Markers in Gynecologic Cancers | 2015 |
A novel monoclonal antibody to a defined peptide epitope in MUC16
L Marcos-Silva, S Ricardo, K Chen, O Blixt, E Arigi, D Pereira, E Høgdall, U Mandel, EP Bennett, SY Vakhrushev, L David, H Clausen |
Glycobiology | 2015 |
CXCR2 Inhibition Combined with Sorafenib Improved Antitumor and Antiangiogenic Response in Preclinical Models of Ovarian Cancer
B Devapatla, A Sharma, S Woo, D Ribatti |
PloS one | 2015 |
Contributions of the Epidermal Growth Factor Receptor to Acquisition of Platinum Resistance in Ovarian Cancer Cells
ML Granados, LG Hudson, SL Samudio-Ruiz, JC States |
PloS one | 2015 |
In vitro selection of RNA aptamers against CA125 tumor marker in ovarian cancer and its study by optical biosensing
I Lamberti, S Scarano, CL Esposito, A Antoccia, G Antonini, C Tanzarella, VD Franciscis, M Minunni |
Methods | 2015 |
Novel Activities of Select NSAID R-Enantiomers against Rac1 and Cdc42 GTPases
TI Oprea, LA Sklar, JO Agola, Y Guo, M Silberberg, J Roxby, A Vestling, E Romero, Z Surviladze, C Murray-Krezan, A Waller, O Ursu, LG Hudson, A Wandinger-Ness, MF Olson |
PloS one | 2015 |
Glycosylation-Based Serum Biomarkers for Cancer Diagnostics and Prognostics
A Kirwan, M Utratna, ME ODwyer, L Joshi, M Kilcoyne |
BioMed Research International | 2015 |
Understanding the Unique Attributes of MUC16 (CA125): Potential Implications in Targeted Therapy
S Das, SK Batra |
Cancer research | 2015 |
CA125-related tumor cell kinetics variables after chemotherapy in advanced ovarian cancer: a systematic review
G Colloca, A Venturino, I Governato |
Clinical and Translational Oncology | 2015 |
Translational Research and Plasma Proteomic in Cancer: P ROTEOMIC IN C ANCER
AC Santini, G Giovane, A Auletta, AD Carlo, A Fiorelli, L Cito, C Astarita, A Giordano, R Alfano, A Feola, MD Domenico |
Journal of Cellular Biochemistry | 2015 |
Efficacy of endocervical curettage and CA-125 measurement in endometrial serous carcinoma: A case series and literature review
AC İyibozkurt, M Doğan, E Baştu, H Sözen, D Vatansever, S Topuz, S Berkman |
Journal of Turkish Society of Obstetric and Gynecology | 2015 |
CEA in Evaluation of Adnexal Mass: Retrospective Cohort Analysis and Review of the Literature
L Sagi-Dain, O Lavie, R Auslander, S Sagi |
The International Journal of Biological Markers | 2015 |
Usefulness of determining CA 125 and HE4 serum concentration in diagnosis of ovarian cancer
I Gumółka |
2015 | |
Carboxyl-terminal domain of MUC16 imparts tumorigenic and metastatic functions through nuclear translocation of JAK2 to pancreatic cancer cells
S Das, S Rachagani, MP Torres-Gonzalez, I Lakshmanan, PD Majhi, LM Smith, KU Wagner, SK Batra |
Oncotarget | 2015 |
Reprogramming ovarian and breast cancer cells into non-cancerous cells by low-dose metformin or SN-38 through FOXO3 activation
T Hu, YM Chung, M Guan, M Ma, J Ma, JS Berek, MC Hu |
Scientific Reports | 2014 |
Tumour Immunogenicity, Antigen Presentation, and Immunological Barriers in Cancer Immunotherapy
D Escors |
New Journal of Science | 2014 |
MUC16 (CA125): tumor biomarker to cancer therapy, a work in progress
M Felder, A Kapur, J Gonzalez-Bosquet, S Horibata, J Heintz, R Albrecht, L Fass, J Kaur, K Hu, H Shojaei, RJ Whelan, MS Patankar |
Molecular Cancer | 2014 |
Utility of Preoperative CA125 Assay in the Management Planning of Women Diagnosed with Uterine Cancer
N Povolotskaya, N Das, K Dhar, D Brinkmann, F Gardner, R Woolas |
Surgery Research and Practice | 2014 |
Baseline and post prophylactic tubal–ovarian surgery CA125 levels in BRCA1 and BRCA2 mutation carriers
Y Chen, E Bancroft, S Ashley, A Arden-Jones, S Thomas, S Shanley, S Saya, E Wakeling, R Eeles |
Familial Cancer | 2014 |
High serum carbohydrate antigen 125 concentration can predict serous effusion but not gastrointestinal malignancy in male patients
X Zhu, W Zhou, Y Chen, J Gao, F Kong, J Liu, Z Li, J Gao, Y Bai |
Tumor Biology | 2014 |
The prognostic significance of pre- and post-treatment CA-125 in grade 1 serous ovarian carcinoma: A Gynecologic Oncology Group study
AN Fader, J Java, TC Krivak, RE Bristow, AI Tergas, MA Bookman, DK Armstrong, EJ Tanner, DM Gershenson |
Gynecologic Oncology | 2014 |
Proteomic and other analyses to determine the functional consequences of deregulated kallikrein-related peptidase (KLK) expression in prostate and ovarian cancer
RA Fuhrman-Luck, ML Silva, Y Dong, H Irving-Rodgers, T Stoll, ML Hastie, D Loessner, JJ Gorman, JA Clements |
PROTEOMICS – CLINICAL APPLICATIONS | 2014 |
Stability of HE4 and CA125 in blood samples from patients diagnosed with ovarian cancer
N Sandhu, MA Karlsen, C Høgdall, IA Laursen, IJ Christensen, EV Høgdall |
Scandinavian Journal of Clinical & Laboratory Investigation | 2014 |
Cancer Biomarkers: Minimal and Noninvasive Early Diagnosis and Prognosis
A Munshi, V Sharma |
Cancer Biomarkers: Minimal and Noninvasive Early Diagnosis and Prognosis | 2014 |
Early inflammatory response in epithelial ovarian tumor cyst fluids
B Kristjánsdóttir, K Partheen, ET Fung, C Yip, K Levan, K Sundfeldt |
Cancer Medicine | 2014 |
An mDia2/ROCK Signaling Axis Regulates Invasive Egress from Epithelial Ovarian Cancer Spheroids
KM Pettee, KM Dvorak, AL Nestor-Kalinoski, KM Eisenmann, P Aspenstrom |
PloS one | 2014 |
Commentary on ‘Performance of ultrasound as a second line test to serum CA125 in ovarian cancer screening’
YL Wan, EJ Crosbie |
BJOG: An International Journal of Obstetrics & Gynaecology | 2014 |
Cancer antigen 125 after delivery in women with a normal pregnancy: a prospective cohort study
PB Szecsi, MR Andersen, B Bjørngaard, KK Hedengran, S Stender |
Acta Obstetricia et Gynecologica Scandinavica | 2014 |
Potential biomarkers for oral squamous cell carcinoma: Proteomics discovery and clinical validation
Y Ni, L Ding, Q Hu, ZC Hua |
PROTEOMICS – CLINICAL APPLICATIONS | 2014 |
Immunoassays for the cancer biomarker CA125 based on a large-birefringence nematic liquid-crystal mixture
SH Sun, MJ Lee, YH Lee, W Lee, X Song, CY Chen |
Biomedical Optics Express | 2014 |
The chicken model of spontaneous ovarian cancer
AM Hawkridge |
PROTEOMICS – CLINICAL APPLICATIONS | 2014 |
Elevated CA-125 in disseminated tuberculosis: a case report
D Kulshreshtha, G Raj, S Singh, PK Maurya, AK Singh, AK Thacker |
QJM | 2014 |
In 2014, can we do better than CA125 in the early detection of ovarian cancer?
JG Cohen |
World journal of biological chemistry | 2014 |
Correlation of Cytohistlogical Expression and Serum Level of Ca125 in Ovarian Neoplasm
C Das |
JOURNAL OF CLINICAL AND DIAGNOSTIC RESEARCH | 2014 |
Characterization of Binding Epitopes of CA125 Monoclonal Antibodies
L Marcos-Silva, Y Narimatsu, A Halim, D Campos, Z Yang, MA Tarp, PJ Pereira, U Mandel, EP Bennett, SY Vakhrushev, SB Levery, L David, H Clausen |
Journal of Proteome Research | 2014 |
Development and Characterization of Three Novel Monoclonal Antibodies Against CA-125
T Michurina, M Kerzhner, B Klimovich |
Monoclonal Antibodies in Immunodiagnosis and Immunotherapy | 2014 |
Serum concentrations of the biomarkers CA125, CA15-3, CA72-4, tPSA and PAPP-A in natural and stimulated ovarian cycles
M Stemp, P Roberts, A McClements, V Chapple, J Natalwala, M Black, P Matson |
Asian Pacific Journal of Reproduction | 2014 |
A simple resonance Rayleigh scattering method for determination of trace CA125 using immuno-AuRu nanoalloy as probe via ultrasonic irradiation
M Tang, G Wen, Y Luo, A Liang, Z Jiang |
Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy | 2014 |
Reference Module in Biomedical Sciences
DL Sackett, RB Haynes |
2014 | |
Uncommon Gynecologic Cancers: del Carmen/Uncommon Gynecologic Cancers
LA Garrett, MG Carmen |
Uncommon Gynecologic Cancers: del Carmen/Uncommon Gynecologic Cancers | 2014 |
Development of Nanoscale Approaches for Ovarian Cancer Therapeutics and Diagnostics
Sarah A. Engelberth, Nadine Hempel, Magnus Bergkvist |
Critical Reviews in Oncogenesis | 2014 |
Role of a Risk of Malignancy Index in Clinical Approaches to Adnexal Masses
HS Simsek, A Tokmak, E Ozgu, M Doganay, N Danisman, S Erkaya, T Gungor |
Asian Pacific Journal of Cancer Prevention | 2014 |
Variant Prostate Carcinoma and Elevated Serum CA-125
Mehmet Asim Bilen, Adriana Reyes, Deb Bhowmick, April Maa, Robert Bast Jr, Louis L. Pisters, Sue-Hwa Lin, Christopher J. Logothetis, Shi-Ming Tu |
The Canadian journal of urology | 2014 |
Nanomaterial-Based Electrochemical Immunosensors for Clinically Significant Biomarkers
N Ronkainen, S Okon |
Materials | 2014 |
Mutation or Loss of p53 Differentially Modifies TGFβ Action in Ovarian Cancer
EÓ hAinmhire, SM Quartuccio, W Cheng, RA Ahmed, SM King, JE Burdette, S Deb |
PloS one | 2014 |
Bioenergetic Analysis of Ovarian Cancer Cell Lines: Profiling of Histological Subtypes and Identification of a Mitochondria-Defective Cell Line
U Dier, DH Shin, LP Hemachandra, LM Uusitalo, N Hempel, J Zhang |
PloS one | 2014 |
Detection of glyco-mucin profiles improves specificity of MUC16 and MUC1 biomarkers in ovarian serous tumours
S Ricardo, L Marcos-Silva, D Pereira, R Pinto, R Almeida, O Söderberg, U Mandel, H Clausen, A Felix, N Lunet, L David |
Molecular Oncology | 2014 |
Transformation of NIH3T3 mouse fibroblast cells by MUC16 mucin (CA125) is driven by its cytoplasmic tail
P Giannakouros, I Matte, C Rancourt, A Piché |
International journal of oncology | 2014 |
MUC16: molecular analysis and its functional implications in benign and malignant conditions
D Haridas, MP Ponnusamy, S Chugh, I Lakshmanan, P Seshacharyulu, SK Batra |
The FASEB Journal | 2014 |
NCCN Working Group report: designing clinical trials in the era of multiple biomarkers and targeted therapies
Alan P Venook, Maria E Arcila, Al B Benson 3rd, Donald A Berry, David Ross Camidge, Robert W Carlson, Toni K Choueiri, Valerie Guild, Gregory P Kalemkerian, Razelle Kurzrock, Christine M Lovly, Amy E McKee, Robert J Morgan, Anthony J Olszanski, Mary W Redman, Vered Stearns, Joan McClure, Marian L Birkeland |
Journal of the National Comprehensive Cancer Network : JNCCN | 2014 |
Human omental-derived adipose stem cells increase ovarian cancer proliferation, migration, and chemoresistance
A Nowicka, FC Marini, TN Solley, PB Elizondo, Y Zhang, HJ Sharp, R Broaddus, M Kolonin, SC Mok, MS Thompson, WA Woodward, K Lu, B Salimian, D Nagrath, AH Klopp |
PloS one | 2013 |
Comprehensive Gynecology
RL Coleman, PT Ramirez, DM Gershenson |
Comprehensive Gynecology | 2013 |
Multi-peptide nLC-PC-IDMS-SRM-based Assay for the quantification of biomarkers in the chicken ovarian cancer model
GL Kingon, JN Petitte, DC Muddiman, AM Hawkridge |
Methods | 2013 |
Amino acid profile index for early detection of endometrial cancer: verification as a novel diagnostic marker
Y Ihata, E Miyagi, R Numazaki, T Muramatsu, A Imaizumi, H Yamamoto, M Yamakado, N Okamoto, F Hirahara |
International Journal of Clinical Oncology | 2013 |
Error-promoting DNA synthesis in ovarian cancer cells
H Dai, RJ Hickey, J Liu, RM Bigsby, C Lanner, LH Malkas |
Gynecologic Oncology | 2013 |
Dual detection of cancer biomarker CA125 using absorbance and electrochemical methods
I Al-Ogaidi, ZP Aguilar, S Suri, H Gou, N Wu |
The Analyst | 2013 |
Prediction of lymph node and distant metastasis in patients with endometrial carcinoma: A new model based on demographics, biochemical factors, and tumor histology
A Luomaranta, A Leminen, M Loukovaara |
Gynecologic Oncology | 2013 |
The Immunoassay Handbook
RF Ritchie |
The Immunoassay Handbook | 2013 |
Cancer antigen 125 detection using the plasmon resonance scattering properties of gold nanorods
K Zhang, X Shen |
The Analyst | 2013 |
Differentiating stage 1 epithelial ovarian cancer from benign ovarian tumours using a combination of tumour markers HE4, CA125, and CEA and patient's age
S Kondalsamy-Chennakesavan, A Hackethal, D Bowtell, A Obermair |
Gynecologic Oncology | 2013 |
Screening for gynecological cancers
JK Kalsi, R Manchanda, U Menon |
Expert Review of Obstetrics & Gynecology | 2013 |
Dendritic cell immunotherapy in ovarian cancer
PJ Stiff, C Czerlanis, ML Drakes |
Expert Review of Anticancer Therapy | 2013 |
The role of tumour-associated MUC1 in epithelial ovarian cancer metastasis and progression
J Deng, L Wang, H Chen, L Li, Y Ma, J Ni, Y Li |
Cancer and Metastasis Reviews | 2013 |
The Clinico-Pathologic Features and Significance of Preoperative CA 125 in Patients Who Had an Operation for Ovarian Tumors
CR Kim, CH Ku, IS Jeon, DW Son, JS Lee |
The Journal of Korean Society of Menopause | 2013 |
Prognostische und prädiktive Marker des Ovarialkarzinoms
I Meinhold-Heerlein, K Bräutigam, U Pecks, N Maass, DO Bauerschlag |
Der Gynäkologe | 2013 |
A three-dimensional microenvironment alters protein expression and chemosensitivity of epithelial ovarian cancer cells in vitro
JM Lee, P Mhawech-Fauceglia, N Lee, LC Parsanian, YG Lin, SA Gayther, K Lawrenson |
Laboratory Investigation | 2013 |
Advances in mass spectrometry-based technologies to direct personalized medicine in ovarian cancer
F Leung, N Musrap, EP Diamandis, V Kulasingam |
Translational Proteomics | 2013 |
Role of cancer antigen 125 in active pulmonary tuberculosis
AF Said, BI Mohamed, E El-Sharkawy, M Al-Sherif |
Egyptian Journal of Chest Diseases and Tuberculosis | 2013 |
Maternal serum CA-125 level is elevated in severe preeclampsia
E Karaman, Y Karaman, İ Alkış, A Han, G Yıldırım, HC Ark |
Pregnancy Hypertension: An International Journal of Women's Cardiovascular Health | 2013 |
The sweet and sour of serological glycoprotein tumor biomarker quantification
U Kuzmanov, H Kosanam, EP Diamandis |
BMC Medicine | 2013 |
The role of glycans in immune evasion: the human fetoembryonic defence system hypothesis revisited
GF Clark |
Molecular Human Reproduction | 2013 |
Predictive value of preoperative serum CA-125 levels in patients with uterine cancer: The Asian experience 2000 to 2012
B Patsner, GW Yim |
Obstetrics & Gynecology Science | 2013 |
Exploring the glycosylation of serum CA125
R Saldova, WB Struwe, K Wynne, G Elia, MJ Duffy, PM Rudd |
International journal of molecular sciences | 2013 |
Nadir CA-125 level as prognosis indicator of high-grade serous ovarian cancer
X Xu, Y Wang, F Wang, L Jia, Y Zhou, F Deng, J Qu, B Zhou, A Meng, B Fu, X Chen, Z Qian, J Wang |
Journal of Ovarian Research | 2013 |
A combined blood based gene expression and plasma protein abundance signature for diagnosis of epithelial ovarian cancer--a study of the OVCAD consortium
D Pils, D Tong, G Hager, E Obermayr, S Aust, G Heinze, M Kohl, E Schuster, A Wolf, J Sehouli, I Braicu, I Vergote, TV Gorp, S Mahner, N Concin, P Speiser, R Zeillinger |
BMC Cancer | 2013 |
Manifestations of immune tolerance in the human female reproductive tract
GF Clark, DJ Schust |
Frontiers in immunology | 2013 |
Glycoprotein disease markers and single protein-omics
K Chandler, R Goldman |
Molecular & cellular proteomics : MCP | 2013 |
HE4 and CA125 levels in the preoperative assessment of endometrial cancer patients: a prospective multicenter study (ENDOMET)
SL Antonsen, E Høgdall, IJ Christensen, M Lydolph, A Tabor, AL Jakobsen, CL Fagö-Olsen, ES Andersen, K Jochumsen, C Høgdall |
Acta Obstetricia et Gynecologica Scandinavica | 2013 |
Clinical Significance of Combined Detection of Serum Tumor Markers in Diagnosis of Patients with Ovarian Cancer
J Bian, B Li, XJ Kou, TZ Liu, L Ming |
Asian Pacific Journal of Cancer Prevention | 2013 |
Pattern of Tissue Expression of CA-125 and HE4 in Primary Epithelial Ovarian Tumours and Correlation with Serum CA-125 Levels
SM Devan, J Pailoor, P Sthaneshwar, V Narayanan |
Asian Pacific Journal of Cancer Prevention | 2013 |
The Chinese herbs Scutellaria baicalensis and Fritillaria cirrhosa target NFκB to inhibit proliferation of ovarian and endometrial cancer cells: CHINESE HERBS INDUCED CYTOTOXICITY
L Kavandi, LR Lee, AA Bokhari, JE Pirog, Y Jiang, KA Ahmad, V Syed |
Molecular Carcinogenesis | 2013 |
Mucins and Cancer
EO Fourkala, A Gentry-Maharaj, U Menon |
Mucins and Cancer | 2013 |
Elevation of carbohydrate antigen 125 in chronic heart failure may be caused by mechanical extension of mesothelial cells from serous cavity effusion
F Huang, K Zhang, J Chen, Q Cai, X Liu, T Wang, Z Lv, J Wang, H Huang |
Clinical Biochemistry | 2013 |
Estradiol 17 and Its Metabolites Stimulate Cell Proliferation and Antagonize Ascorbic Acid-Suppressed Cell Proliferation in Human Ovarian Cancer Cells
HH Li, YJ Zhao, Y Li, CF Dai, SO Jobe, XS Yang, XF Li, MS Patankar, RR Magness, J Zheng |
Reproductive sciences (Thousand Oaks, Calif.) | 2013 |
Human Omental-Derived Adipose Stem Cells Increase Ovarian Cancer Proliferation, Migration, and Chemoresistance
A Nowicka, FC Marini, TN Solley, PB Elizondo, Y Zhang, HJ Sharp, R Broaddus, M Kolonin, SC Mok, MS Thompson, WA Woodward, K Lu, B Salimian, D Nagrath, AH Klopp, P Rameshwar |
PloS one | 2013 |
An Adenovirus Vector Incorporating Carbohydrate Binding Domains Utilizes Glycans for Gene Transfer
JW Kim, JN Glasgow, M Nakayama, F Ak, H Ugai, DT Curiel, CC Dash |
PloS one | 2013 |
Screening for Familial Ovarian Cancer: A Ray of Hope and a Light to Steer by
KC Long, ND Kauff |
Journal of Clinical Oncology | 2013 |
Painless ascites and elevated CA125: initial presentation of lupus-associated protein-losing enteropathy
CS Ong, TE Cheah, R Jasmin, F Yahya, S Sockalingam, CT Ng |
Lupus | 2013 |
Saliva CA125 and TPS Levels in Patients with Oral Squamous Cell Carcinoma
X Geng, M Du, J Han, M Zhang, X Tang, R Xing |
The International Journal of Biological Markers | 2013 |
An Immune AuRu Nanoalloy Probe for Trace CA125 Using Resonance Rayleigh Scattering as Detection Technique
ZL Jiang, ML Tang, AH Liang |
Advanced Materials Research | 2013 |
Gynecological Imaging
JN Buy, M Ghossain |
2013 | |
Non-coding RNAs and Cancer
M Fabbri |
2013 | |
Advances in Diagnosis and Management of Ovarian Cancer
SA Farghaly |
2013 | |
Reflection on the Discovery of Carcinoembryonic Antigen, Prostate-Specific Antigen, and Cancer Antigens CA125 and CA19-9
EP Diamandis, RC Bast, P Gold, TM Chu, JL Magnani |
Clinical chemistry | 2013 |
CA-125 AS A SURROGATE MARKER IN A CLINICAL AND HISTOPATHOLOGICAL STUDY OF PELVIC MASS AT A TERTIARY CARE HOSPITAL
M Kulkarni, A Bhandiwad, S R, S Sumangala |
2013 | |
The Mucin MUC16 (CA125) Binds to NK Cells and Monocytes from Peripheral Blood of Women with Healthy Pregnancy and Preeclampsia
C Tyler, A Kapur, M Felder, JA Belisle, C Trautman, JA Gubbels, JP Connor, MS Patankar |
American Journal of Reproductive Immunology | 2012 |
TAp73-Mediated the Activation of C-Jun N-Terminal Kinase Enhances Cellular Chemosensitivity to Cisplatin in Ovarian Cancer Cells
P Zhang, SS Liu, HY Ngan |
PloS one | 2012 |
Specificity and prognostic validation of a polyclonal antibody to detect Six1 homeoprotein in ovarian cancer
L Qamar, E Deitsch, AN Patrick, MD Post, MA Spillman, R Iwanaga, A Thorburn, HL Ford, K Behbakht |
Gynecologic Oncology | 2012 |
Protein biomarkers of ovarian cancer: the forest and the trees
BM Nolen, AE Lokshin |
Future Oncology | 2012 |
Performance of a multianalyte test as an aid for the diagnosis of ovarian cancer in symptomatic women
DJ Autelitano, L Raineri, K Knight, K Bannister, GE Rice |
Journal of Translational Medicine | 2012 |
DNA profiling analysis of endometrial and ovarian cell lines reveals misidentification, redundancy and contamination
C Korch, MA Spillman, TA Jackson, BM Jacobsen, SK Murphy, BA Lessey, VC Jordan, AP Bradford |
Gynecologic Oncology | 2012 |
Combined panel of serum human tissue kallikreins and CA-125 for the detection of epithelial ovarian cancer
SC Koh, CY Huak, D Lutan, J Marpuang, S Ketut, NG Budiana, AZ Saleh, MF Aziz, H Winarto, H Pradjatmo, NK Hoan, PV Thanh, M Choolani |
Journal of Gynecologic Oncology | 2012 |
Detection of biomarkers using recombinant antibodies coupled to nanostructured platforms
MR Kierny, TD Cunningham, BK Kay |
Nano Reviews | 2012 |
Deciphering the Molecular Nature of Ovarian Cancer Biomarker CA125
F Weiland, K Martin, MK Oehler, P Hoffmann |
International journal of molecular sciences | 2012 |
IGFBP-4 tumor and serum levels are increased across all stages of epithelial ovarian cancer
RA Mosig, M Lobl, E Senturk, H Shah, S Cohen, E Chudin, R Fruscio, S Marchini, M D'Incalci, R Sachidanandam, P Dottino, JA Martignetti |
Journal of Ovarian Research | 2012 |
Evaluation and Management of Women Presenting with a Pelvic Mass
S MacLaughlan, B Cronin, RG Moore |
Current Obstetrics and Gynecology Reports | 2012 |
Epigenetic biomarkers in epithelial ovarian cancer
BS Gloss, G Samimi |
Cancer Letters | 2012 |
Ovarian Cancer Screening :
JO van NAGELL, EJ Pavlik |
Clinical Obstetrics & Gynecology | 2012 |
Parallel factor analysis of ovarian autofluorescence as a cancer diagnostic
R George, M Michaelides, MA Brewer, U Utzinger |
Lasers in Surgery and Medicine | 2012 |
Different Levels of Sialyl-Tn Antigen Expressed on MUC16 in Patients With Endometriosis and Ovarian Cancer :
K Akita, S Yoshida, Y Ikehara, S Shirakawa, M Toda, M Inoue, J Kitawaki, H Nakanishi, H Narimatsu, H Nakada |
International Journal of Gynecological Cancer | 2012 |
Serum IgG-Like Glycoferroprotein: Identifi cation of Its Final Dissociation Form of Thermostable Protein Coupled with Albumin
PG Prokopenko, VS Poltoranina, VM Shelepova, AA Terent’ev |
Bulletin of Experimental Biology and Medicine | 2012 |
Ovarian cancer: role of ultrasound in preoperative diagnosis and population screening
S Campbell |
Ultrasound in Obstetrics & Gynecology | 2012 |
Overcoming soluble target interference in an anti-therapeutic antibody screening assay for an antibody–drug conjugate therapeutic
M Carrasco-Triguero, C Mahood, M Milojic-Blair, C Amaya, J Ruppel, K Hong, JH Yi, S Kaur |
Bioanalysis | 2012 |
Flow cytometric determination of stem/progenitor content in epithelial tissues: An example from nonsmall lung cancer and normal lung
VS Donnenberg, RJ Landreneau, ME Pfeifer, AD Donnenberg |
Cytometry Part A | 2012 |
An Electronic Sensor for Detection of Early-Stage Biomarker/s for Ovarian Cancer
AM Whited, KV Singh, D Evans, R Solanki |
BioNanoScience | 2012 |
New label free CA125 detection based on gold nanostructured screen-printed electrode
A Ravalli, GP Santos, M Ferroni, G Faglia, H Yamanaka, G Marrazza |
Sensors and Actuators B: Chemical | 2012 |
From bench to bedside: discovery of ovarian cancer biomarkers using high-throughput technologies in the past decade
F Leung, EP Diamandis, V Kulasingam |
Biomarkers in Medicine | 2012 |
Detection and Monitoring of Ovarian Cancer
Z Su, WS Graybill, Y Zhu |
Clinica Chimica Acta | 2012 |
Nanocarriers for the targeted treatment of ovarian cancers
J Tomasina, S Lheureux, P Gauduchon, S Rault, A Malzert-Fréon |
Biomaterials | 2012 |
NOT THAT RIGID MIDGETS AND NOT SO FLEXIBLE GIANTS: ON THE ABUNDANCE AND ROLES OF INTRINSIC DISORDER IN SHORT AND LONG PROTEINS
M Howell, R Green, A Killeen, L Wedderburn, V Picascio, A Rabionet, Z Peng, M Larina, B Xue, L Kurgan, VN Uversky |
Journal of Biological Systems | 2012 |
Methods for Identification of CA125 from Ovarian Cancer Ascites by High Resolution Mass Spectrometry
F Weiland, K Fritz, MK Oehler, P Hoffmann |
International journal of molecular sciences | 2012 |
Ovarian Cyst Enlargement in a 14 Year Old Female with Persistent Ascities, Severe Hypothyroidism and Elevated Serum CA-125 Level
F Motamed, K Eftekhari, MA Kiani, A Rabbani |
Iranian Red Crescent Medical Journal | 2012 |
The immunomodulating roles of glycoproteins in epithelial ovarian cancer
Manish S. Patankar, Jennifer A.A. Gubbels, Mildred Felder, Joseph P. Connor |
Frontiers in bioscience (Elite edition) | 2012 |
Antibody-Drug Conjugates and Immunotoxins
GL Phillips |
2012 | |
Cystic Fibrosis
MD Amaral, K Kunzelmann |
Cystic Fibrosis | 2011 |
Cystic Fibrosis
MD Amaral, K Kunzelmann |
Cystic Fibrosis | 2011 |
Cystic Fibrosis
MD Amaral, K Kunzelmann |
Cystic Fibrosis | 2011 |
Cystic Fibrosis
MD Amaral, K Kunzelmann |
Cystic Fibrosis | 2011 |
Cystic Fibrosis
MD Amaral, K Kunzelmann |
Cystic Fibrosis | 2011 |
Cystic Fibrosis
MD Amaral, K Kunzelmann |
Cystic Fibrosis | 2011 |
Cystic Fibrosis
MD Amaral, K Kunzelmann |
Cystic Fibrosis | 2011 |
Cystic Fibrosis
MD Amaral, K Kunzelmann |
Cystic Fibrosis | 2011 |
Cystic Fibrosis
MD Amaral, K Kunzelmann |
Cystic Fibrosis | 2011 |
Cystic Fibrosis
MD Amaral, K Kunzelmann |
Cystic Fibrosis | 2011 |
Cystic Fibrosis
MD Amaral, K Kunzelmann |
Cystic Fibrosis | 2011 |
Cystic Fibrosis
MD Amaral, K Kunzelmann |
Cystic Fibrosis | 2011 |
Cystic Fibrosis
MD Amaral, K Kunzelmann |
Cystic Fibrosis | 2011 |
Cystic Fibrosis
MD Amaral, K Kunzelmann |
Cystic Fibrosis | 2011 |
Cystic Fibrosis
MD Amaral, K Kunzelmann |
Cystic Fibrosis | 2011 |
Cystic Fibrosis
MD Amaral, K Kunzelmann |
Cystic Fibrosis | 2011 |
Cystic Fibrosis
MD Amaral, K Kunzelmann |
Cystic Fibrosis | 2011 |
Cystic Fibrosis
MD Amaral, K Kunzelmann |
Cystic Fibrosis | 2011 |
Cystic Fibrosis
MD Amaral, K Kunzelmann |
Cystic Fibrosis | 2011 |
Prognostic biomarkers in ovarian cancer
J Huang, W Hu, AK Sood |
Cancer biomarkers : section A of Disease markers | 2011 |
Regulation of ovarian cancer progression by microRNA-187 through targeting Disabled homolog-2
A Chao, CY Lin, YS Lee, CL Tsai, PC Wei, S Hsueh, TI Wu, CN Tsai, CJ Wang, AS Chao, TH Wang, CH Lai |
Oncogene | 2011 |
Gynecologic Oncology
A Vasilev, S Vasilev |
Gynecologic Oncology | 2011 |
Advances in Clinical Chemistry
M Mahler |
Advances in Clinical Chemistry Volume 54 | 2011 |
Downregulation of cell surface CA125/MUC16 induces epithelial-to-mesenchymal transition and restores EGFR signalling in NIH:OVCAR3 ovarian carcinoma cells
M Comamala, M Pinard, C Thériault, I Matte, A Albert, M Boivin, J Beaudin, A Piché, C Rancourt |
British Journal of Cancer | 2011 |
The impact of sample storage time on estimates of association in biomarker discovery studies
KG Kugler, WO Hackl, LA Mueller, H Fiegl, A Graber, RM Pfeiffer |
Journal of Clinical Bioinformatics | 2011 |
No benefit from combining HE4 and CA125 as ovarian tumor markers in a clinical setting
F Jacob, M Meier, R Caduff, D Goldstein, T Pochechueva, N Hacker, D Fink, V Heinzelmann-Schwarz |
Gynecologic Oncology | 2011 |
More than a biomarker: CA125 may contribute to ovarian cancer pathogenesis
RC Bast, DR Spriggs |
Gynecologic Oncology | 2011 |
Soluble MUC1 and serum MUC1-specific antibodies are potential prognostic biomarkers for platinum-resistant ovarian cancer
RA Budiu, G Mantia-Smaldone, E Elishaev, T Chu, J Thaller, K McCabe, D Lenzner, RP Edwards, AM Vlad |
Cancer Immunology, Immunotherapy | 2011 |
Meigs’ syndrome with elevated serum cancer antigen 125 levels in a case of ovarian sclerosing stromal tumor
JH Liou, TC Su, JC Hsu |
Taiwanese Journal of Obstetrics and Gynecology | 2011 |
Granulin: Biomarker or Interesting Window into Host/tumor Biology?
EM Swisher |
Gynecologic Oncology | 2011 |
Progesterone inhibits growth and induces apoptosis in cancer cells through modulation of reactive oxygen species
H Nguyen, V Syed |
Gynecological Endocrinology | 2011 |
Immune Therapy for Ovarian Cancer: Promise and Pitfalls
SR Thibodeaux, TJ Curiel |
International Reviews of Immunology | 2011 |
Exploring the immunoproteome for ovarian cancer biomarker discovery
K Martin, C Ricciardelli, P Hoffmann, MK Oehler |
International journal of molecular sciences | 2011 |
Ovarian cancer screening and early detection in the general population
JA Rauh-Hain, TC Krivak, MG Carmen, AB Olawaiye |
Reviews in obstetrics and gynecology | 2011 |
HN125: A Novel Immunoadhesin Targeting MUC16 with Potential for Cancer Therapy
X Xiang, M Feng, M Felder, JP Connor, YG Man, MS Patankar, M Ho |
Journal of Cancer | 2011 |
CA125—A Test with a Change of Heart
KA Sikaris |
Heart Lung and Circulation | 2011 |
Human epididymis protein 4 reference limits and natural variation in a Nordic reference population
N Bolstad, M Øijordsbakken, K Nustad, J Bjerner |
Tumor Biology | 2011 |
Serum levels of the ovarian cancer biomarker HE4 are decreased in pregnancy and increase with age
RG Moore, MC Miller, EE Eklund, KH Lu, RC Bast, G Lambert-Messerlian |
American Journal of Obstetrics and Gynecology | 2011 |
A családi halmozódású petefészekrák genetikai és onkológiai ellátása
JG Joó, S Ládi, BZ Nagy, Z Langmár |
Orvosi Hetilap | 2011 |
Serum HE4 levels are less frequently elevated than CA125 in women with benign gynecologic disorders
RG Moore, MC Miller, MM Steinhoff, SJ Skates, KH Lu, G Lambert-Messerlian, RC Bast |
American Journal of Obstetrics and Gynecology | 2011 |
Improved blood tests for cancer screening: general or specific?
IA Cree |
BMC Cancer | 2011 |
Immunohistology of Lung and Pleural Neoplasms
SP Hammar, S Dacic |
Diagnostic Immunohistochemistry | 2011 |
Co-Expression of Mesothelin and CA125 Correlates With Unfavorable Patient Outcome in Pancreatic Ductal Adenocarcinoma :
H Kamachi, H Nishihara, S Homma, H Kanno, K Takahashi, A Sasaki, T Einama, M Tahara, K Okada, S Muraoka |
Pancreas | 2011 |
Mucins in human neoplasms: Clinical pathology, gene expression and diagnostic application : Mucins in human neoplasms
S Yonezawa, M Higashi, N Yamada, S Yokoyama, S Kitamoto, S Kitajima, M Goto |
Pathology International | 2011 |
Advances in Cancer Research
M Lemaire, S Deleu, ED Bruyne, EV Valckenborgh, E Menu, K Vanderkerken |
Advances in Cancer Research Volume 110 | 2011 |
A novel high affinity human monoclonal antibody to mesothelin
M Ho, M Feng, RJ Fisher, C Rader, I Pastan |
International Journal of Cancer | 2011 |
Aberrant glycosylation associated with enzymes as cancer biomarkers
DL Meany, DW Chan |
Clinical Proteomics | 2011 |
fTwo novel biomarkers, mesothelin and HE4, for diagnosis of ovarian carcinoma
I Hellstrom, KE Hellstrom |
Expert Opinion on Medical Diagnostics | 2011 |
Can Ovarian Cancer Screening Save Lives? : The Question Remains Unanswered
&NA; |
Obstetrics and gynecology | 2011 |
The Management of Anxiety and Knowledge of Serum CA-125 After an Ovarian Cancer Diagnosis
A Reid, E Ercolano, P Schwartz, R McCorkle |
Clinical Journal of Oncology Nursing | 2011 |
Follow-up with CA125 after primary therapy of advanced ovarian cancer: in favor of continuing to prescribe CA125 during follow-up
S Pignata, L Cannella, D Leopardo, GS Bruni, G Facchini, C Pisano |
Annals of Oncology | 2011 |
Incorporation of Bevacizumab in the Primary Treatment of Ovarian Cancer
RA Burger, MF Brady, MA Bookman, GF Fleming, BJ Monk, H Huang, RS Mannel, HD Homesley, J Fowler, BE Greer, M Boente, MJ Birrer, SX Liang |
New England Journal of Medicine | 2011 |
Il carcinoma ovarico: nuove acquisizioni sulla patogenesi e nella diagnostica di laboratorio
S Orciari, C Micucci, AD Procopio, R Testa, A Catalano |
La Rivista Italiana della Medicina di Laboratorio - Italian Journal of Laboratory Medicine | 2011 |
The Past, Present, and Future of Biomarkers: A Need for Molecular Beacons for the Clinical Management of Pancreatic Cancer
JR Brody, AK Witkiewicz, CJ Yeo |
Advances in Surgery | 2011 |
Co-Expression of Mesothelin and CA125 Correlates With Unfavorable Patient Outcome in Pancreatic Ductal Adenocarcinoma:
T Einama, H Kamachi, H Nishihara, S Homma, H Kanno, K Takahashi, A Sasaki, M Tahara, K Okada, S Muraoka, T Kamiyama, Y Matsuno, M Ozaki, S Todo |
Pancreas | 2011 |
Diagnostic Immunohistochemistry
SP Hammar, S Dacic |
Diagnostic Immunohistochemistry | 2011 |
Can Ovarian Cancer Screening Save Lives?: The Question Remains Unanswered
&NA; |
Obstetrics & Gynecology | 2011 |
Q: Can I be screened for ovarian cancer?:
HM Felix |
Journal of the American Academy of Physician Assistants | 2011 |
An Atlas of Gynecologic Oncology: Investigation and Surgery, Third Edition
R Manchanda, I Jacobs, U Menon |
An Atlas of Gynecologic Oncology: Investigation and Surgery, Third Edition | 2011 |
Determination of CA-125 levels in the serum, cervical and vaginal secretions, and endometrium in Chinese women with precancerous disease or endometrial cancer
SM He, F Xing, H Sui, Y Wu, Y Wang, D Wang, G Chen, Z Kong, SF Zhou |
Medical science monitor : international medical journal of experimental and clinical research | 2011 |
Prognostic and predictive relevance of CA-125 at primary surgery of ovarian cancer
D Mury, L Woelber, S Jung, C Eulenburg, M Choschzick, I Witzel, J Schwarz, F Jaenicke, S Mahner |
Journal of Cancer Research and Clinical Oncology | 2011 |
The Role of Proteomics in the Diagnosis and Treatment of Women's Cancers: Current Trends in Technology and Future Opportunities
EK Breuer, MM Murph |
International Journal of Proteomics | 2011 |
Pathobiological Implications of MUC16 Expression in Pancreatic Cancer
D Haridas, S Chakraborty, MP Ponnusamy, I Lakshmanan, S Rachagani, E Cruz, S Kumar, S Das, SM Lele, JM Anderson, UA Wittel, MA Hollingsworth, SK Batra, RK Srivastava |
PloS one | 2011 |
125 Jahre Deutsche Gesellschaft für Gynäkologie und Geburtshilfe
R Kreienberg, H Ludwig |
2011 | |
Challenges Related to Developing Serum-Based Biomarkers for Early Ovarian Cancer Detection: Table 1
PL Mai, N Wentzensen, MH Greene |
Cancer prevention research (Philadelphia, Pa.) | 2011 |
Stress-induced Phosphoprotein 1 as a Secreted Biomarker for Human Ovarian Cancer Promotes Cancer Cell Proliferation*
TH Wang, A Chao, CL Tsai, CL Chang, SH Chen, YS Lee, JK Chen, YJ Lin, PY Chang, CJ Wang, AS Chao, SD Chang, TC Chang, CH Lai, HS Wang |
Molecular & cellular proteomics : MCP | 2010 |
Hormonal Regulation and Distinct Functions of Semaphorin-3B and Semaphorin-3F in Ovarian Cancer
D Joseph, SM Ho, V Syed |
Molecular cancer therapeutics | 2010 |
Ovarian cancer immunotherapy: opportunities, progresses and challenges
B Liu, J Nash, C Runowicz, H Swede, R Stevens, Z Li |
Journal of Hematology & Oncology | 2010 |
Comparison of total plasma lysophosphatidic acid and serum CA-125 as a tumor marker in the diagnosis and follow-up of patients with epithelial ovarian cancer
T Bese, M Barbaros, E Baykara, O Guralp, S Cengiz, F Demirkiran, C Sanioglu, M Arvas |
Journal of Gynecologic Oncology | 2010 |
Current state of biomarker development for clinical application in epithelial ovarian cancer
RG Moore, S MacLaughlan, RC Bast |
Gynecologic Oncology | 2010 |
Ovarian cancer: the duplicity of CA125 measurement
AK Karam, BY Karlan |
Nature Reviews Clinical Oncology | 2010 |
Inhibition of mesothelin–CA-125 interaction in patients with mesothelioma by the anti-mesothelin monoclonal antibody MORAb-009: Implications for cancer therapy
R Hassan, C Schweizer, KF Lu, B Schuler, AT Remaley, SC Weil, I Pastan |
Lung Cancer | 2010 |
Synthesis and structural characterization of the peptide epitope of the ovarian cancer biomarker CA125 (MUC16)
ZT Berman, LJ Moore, KE Knudson, RJ Whelan |
Tumor Biology | 2010 |
Measuring the intra-individual variability of the plasma proteome in the chicken model of spontaneous ovarian adenocarcinoma
AM Hawkridge, RB Wysocky, JN Petitte, KE Anderson, PE Mozdziak, OJ Fletcher, JM Horowitz, DC Muddiman |
Analytical and Bioanalytical Chemistry | 2010 |
Rational application of tumor marker CA 125 in gynecological oncology
S Djurdjevic, S Stojanovic, M Basta-Nikolic, M Maksimovic |
Medicinski pregled | 2010 |
ElevatedMALexpression is accompanied by promoter hypomethylation and platinum resistance in epithelial ovarian cancer
PS Lee, VS Teaberry, AE Bland, Z Huang, RS Whitaker, T Baba, S Fujii, AA Secord, A Berchuck, SK Murphy |
International Journal of Cancer | 2010 |
From the endometrium physiology to a comprehensive strategy for the discovery of ovarian cancer biomarkers
JL Tanyi, N Scholler |
Oncology Reviews | 2010 |
Curcumin suppresses constitutive activation of STAT-3 by up-regulating protein inhibitor of activated STAT-3 (PIAS-3) in ovarian and endometrial cancer cells
M Saydmohammed, D Joseph, V Syed |
Journal of Cellular Biochemistry | 2010 |
Novel targeting strategies using recombinant antibodies for early diagnosis and therapy of ovarian cancer
N Scholler |
Therapy | 2010 |
CA125 nadir concentration is an independent predictor of tumor recurrence in patients with ovarian cancer: A population-based study
AM van Altena, E Kolwijck, MJ Spanjer, JC Hendriks, LF Massuger, JA de Hullu |
Gynecologic Oncology | 2010 |
Current clinical use of biomarkers for epithelial ovarian cancer
RG Moore, S MacLaughlan |
Current Opinion in Oncology | 2010 |
Prognostic value of serum CA125 levels in diffuse large B-cell lymphoma: potential role of a new sex- and age-adjusted reference value
A Gutiérrez, J Martínez-Serra, B Barceló, A Sampol, L Viñas, G González, MD Bea, JC Amat, J Martín, R Ramos, A Bautista, J Forteza-Rey, J Rodríguez, J Besalduch |
International Journal of Laboratory Hematology | 2010 |
Cancer antigen 125 level after a bilateral salpingo-oophorectomy
AM van Altena, H Holtsema, JC Hendriks, LF Massuger, JA de Hullu |
Menopause | 2010 |
Differential Expression of Hypoxia-Inducible Protein 2 Among Different Histological Types of Epithelial Ovarian Cancer and in Clear Cell Adenocarcinomas
S Nishimura, H Tsuda, K Ito, M Takano, Y Terai, T Jobo, J Kigawa, T Sugiyama, N Yaegashi, D Aoki |
International Journal of Gynecological Cancer | 2010 |
Sorafenib in Combination With Gemcitabine in Recurrent Epithelial Ovarian Cancer
SA Welch, HW Hirte, L Elit, RJ Schilder, L Wang, K MacAlpine, JJ Wright, AM Oza |
International Journal of Gynecological Cancer | 2010 |
Production and Characterization of Monoclonal Antibodies against the Extracellular Domain of CA 125
S Shojaeian, A Allameh, AH Zarnani, M Chamankhah, R Ghods, AA Bayat, M Jeddi-Tehrani |
Immunological Investigations | 2010 |
Identification of Siglec-9 as the receptor for MUC16 on human NK cells, B cells, and monocytes
JA Belisle, S Horibata, GA Jennifer, S Petrie, A Kapur, S André, HJ Gabius, C Rancourt, J Connor, JC Paulson, MS Patankar |
Molecular Cancer | 2010 |
Pelvic mass associated with raised CA 125 for benign condition: a case report
V Asher, R Hammond, TJ Duncan |
World journal of surgical oncology | 2010 |
Serum tumour markers in gynaecological cancers
P Aggarwal, S Kehoe |
Maturitas | 2010 |
Molecular Signatures of Ovarian Cancer: From Detection to Prognosis
CS Walsh, BY Karlan |
Molecular diagnosis & therapy | 2010 |
Elevated MAL expression is accompanied by promoter hypomethylation and platinum resistance in epithelial ovarian cancer
PS Lee, VS Teaberry, AE Bland, Z Huang, RS Whitaker, T Baba, S Fujii, AA Secord, A Berchuck, SK Murphy |
International Journal of Cancer | 2010 |
Current clinical use of biomarkers for epithelial ovarian cancer:
RG Moore, S MacLaughlan |
Current Opinion in Oncology | 2010 |
Cancer antigen 125 level after a bilateral salpingo-oophorectomy: what is the contribution of the ovary to the cancer antigen 125 level?
AM van Altena, H Holtsema, JC Hendriks, LF Massuger, JA de Hullu |
Menopause | 2010 |
Differential Expression of Hypoxia-Inducible Protein 2 Among Different Histological Types of Epithelial Ovarian Cancer and in Clear Cell Adenocarcinomas:
S Nishimura, H Tsuda, K Ito, M Takano, Y Terai, T Jobo, J Kigawa, T Sugiyama, N Yaegashi, D Aoki |
International Journal of Gynecological Cancer | 2010 |
Sorafenib in Combination With Gemcitabine in Recurrent Epithelial Ovarian Cancer: A Study of the Princess Margaret Hospital Phase II Consortium
SA Welch, HW Hirte, L Elit, RJ Schilder, L Wang, K MacAlpine, JJ Wright, AM Oza |
International Journal of Gynecological Cancer | 2010 |
The predictive efficacy of maternal serum CA125 in intrauterine early pregnancy with vaginal bleeding
JY Chung, CS Moon |
Korean Journal of Obstetrics and Gynecology | 2010 |
Novel Monoclonal Antibodies Against the Proximal (Carboxy-Terminal) Portions of MUC16:
TD Rao, KJ Park, P Smith-Jones, A Iasonos, I Linkov, RA Soslow, DR Spriggs |
Applied Immunohistochemistry & Molecular Morphology | 2010 |
Prognostic Biomarkers in Ovarian Cancer
J Huang, W Hu, AK Sood |
Cancer biomarkers : section A of Disease markers | 2010 |
Selective removal of ovarian cancer cells from human ascites fluid using magnetic nanoparticles
KE Scarberry, EB Dickerson, ZJ Zhang, BB Benigno, JF McDonald |
Nanomedicine: Nanotechnology, Biology and Medicine | 2010 |
Epithelial Membrane Protein-2 Is a Novel Therapeutic Target in Ovarian Cancer
M Fu, EL Maresh, RA Soslow, M Alavi, V Mah, Q Zhou, A Iasonos, L Goodglick, LK Gordon, J Braun, M Wadehra |
Clinical cancer research | 2010 |
Pulmonary surfactant: an immunological perspective
ZC Chroneos, Z Sever-Chroneos, VL Shepherd |
Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology | 2009 |
Mucins in cancer: function, prognosis and therapy
DW Kufe |
Nature Reviews Cancer | 2009 |
Genomic and proteomic biomarkers for cancer: A multitude of opportunities
MA Tainsky |
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer | 2009 |
General and Applied Toxicology
TC Marrs, S Warren |
General and Applied Toxicology | 2009 |
The utility of serum human epididymis protein 4 (HE4) in patients with a pelvic mass
M Montagnana, G Lippi, O Ruzzenente, V Bresciani, E Danese, S Scevarolli, GL Salvagno, S Giudici, M Franchi, GC Guidi |
Journal of Clinical Laboratory Analysis | 2009 |
Generation of CA125-specific cytotoxic T lymphocytes in human leukocyte antigen-A2.1-positive healthy donors and patients with advanced ovarian cancer
S Bellone, S Anfossi, TJ O'Brien, MJ Cannon, DA Silasi, M Azodi, PE Schwartz, TJ Rutherford, S Pecorelli, AD Santin |
American Journal of Obstetrics and Gynecology | 2009 |
Beyond CA125: the coming of age of ovarian cancer biomarkers
D Sasaroli, G Coukos, N Scholler |
Biomarkers in Medicine | 2009 |
Exploratory analysis of serum CA-125 response to surgery and the risk of relapse in patients with FIGO stage IIIC ovarian cancer
O Zivanovic, CS Sima, A Iasonos, KM Bell-McGuinn, PJ Sabbatini, MM Leitao, DA Levine, GJ Gardner, RR Barakat, DS Chi |
Gynecologic Oncology | 2009 |
A Gynecologic Oncology Group Study of serum CA-125 levels in patients with stage III optimally debulked ovarian cancer treated with intraperitoneal compared to intravenous chemotherapy: An analysis of patients enrolled in GOG 172
TC Krivak, C Tian, GS Rose, DK Armstrong, GL Maxwell |
Gynecologic Oncology | 2009 |
The prognostic value of pretreatment CA 125 in patients with advanced ovarian carcinoma
KK Zorn, C Tian, WP McGuire, WJ Hoskins, M Markman, FM Muggia, PG Rose, RF Ozols, D Spriggs, DK Armstrong |
Cancer | 2009 |
N-Acetylglucosamine 6-O-sulfotransferase-2 as a tumor marker for uterine cervical and corpus cancer
A Seko, F Kataoka, D Aoki, M Sakamoto, T Nakamura, M Hatae, S Yonezawa, K Yamashita |
Glycoconjugate Journal | 2009 |
Preclinical studies and clinical utilization of monoclonal antibodies in epithelial ovarian cancer
PJ Frederick, JM Straughn, RD Alvarez, DJ Buchsbaum |
Gynecologic Oncology | 2009 |
OC-125 immunostaining in endometriotic lesion samples
CP Barbosa, ÂM Souza, B Bianco, DM Christofolini, FA Mafra, GR Lima |
Archives of Gynecology and Obstetrics | 2009 |
Predicting the Response of Advanced Cervical and Ovarian Tumors to Therapy
VN Harry, FJ Gilbert, DE Parkin |
Obstetrical & Gynecological Survey | 2009 |
Meigs' Syndrome with Elevated Serum CA125: Case Report and Review of the Literature
M Benjapibal, S Sangkarat, S Laiwejpithaya, B Viriyapak, P Chaopotong, A Jaishuen |
Case reports in oncology | 2009 |
Identification of Mac-2-binding protein as a putative marker of neuroendocrine tumors from the analysis of cell line secretomes
R Srirajaskanthan, ME Caplin, MG Waugh, J Watkins, T Meyer, JJ Hsuan, NJ Beaumont |
Molecular & cellular proteomics : MCP | 2009 |
Role of CA125 in predicting ovarian cancer survival - a review of the epidemiological literature
D Gupta, CG Lis |
Journal of Ovarian Research | 2009 |
Ovarian cancer pathogenesis: a model in evolution
AM Karst, R Drapkin |
Journal of Oncology | 2009 |
HE4 as a biomarker for ovarian and endometrial cancer management
J Li, S Dowdy, T Tipton, K Podratz, WG Lu, X Xie, SW Jiang |
Expert Review of Molecular Diagnostics | 2009 |
Predicting the Response of Advanced Cervical and Ovarian Tumors to Therapy:
VN Harry, FJ Gilbert, DE Parkin |
Obstetrical & Gynecological Survey | 2009 |
Technological challenges of theranostics in oncology
HM Warenius |
Expert Opinion on Medical Diagnostics | 2009 |
The Clinical Utility of Tumor Markers
B Handy |
Laboratory Medicine | 2009 |
Methods of Cancer Diagnosis, Therapy, and Prognosis
MA Hayat |
2009 | |
Single Conducting Polymer Nanowire Chemiresistive Label-Free Immunosensor for Cancer Biomarker
MA Bangar, DJ Shirale, W Chen, NV Myung, A Mulchandani |
Analytical Chemistry | 2009 |
Differential methylation profile of ovarian cancer as a possible detection biomarker
Anatoliy A. Melnikov, Denise Scholtens, Andrew K. Godwin, Victor V. Levenson |
The Journal of Molecular Diagnostics | 2008 |
Proteomic contributions to personalized cancer care
JM Koomen, EB Haura, G Bepler, R Sutphen, ER Remily-Wood, K Benson, M Hussein, LA Hazlehurst, TJ Yeatman, LT Hildreth, TA Sellers, PB Jacobsen, DA Fenstermacher, WS Dalton |
Molecular & cellular proteomics : MCP | 2008 |
Lights and shadows of the tumoral marker CA-125 in ovarian cancer
AS Muñoz, AG Martín, CM Fernández |
Clinical and Translational Oncology | 2008 |
Distribution of mucins and antimicrobial substances lysozyme and lactoferrin in the laryngeal subglottic region
H Kutta, A Willer, P Steven, L Bräuer, M Tsokos, F Paulsen |
Journal of Anatomy | 2008 |
Significance of postoperative CA-125 decline after cytoreductive surgery in stage IIIC/IV ovarian cancer
SC Yoo, JH Yoon, MO Lyu, WY Kim, SJ Chang, KH Chang, HS Ryu |
Journal of Gynecologic Oncology | 2008 |
Early detection of ovarian cancer
PM Das, RC Bast |
Biomarkers in Medicine | 2008 |
Biomarkers in carcinoma of the gallbladder
P Rupesh, P Manoj, SV Kumar |
Expert Opinion on Medical Diagnostics | 2008 |
Alternative antibody for the detection of CA125 antigen: a European multicenter study for the evaluation of the analytical and clinical performance of the Access®OV Monitor assay on the UniCel®DxI 800 Immunoassay System
S Holdenrieder, R Molina, M Gion, A Gressner, F Troalen, JM Auge, M Zancan, M Wycislo, P Stieber |
Clinical Chemistry and Laboratory Medicine | 2008 |
Strategies for discovering novel cancer biomarkers through utilization of emerging technologies
V Kulasingam, EP Diamandis |
Nature Clinical Practice Oncology | 2008 |
Human monoclonal antibody for ovarian clear cell carcinoma-2, a human monoclonal antibody with antitumor activity against ovarian cancer cells that recognizes CA125-like antigen
N Suzuki, Y Tamada, K Shigirahara, A Suzuki, N Susumu, I Ishida, D Aoki |
International Journal of Gynecological Cancer | 2008 |
Cancer antigen 125 and prognosis
E Høgdall |
Current Opinion in Obstetrics and Gynecology | 2008 |
Characterization of three new serous epithelial ovarian cancer cell lines
V Ouellet, M Zietarska, L Portelance, J Lafontaine, J Madore, ML Puiffe, SL Arcand, Z Shen, J Hébert, PN Tonin, DM Provencher, AM Mes-Masson |
BMC Cancer | 2008 |
Evaluation of biomarker panels for early stage ovarian cancer detection and monitoring for disease recurrence
LJ Havrilesky, CM Whitehead, JM Rubatt, RL Cheek, J Groelke, Q He, DP Malinowski, TJ Fischer, A Berchuck |
Gynecologic Oncology | 2008 |
Utility of pre-operative serum CA-125 in the management of uterine papillary serous carcinoma
AB Olawaiye, JA Rauh-Hain, M Withiam-Leitch, B Rueda, A Goodman, MG Carmen |
Gynecologic Oncology | 2008 |
Proposed reference value of the CA 125 tumour marker in men. Potential applications in clinical practice
B Barceló, O Ayllón, M Belmonte, A Barceló, R Vidal, J Forteza-Rey, A Gutiérrez |
Clinical Biochemistry | 2008 |
Alternative antibody for the detection of CA125 antigen: a European multicenter study for the evaluation of the analytical and clinical performance of the Access ® OV Monitor assay on the UniCel ® DxI 800 Immunoassay System
S Holdenrieder, R Molina, M Gion, A Gressner, F Troalen, JM Auge, M Zancan, M Wycislo, P Stieber |
Clinical Chemistry and Laboratory Medicine | 2008 |
Cancer antigen 125 and prognosis:
E Høgdall |
Current Opinion in Obstetrics and Gynecology | 2008 |
Regulation of MUC16 by inflammatory mediators in ocular surface epithelial cell lines
F Paulsen, K Jäger, D Worlitzsch, L Bräuer, U Schulze, G Schäfer, S Sel |
Annals of Anatomy - Anatomischer Anzeiger | 2008 |
Abeloff's Clinical Oncology
ER Fearon, GT Bommer |
Abeloff's Clinical Oncology | 2008 |
MUC16 expression during embryogenesis, in adult tissues, and ovarian cancer in the mouse
Y Wang, DJ Cheon, Z Lu, SL Cunningham, CM Chen, RZ Luo, D Xing, S Orsulic, RC Bast, RR Behringer |
Differentiation | 2008 |
Proteomic Contributions to Personalized Cancer Care
JM Koomen, EB Haura, G Bepler, R Sutphen, ER Remily-Wood, K Benson, M Hussein, LA Hazlehurst, TJ Yeatman, LT Hildreth, TA Sellers, PB Jacobsen, DA Fenstermacher, WS Dalton |
Molecular & cellular proteomics : MCP | 2008 |
A Binding Domain on Mesothelin for CA125/MUC16
O Kaneko, L Gong, J Zhang, JK Hansen, R Hassan, B Lee, M Ho |
The Journal of biological chemistry | 2008 |
CA-125: A Marker for Diagnosis and Follow-Up of Pleuroperitoneal and Lymph Node Tuberculosis
AM Wani, M Akhtar |
Annals of Saudi medicine | 2008 |
CA-125: a marker for diagnosis and follow-up of pleuroperitoneal and lymph node tuberculosis
Abdul Majid Wani, Mubeena Akhtar |
Annals of Saudi medicine | 2008 |
National Academy of Clinical Biochemistry Laboratory Medicine Practice Guidelines for Use of Tumor Markers in Testicular, Prostate, Colorectal, Breast, and Ovarian Cancers
CM Sturgeon, MJ Duffy, UH Stenman, H Lilja, N Brünner, DW Chan, R Babaian, RC Bast, B Dowell, FJ Esteva, C Haglund, N Harbeck, DF Hayes, M Holten-Andersen, GG Klee, R Lamerz, LH Looijenga, R Molina, HJ Nielsen, H Rittenhouse, A Semjonow, IM Shih, P Sibley, G Sölétormos, C Stephan, L Sokoll, BR Hoffman, EP Diamandis |
Clinical chemistry | 2008 |
PEA-15 Induces Autophagy in Human Ovarian Cancer Cells and Is Associated with Prolonged Overall Survival
C Bartholomeusz, D Rosen, C Wei, A Kazansky, F Yamasaki, T Takahashi, H Itamochi, S Kondo, J Liu, NT Ueno |
Cancer research | 2008 |
Glycans as a Target in the Detection of Reproductive Tract Cancers
M Janković, M Kosanović, B Milutinović |
Journal of Medical Biochemistry | 2008 |
Contemporary progress in ovarian cancer screening
CS Walsh, BY Karlan |
Current Oncology Reports | 2007 |
Peritoneal lavage CEA/CA125 is a prognostic factor for gastric cancer patients
M Yamamoto, H Baba, Y Toh, T Okamura, Y Maehara |
Journal of Cancer Research and Clinical Oncology | 2007 |
Tumour markers: An overview
T Malati |
Indian Journal of Clinical Biochemistry | 2007 |
Development of a CA125-mesothelin cell adhesion assay as a screening tool for biologics discovery
N Scholler, B Garvik, M Hayden-Ledbetter, T Kline, N Urban |
Cancer Letters | 2007 |
MUC16 in the lacrimal apparatus
K Jäger, G Wu, S Sel, F Garreis, L Bräuer, FP Paulsen |
Histochemistry and Cell Biology | 2007 |
Peritoneal natural killer cells from epithelial ovarian cancer patients show an altered phenotype and bind to the tumour marker MUC16 (CA125)
JA Belisle, JA Gubbels, CA Raphael, M Migneault, C Rancourt, JP Connor, MS Patankar |
Immunology | 2007 |
CA125 in ovarian cancer
N Scholler, N Urban |
Biomarkers in Medicine | 2007 |
Analysis of the protein and glycan parts of CA125 antigen from human amniotic fluid
B Milutinovic, M Jankovic |
Archives of Biological Sciences | 2007 |
Transient Elevation of Serum Tumor Markers in a Patient with Hypothyroidism
N Takahashi, T Shimada, Y Ishibashi, N Oyake, Y Murakami |
The American Journal of the Medical Sciences | 2007 |
Specificity of Serum Tumor Markers (CA125, CEA, AFP, Beta HCG) in Ovarian Malignancies
RM ., KJ . |
Trends in Medical Research | 2007 |
Progesterone induces Apoptosis in TRAIL-resistant ovarian cancer cells by circumventing c-FLIPL overexpression
V Syed, K Mukherjee, S Godoy-Tundidor, SM Ho |
Journal of Cellular Biochemistry | 2007 |
Use of a novel 3D culture model to elucidate the role of mesothelial cells, fibroblasts and extra-cellular matrices on adhesion and invasion of ovarian cancer cells to the omentum
HA Kenny, T Krausz, SD Yamada, E Lengyel |
International Journal of Cancer | 2007 |
Ginkgo biloba and ovarian cancer prevention: Epidemiological and biological evidence
B Ye, M Aponte, Y Dai, L Li, MC Ho, A Vitonis, D Edwards, TN Huang, DW Cramer |
Cancer Letters | 2007 |
Metastatic colorectal adenocarcinoma involving the ovary with elevated serum CA125: A potential diagnostic pitfall
MR Lewis, ED Euscher, MT Deavers, EG Silva, A Malpica |
Gynecologic Oncology | 2007 |
CA125 expression pattern, prognosis and correlation with serum CA125 in ovarian tumor patients
EV Høgdall, L Christensen, SK Kjaer, J Blaakaer, A Kjærbye-Thygesen, S Gayther, IJ Jacobs, CK Høgdall |
Gynecologic Oncology | 2007 |
CA125: Megadaltons of novel opportunities
O Dorigo, JS Berek |
Gynecologic Oncology | 2007 |
Modulation of CA-125 tumor marker shedding in ovarian cancer cells by erlotinib or cetuximab
C Marth, D Egle, D Auer, J Rössler, AG Zeimet, I Vergote, G Daxenbichler |
Gynecologic Oncology | 2007 |
Use of high density antibody arrays to validate and discover cancer serum biomarkers
CM Loch, AB Ramirez, Y Liu, CL Sather, JJ Delrow, N Scholler, BM Garvik, ND Urban, MW McIntosh, PD Lampe |
Molecular Oncology | 2007 |
Assay of mucins in human tear fluid
S Spurr-Michaud, P Argüeso, I Gipson |
Experimental Eye Research | 2007 |
Differential expression of ABCF2 protein among different histologic types of epithelial ovarian cancer and in clear cell adenocarcinomas of different organs
S Nishimura, H Tsuda, K Ito, T Jobo, N Yaegashi, T Inoue, T Sudo, RS Berkowitz, SC Mok |
Human Pathology | 2007 |
Current Management Strategies for Ovarian Cancer
GD Aletti, MM Gallenberg, WA Cliby, A Jatoi, LC Hartmann |
Mayo Clinic Proceedings | 2007 |
Transient Elevation of Serum Tumor Markers in a Patient with Hypothyroidism:
N Takahashi, T Shimada, Y Ishibashi, N Oyake, Y Murakami |
The American Journal of the Medical Sciences | 2007 |
Long-term follow-up study on the role of serum CA-125 as a prognostic factor in 221 newly diagnosed patients with Hodgkin's lymphoma
F Russo, S Lastoria, G Svanera, G Capobianco, A Chiara, R Francia, E Squame, F Martinis, A Pinto |
Leukemia & Lymphoma | 2007 |
Management of asymptomatic patients on follow-up for ovarian cancer with rising CA-125 concentrations
TI Goonewardene, MR Hall, GJ Rustin |
The Lancet Oncology | 2007 |
Tumor Markers In Biological Fluids Associated With Pregnancy
A Sarandakou, E Protonotariou, D Rizos |
Critical Reviews in Clinical Laboratory Sciences | 2007 |
Biochemical recurrent ovarian cancer: CA 125 elevation without symptoms or clinical evidence of disease. What is the optimal management?
E Berry, JA Hurteau |
The Women's Oncology Review | 2007 |
Immunologic Approaches to Ovarian Cancer Treatment
P Sabbatini, K Odunsi |
Journal of Clinical Oncology | 2007 |
How Do You Distinguish a Malignant Pelvic Mass From a Benign Pelvic Mass? Imaging, Biomarkers, or None of the Above
RG Moore, RC Bast |
Journal of Clinical Oncology | 2007 |
Molecular Pathology of Gynecologic Cancer
A Giordano, A Bovicelli, RJ Kurman |
2007 | |
Cancer Prevention
HJ Senn, U Kapp |
2007 | |
Myxedema Ascites with an Extremely Elevated CA125 Level: A Case Report
H KANEHARA, Y BANDO, M TOMITA, M KONTANI, Y TAKEGOSHI, N TANAKA |
Endocrine Journal | 2007 |
Complement-inhibiting effect of ovarian cancer antigen CA-125
WJ Murdoch, EA van Kirk, AM Smedts |
Cancer Letters | 2006 |
Preoperative CA125 as a prognostic factor in stage I epithelial ovarian cancer
AL Petri, E Hogdall, IJ Christensen, SK Kjaer, J Blaakaer, CK Hogdall |
APMIS | 2006 |
Aberrant expression of MUC4 in ovarian carcinoma: diagnostic significance alone and in combination with MUC1 and MUC16 (CA125)
SC Chauhan, AP Singh, F Ruiz, SL Johansson, M Jain, LM Smith, N Moniaux, SK Batra |
Modern Pathology | 2006 |
A new generation of carbohydrate-based therapeutics: recombinant mucin-type fusion proteins as versatile inhibitors of protein-carbohydrate interactions
A Gustafsson, J Holgersson |
Expert Opinion on Drug Discovery | 2006 |
Screening for Ovarian Cancer
AN Rosenthal, U Menon, IJ Jacobs |
Clinical Obstetrics and Gynecology | 2006 |
Immunohistochemical characterization of cancer antigen in uterine cancers
S Nur, L Chuang, G Ramaswamy |
International Journal of Gynecological Cancer | 2006 |
Circulating CA125 in Patients with Peritoneal Mesothelioma Treated with Cytoreductive Surgery and Intraperitoneal Hyperthermic Perfusion
D Baratti, S Kusamura, A Martinetti, E Seregni, DG Oliva, B Laterza, M Deraco |
Annals of Surgical Oncology | 2006 |
A Review and an Update on the Screening of Epithelial Ovarian Cancer
EA Reynolds, KA Moller |
Current Problems in Cancer | 2006 |
Molecular predictors of response and outcome in ovarian cancer
S Canevari, M Gariboldi, JF Reid, I Bongarzone, MA Pierotti |
Critical Reviews in Oncology/Hematology | 2006 |
Mucins and TFF peptides of the tear film and lacrimal apparatus
FP Paulsen, MS Berry |
Progress in Histochemistry and Cytochemistry | 2006 |
Marked Decrease of Serum Ca 125 Levels After Denver Shunt Placement in a Patient With Cirrhosis and Refractory Ascites
L Leggio, L Abenavoli, C D’Angelo, A Ferrulli, L Vonghia, A Mirijello, R Barbarino, TD Michele, C Zuppi, D Gui, GL Rapaccini, G Gasbarrini, G Addolorato |
Digestive Diseases and Sciences | 2006 |
Regulation of mucin expression: Mechanistic aspects and implications for cancer and inflammatory diseases
M Andrianifahanana, N Moniaux, SK Batra |
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer | 2006 |
Mesothelin-MUC16 binding is a high affinity, N-glycan dependent interaction that facilitates peritoneal metastasis of ovarian tumors
JA Gubbels, J Belisle, M Onda, C Rancourt, M Migneault, M Ho, TK Bera, J Connor, BK Sathyanarayana, B Lee, I Pastan, MS Patankar |
Molecular Cancer | 2006 |
Bead-based ELISA for validation of ovarian cancer early detection markers
N Scholler, M Crawford, A Sato, CW Drescher, KC O'Briant, N Kiviat, GL Anderson, N Urban |
Clinical cancer research | 2006 |
Distinct evolution of the human carcinoma-associated transmembrane mucins, MUC1, MUC4 AND MUC16
S Duraisamy, S Ramasamy, S Kharbanda, D Kufe |
Gene | 2006 |
Variabilidad de las concentraciones séricas de CA 125 en mujeres sanas en función de la edad, situación hormonal y otras condiciones
B Barceló, A Barceló, M Riesco, G Pérez, B Castanyer, M Vila |
Clínica e Investigación en Ginecología y Obstetricia | 2006 |
Testing for ovarian cancer
K Chan, T Selman |
Best Practice & Research Clinical Obstetrics & Gynaecology | 2006 |
Screening for ovarian cancer in the general population
CS Chu, SC Rubin |
Best Practice & Research Clinical Obstetrics & Gynaecology | 2006 |
Récurrences du cancer épithélial de l'ovaire : valeur du CA125
H Bouanène, S Ferchichi, HB Limem, LB Fatma, SB Ahmed, S Laradi, A Miled |
Immuno-analyse & Biologie Spécialisée | 2006 |
The value of ovarian cancer screening
A Sharma, U Menon |
BRIT J HOSP MED | 2006 |
Prognostic value of CA125 regression following surgery and chemotherapy in patients with advanced epithelial ovarian carcinoma
M Tanaka, Y IIDA, H Nishimura, K Miyai, Y Terao, D Ogishima, M Yoshida, K Kinoshita |
Juntendo Medical Journal | 2006 |
Marked Decrease of Serum Ca 125 Levels After Denver Shunt Placement in a Patient With Cirrhosis and Refractory Ascites
L Leggio, L Abenavoli, C DAngelo, A Ferrulli, L Vonghia, A Mirijello, R Barbarino, TD Michele, C Zuppi, D Gui, GL Rapaccini, G Gasbarrini, G Addolorato |
Digestive Diseases and Sciences | 2006 |
Profiling estrogen-regulated gene expression changes in normal and malignant human ovarian surface epithelial cells
V Syed, X Zhang, KM Lau, R Cheng, K Mukherjee, SM Ho |
Oncogene | 2005 |
Estrogen-induced loss of progesterone receptor expression in normal and malignant ovarian surface epithelial cells
K Mukherjee, V Syed, SM Ho |
Oncogene | 2005 |
Serum CA 125 levels in patients with chronic lymphocytic leukemia
O Bairey, M Shaklai |
Clinical and Laboratory Haematology | 2005 |
CA125: Holy Grail or a Poisoned Chalice
N Topley, D Michael, T Bowen |
Nephron Clinical Practice | 2005 |
A sensitive and rapid immunoassay for quantification of CA125 in human sera by capillary electrophoresis with enhanced chemiluminescence detection
J Wang, J Ren |
Electrophoresis | 2005 |
Marked ascites and serum carbohydrate antigen (CA) 125 elevation in a patient with anorexia nervosa
T Suwabe, M Taguchi, A Takeshita, Y Ozawa |
International Journal of Eating Disorders | 2005 |
CA125 in ovarian cancer: European Group on Tumor Markers guidelines for clinical use
M Duffy, J Bonfrer, J Kulpa, G Rustin, G Soletormos, G Torre, M Tuxen, M Zwirner |
International Journal of Gynecological Cancer | 2005 |
New tumor markers: CA125 and beyond
R Bast, D Badgwell, Z Lu, R Marquez, D Rosen, J Liu, K Baggerly, E Atkinson, S Skates, Z Zhang, A Lokshin, U Menon, I Jacobs, K Lu |
International Journal of Gynecological Cancer | 2005 |
Diagnostic accuracy of frozen section diagnosis of the adnexal mass: a metaanalysis
P Geomini, G Bremer, R Kruitwagen, BW Mol |
Gynecologic Oncology | 2005 |
Greatly Elevated Serum CA-125 Level in a Patient with a Ruptured Endometrioma
MA Rettenmaier, BH Goldstein, JM Stallman, JV Brown, JP Micha |
Journal of Gynecologic Surgery | 2005 |
Epitomics: serum screening for the early detection of cancer on microarrays using complex panels of tumor antigens
S Draghici, M Chatterjee, MA Tainsky |
Expert Review of Molecular Diagnostics | 2005 |
The role of CA125 in clinical practice
EL Moss, J Hollingworth, TM Reynolds |
Journal of clinical pathology | 2005 |
External quality assessment of tumour marker analysis: state of the art and consequences for estimating diagnostic sensitivity and specificity
H Reinauer, WG Wood |
German medical science : GMS e-journal | 2005 |
El CA125 citosólico en adenocarcinomas pulmonares. Nuevos aspectos biológicos
A Ruibal, IN Cambre, AS Salmón, MI Nuñez, J Rodríguez |
Revista Española de Medicina Nuclear | 2005 |
Pseudo-pseudo Meigs' syndrome
R Schmitt, W Weichert, W Schneider, FC Luft, R Kettritz |
The Lancet | 2005 |
Surgery for Ovarian Cancer: Principles and Practice
M Carmen, L Duska |
Surgery for Ovarian Cancer: Principles and Practice | 2005 |
Prognostic factors in ovarian cancer: how close are we to a complete picture?
R Agarwal, SB Kaye |
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO | 2005 |
Identification of ATF-3, caveolin-1, DLC-1 and NM23-H2 as putative antitumorigenic, progesterone-regulated genes for ovarian cancer cells by gene profiling
V Syed, K Mukherjee, J Lyons-Weiler, KM Lau, T Mashima, T Tsuruo, S Ho |
Oncogene | 2005 |
Introducing the MUC16 Gene: Implications for Prevention and Early Detection in Epithelial Ovarian Cancer
MR McLemore, B Aouizerat |
Biological research for nursing | 2005 |
Telomere-mediated mitotic disturbances in immortalized ovarian epithelial cells reproduce chromosomal losses and breakpoints from ovarian carcinoma
D Gisselsson, M Lv, SW Tsao, C Man, C Jin, M H�glund, YL Kwong, Y Jin |
Genes, Chromosomes and Cancer | 2004 |
CA 125 Elevation in Breast Cancer: A Case Report and Review of the Literature
GD Leonard, JA Low, AW Berman, SM Swain |
The Breast Journal | 2004 |
HMOCC-1, a human monoclonal antibody that inhibits adhesion of ovarian cancer cells to human mesothelial cells
N Suzuki, D Aoki, Y Tamada, N Susumu, K Orikawa, K Tsukazaki, M Sakayori, A Suzuki, T Fukuchi, M Mukai, K Kojima-Aikawa, I Ishida, S Nozawa |
Gynecologic Oncology | 2004 |
Identification of p53 regulators by genome-wide functional analysis
Q Huang, A Raya, P DeJesus, SH Chao, KC Quon, JS Caldwell, SK Chanda, JC Izpisua-Belmonte, PG Schultz |
Proceedings of the National Academy of Sciences | 2004 |
Early detection of ovarian cancer: new technologies in pursuit of a disease that is neither common nor rare
RC Bast |
Transactions of the American Clinical and Climatological Association | 2004 |
Prognostic utility of a glycoprotein tumor-associated antigen (TA90) specific immune complex assay in patients with cancer
RK Gupta, DL Morton |
Clinical and Applied Immunology Reviews | 2004 |
Diagnosis and Management of Ovarian Disorders
AB Copperman, T Mukherjee, NG Kase |
Diagnosis and Management of Ovarian Disorders | 2004 |
El CA125 citosólico en carcinomas escamosos de pulmón
A Ruibal, IN Cambre, MI Núñez, J Rodríguez |
Revista Española de Medicina Nuclear | 2004 |
Ca 125 elevado en la hepatopatía crónica con ascitis
EC Valadés, MM Corral |
Gastroenterología y Hepatología | 2004 |
Solution Structure of the SEA Domain from the Murine Homologue of Ovarian Cancer Antigen CA125 (MUC16)
T Maeda, M Inoue, S Koshiba, T Yabuki, M Aoki, E Nunokawa, E Seki, T Matsuda, Y Motoda, A Kobayashi, F Hiroyasu, M Shirouzu, T Terada, N Hayami, Y Ishizuka, N Shinya, A Tatsuguchi, M Yoshida, H Hirota, Y Matsuo, K Tani, T Arakawa, P Carninci, J Kawai, Y Hayashizaki, T Kigawa, S Yokoyama |
The Journal of biological chemistry | 2004 |
Progress and Challenges in Screening for Early Detection of Ovarian Cancer
IJ Jacobs, U Menon |
Molecular & cellular proteomics : MCP | 2004 |
Mucins in cancer: protection and control of the cell surface
MA Hollingsworth, BJ Swanson |
Nature Reviews Cancer | 2004 |
Cancer Diagnostics
RM Nakamura, WW Grody, JT Wu, RB Nagle |
2004 | |
Determination of cancer antigen 125 in ovarian carcinoma
V Thakur, AK Anand, U Mukherjee, D Ghosh |
Indian Journal of Clinical Biochemistry | 2003 |
Influence of tumor grade on expression of CA 125 in serum and tissue in patients with serous ovarian carcinoma
I But |
Wiener klinische Wochenschrift | 2003 |
Clinical indices of in vivo biocompatibility: The role of ex vivo cell function studies and effluent markers in peritoneal dialysis patients
R Mackenzie, CJ Holmes, S Jones, JD Williams, N Topley |
Kidney International | 2003 |
Activated Src Protein Tyrosine Kinase Is Overexpressed in Late-Stage Human Ovarian Cancers
JR Wiener, TC Windham, VC Estrella, NU Parikh, PF Thall, MT Deavers, RC Bast, GB Mills, GE Gallick |
Gynecologic Oncology | 2003 |
Current Status of the Molecular Characterization of the Ovarian Cancer Antigen CA125 and Implications for Its Use in Clinical Screening
C Whitehouse, E Solomon |
Gynecologic Oncology | 2003 |
CA125 and UQCRFS1 FISH studies of ovarian carcinoma
SJ Kaneko, T Gerasimova, ST Smith, KO Lloyd, K Suzumori, SR Young |
Gynecologic Oncology | 2003 |
Serum CA 125 as a Prognostic Factor in Non-Hodgkin's Lymphoma
O Bairey, D Blickstein, P Stark, M Prokocimer, HM Nativ, I Kirgner, M Shaklai |
Leukemia & Lymphoma | 2003 |
Determination of tumor marker CA125 by capillary electrophoretic enzyme immunoassay with electrochemical detection
Z He, N Gao, W Jin |
Analytica Chimica Acta | 2003 |
Doppler flow and arterial location in ovarian tumors
T Itakura, F Kikkawa, H Kajiyama, T Mitsui, M Kawai, S Mizutani |
International Journal of Gynecology & Obstetrics | 2003 |
The follow-up of ovarian cancer
AP Vaidya, JP Curtin |
Seminars in Oncology | 2003 |
Characterization of novel human ovarian cancer-specific transcripts (HOSTs) identified by serial analysis of gene expression
LB Rangel, CA Sherman-Baust, RP Wernyj, DR Schwartz, KR Cho, PJ Morin |
Oncogene | 2003 |
Characterization of the Oligosaccharides Associated with the Human Ovarian Tumor Marker CA125
NK Wong, RL Easton, M Panico, M Sutton-Smith, JC Morrison, FA Lattanzio, HR Morris, GF Clark, A Dell, MS Patankar |
The Journal of biological chemistry | 2003 |
Progesterone-induced apoptosis in immortalized normal and malignant human ovarian surface epithelial cells involves enhanced expression of FasL
V Syed, SM Ho |
Oncogene | 2003 |
Profiling follicle stimulating hormone-induced gene expression changes in normal and malignant human ovarian surface epithelial cells
SM Ho, KM Lau, SC Mok, V Syed |
Oncogene | 2003 |
Serologic analysis of ovarian tumor antigens reveals a bias toward antigens encoded on 17q
B Stone, M Schummer, PJ Paley, L Thompson, J Stewart, M Ford, M Crawford, N Urban, K O'Briant, BH Nelson |
International Journal of Cancer | 2003 |
Ultrasound and Endoscopic Surgery in Obstetrics and Gynaecology
D Timmerman, J Deprest, T Bourne |
2003 | |
The cancer antigen CA125 represents a novel counter receptor for galectin-1
C Seelenmeyer, S Wegehingel, J Lechner, W Nickel |
Journal of cell science | 2003 |
Value of mesothelial and epithelial antibodies in distinguishing diffuse peritoneal mesothelioma in females from serous papillary carcinoma of the ovary and peritoneum
RL Attanoos, R Webb, SD Dojcinov, AR Gibbs |
Histopathology | 2002 |
The effect of ascites, mass volume, and peritoneal carcinomatosis on serum CA125 levels in patients with ovarian carcinoma
U Saygili, S Guclu, T Uslu, O Erten, E Dogan |
International Journal of Gynecological Cancer | 2002 |
Can Serum CA-125 Levels Predict the Optimal Primary Cytoreduction in Patients with Advanced Ovarian Carcinoma?
U Saygili, S Guclu, T Uslu, O Erten, N Demir, A Onvural |
Gynecologic Oncology | 2002 |
Preoperative CA-125 Levels in Patients with Hereditary Compared to Sporadic Epithelial Ovarian Carcinoma
M Leitao, J Boyd |
Gynecologic Oncology | 2002 |
The prognostic significance of CA 125 in patients with non-Hodgkin's lymphoma
ID Zacharos, SP Efstathiou, E Petreli, G Georgiou, DI Tsioulos, SE Mastorantonakis, I Christakopoulou, PP Roussou |
European Journal of Haematology | 2002 |
Immunohistochemical expression of CA19-9 and CA125 in mucoepidermoid and adenoid cystic carcinomas of the salivary gland
K Okamura |
Oral Oncology | 2002 |
Serum sialyl Lewis X-i antigen in lung adenocarcinoma and idiopathic pulmonary fibrosis
H Satoh, H Ishikawa, YT Yamashita, M Ohtsuka, K Sekizawa |
Thorax | 2002 |
Cancer Antigen 125 in Patients With Chronic Liver Disease
H Devarbhavi, D Kaese, AW Williams, J Rakela, GG Klee, PS Kamath |
Mayo Clinic Proceedings | 2002 |
Detection of telomerase-positive circulating epithelial cells in ovarian cancer patients
E Sapi, NI Okpokwasili, T Rutherford |
Cancer Detection and Prevention | 2002 |
Detection of polyol accumulation in a new ovarian carcinoma cell line, CABA I: a1H NMR study
A Ferretti, S D'Ascenzo, A Knijn, E Iorio, V Dolo, A Pavan, F Podo |
British Journal of Cancer | 2002 |
Detection of polyol accumulation in a new ovarian carcinoma cell line, CABA I: a1H NMR study
A Ferretti, S D'Ascenzo, A Knijn, E Iorio, V Dolo, A Pavan, F Podo |
British Journal of Cancer | 2002 |
High concentrations of CA 125 in uterine flushings: influence of cause of infertility and menstrual cycle day
JA Hamilton, RK Iles, LK Gunn, CM Wilson, AM Lower, JG Grudzinskas |
Gynecological Endocrinology | 2002 |
Lung tumour markers in oncology practice: a study of TPA and CA125
G Buccheri, D Ferrigno |
British Journal of Cancer | 2002 |
Ovarian cancer antigen CA125 is encoded by theMUC16 mucin gene
BW Yin, A Dnistrian, KO Lloyd |
International Journal of Cancer | 2002 |
CA125 Response: Can it Replace the Traditional Response Criteria in Ovarian Cancer?
AE Guppy, GJ Rustin |
The oncologist | 2002 |
Application of tumor markers in ovarian malignancies
T Malati, GR Kumari, B Yadagiri |
Indian Journal of Clinical Biochemistry | 2001 |
OVX1, macrophage-colony stimulating factor, and CA-125-II as tumor markers for epithelial ovarian carcinoma
C Haaften-Day, Y Shen, F Xu, Y Yu, A Berchuck, LJ Havrilesky, HW de Bruijn, AG van der Zee, RC Bast, NF Hacker |
Cancer | 2001 |
A novel homozygous deletion at chromosomal band 6q27 in an ovarian cancer cell line delineates the position of a putative tumor suppressor gene
H Lin, PJ Morin |
Cancer Letters | 2001 |
Loss of Expression of the p16 Tumor Suppressor Gene Is More Frequent in Advanced Ovarian Cancers Lacking p53 Mutations
LJ Havrilesky, AA Alvarez, RS Whitaker, JR Marks, A Berchuck |
Gynecologic Oncology | 2001 |
Whole cell ELISA for detection of tumor antigen expression in tumor samples
LF Erdile, D Smith, D Berd |
Journal of Immunological Methods | 2001 |
OVX1, macrophage-colony stimulating factor, and CA-125-II as tumor markers for epithelial ovarian carcinoma: A critical appraisal
C Haaften-Day, Y Shen, F Xu, Y Yu, A Berchuck, LJ Havrilesky, HW de Bruijn, AG van der Zee, RC Bast, NF Hacker |
Cancer | 2001 |
CA 125
O Gaillard |
Immuno-analyse & Biologie Spécialisée | 2001 |
Microarray analysis of gene expression mirrors the biology of an ovarian cancer model
PN Tonin, TJ Hudson, F Rodier, M Bossolasco, PD Lee, J Novak, EN Manderson, D Provencher, AM Mes-Masson |
Oncogene | 2001 |
Molecular Cloning of the CA125 Ovarian Cancer Antigen: IDENTIFICATION AS A NEW MUCIN, MUC16
BW Yin, KO Lloyd |
The Journal of biological chemistry | 2001 |
Measurement of serum CA-125 concentrations does not improve the value of Chlamydia trachomatis antibody in predicting tubal pathology at laparoscopy
EH Ng, OS Tang, PC Ho |
Human Reproduction | 2001 |
Relationship Between Expression of Coactivators and Corepressors of Hormone Receptors and Resistance of Ovarian Cancers to Growth Regulation by Steroid Hormones
LJ Havrilesky, CP McMahon, EK Lobenhofer, R Whitaker, JR Marks, A Berchuck |
Journal of the Society for Gynecologic Investigation | 2001 |
ELEVATION OF CA-125 LEVEL IS DUE TO ABDOMINAL DISTENSION IN LIVER TRANSPLANTATION CANDIDATES:
M Deschnes, RP Michel, E Alpert, JS Barkun, P Metrakos, J Tchervenkov |
Transplantation | 2001 |
Dialysate Cancer Antigen 125 Concentration as Marker of Peritoneal Membrane Status in Patients Treated with Chronic Peritoneal Dialysis
RT Krediet |
Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis | 2001 |
Evaluation of Plasma Lysophospholipids for Diagnostic Significance Using Electrospray Ionization Mass Spectrometry (ESI-MS) Analyses
Y Xiao, Y Chen, AW Kennedy, J Belinson, Y Xu |
Annals of the New York Academy of Sciences | 2000 |
Increased CA 125 serum levels in patients with advanced acute leukemia with serosal involvement
A Camera, MR Villa, S Rocco, TD Novellis, S Costantini, L Pezzullo, A Lucania, A Mariano, V Macchia, B Rotoli |
Cancer | 2000 |
Tumour markers and ovarian cancer screening
B Kumar, J Davies-Humphreys |
The Obstetrician & Gynaecologist | 2000 |
Rare Activation of the TCF/β-Catenin Pathway in Ovarian Cancer
MT Furlong, PJ Morin |
Gynecologic Oncology | 2000 |
Rhenium-188-labeled anti-neural cell adhesion molecule antibodies with 2-iminothiolane modification for targeting small-cell lung cancer
MN Hosono, M Hosono, AK Mishra, A Faivre-Chauvet, E Gautherot, J Barbet, FF Knapp, JF Chatal |
Annals of Nuclear Medicine | 2000 |
Recent Advances in the Management of Gynecologic Cancers
SJ Kim |
Journal of Obstetrics and Gynaecology Research | 2000 |
Uterine Leiomyoma Causing Massive Ascites and Left Pleural Effusion with Elevated CA 125: A Case Report
F Migishima, T Jobo, H Hata, R Sato, Y Ikeda, M Arai, H Kuramoto |
Journal of Obstetrics and Gynaecology Research | 2000 |
Intraperitoneal Photoimmunotherapy of Ovarian Carcinoma Xenografts in Nude Mice Using Charged Photoimmunoconjugates
KL Molpus, MR Hamblin, I Rizvi, T Hasan |
Gynecologic Oncology | 2000 |
The clinical value of serum concentrations of cancer antigen 125 in patients with primary fallopian tube carcinoma
LA Hefler, AC Rosen, AH Graf, M Lahousen, M Klein, S Leodolter, A Reinthaller, C Kainz, CB Tempfer |
Cancer | 2000 |
Role of tumour markers in monitoring epithelial ovarian cancer
T Meyer, GJ Rustin |
British Journal of Cancer | 2000 |
CHARACTERIZATION OF FOUR NOVEL EPITHELIAL OVARIAN CANCER CELL LINES
DM Provencher, H Lounis, L Champoux, M Tétrault, EN Manderson, JC Wang, P Eydoux, R Savoie, PN Tonin, AM Mes-Masson |
In Vitro Cellular & Developmental Biology - Animal | 2000 |
The clinical value of serum concentrations of cancer antigen 125 in patients with primary fallopian tube carcinoma: A multicenter study
LA Hefler, AC Rosen, AH Graf, M Lahousen, M Klein, S Leodolter, A Reinthaller, C Kainz, CB Tempfer |
Cancer | 2000 |
Preoperative CA 125 in endometrial cancer: Is it useful?
DJ Dotters |
American Journal of Obstetrics and Gynecology | 2000 |
The Prognostic Significance of Expression of CA125 and Proliferation Markers and Architectural Type in Ovarian Clear Cell Adenocarcinoma
T OKUDA, H SAITO, A SEKIZAWA, T AKAMATSU, A SUZUKI, A SHIMIZU, M KUSHIMA, H OTA, T YANAIHARA |
The Showa University Journal of Medical Sciences | 2000 |
Handbook of Oxidants and Antioxidants in Exercise
RR Jenkins, J Beard |
Handbook of Oxidants and Antioxidants in Exercise | 2000 |
Biological variation and analytical imprecision of CA 125 in patients with ovarian cancer
MK Tuxen, GJ Rustin, P Dombernowsky, G Sölétormos, AE Nelstrop |
Scandinavian Journal of Clinical & Laboratory Investigation | 2000 |
CA125 production by the peritoneum: in-vitro and in-vivo studies
M Epiney, C Bertossa, A Weil, A Campana, P Bischof |
Human Reproduction | 2000 |
Lessons to be learned: a case study approach: Ascites and elevated serum CA 125 due to a pancreatic carcinoma. A diagnostic dilemma
AS Ahmed, M Long, D Donaldson |
The Journal of the Royal Society for the Promotion of Health | 2000 |
CHARACTERIZATION OF FOUR NOVEL EPITHELIAL OVARIAN CANCER CELL LINES
DM Provencher, H Lounis, L Champoux, M Tétrault, EN Manderson, JC Wang, P Eydoux, R Savoie, PN Tonin, AM Mes-Masson |
In vitro cellular & developmental biology. Animal | 2000 |
Screening for ovarian cancer: a pilot randomised controlled trial
IJ Jacobs, SJ Skates, N MacDonald, U Menon, AN Rosenthal, AP Davies, R Woolas, AR Jeyarajah, K Sibley, DG Lowe, DH Oram |
The Lancet | 1999 |
Cancer antigen 125: a sensitive marker of ascites in patients with liver cirrhosis
E Zuckerman, A Lanir, E Sabo, T Rosenvald-Zuckerman, I Matter, D Yeshurun, S Eldar |
The American Journal of Gastroenterology | 1999 |
Assessment of Biological Variation and Analytical Imprecision of CA 125, CEA, and TPA in Relation to Monitoring of Ovarian Cancer
MK Tuxen, G Sölétormos, PH Petersen, V Schiøler, P Dombernowsky |
Gynecologic Oncology | 1999 |
Immunohistochemical differentiation between primary adenocarcinomas of the ovary and ovarian metastases of colonic and breast origin. Comparison between a statistical and an intuitive approach
JH Lagendijk, H Mullink, PJ van Diest, GA Meijer, CJ Meijer |
Journal of clinical pathology | 1999 |
Autocrine regulation of growth stimulation in human epithelial ovarian carcinoma by serine-proteinase-catalysed release of the urinary-type-plasminogen-activator N-terminal fragment
DA Fishman, A Kearns, S Larsh, JJ Enghild, MS Stack |
Biochemical Journal | 1999 |
Technical and clinical comparison of two fully automated methods for the immunoassay of CA 125 in serum
G Yan, H Ju, Z Liang, T Zhang |
Journal of Immunological Methods | 1999 |
Is there a place for screening in ovarian cancer?
ND MacDonald, IJ Jacobs |
European Journal of Obstetrics & Gynecology and Reproductive Biology | 1999 |
Radioimmunoscintigraphy in Patients with Ovarian Cancer
HH Constantino |
Acta Oncologica | 1999 |
Developments in Serologic Detection of Human Pancreatic Adenocarcinoma
ME Haglund |
Scandinavian Journal of Gastroenterology | 1999 |
Ovarian Cancer Antigen CA 125 Enhances the Invasiveness of the Endometriotic Cell Line EEC 145
R Gaetje, DW Winnekendonk, A Scharl, M Kaufmann |
Journal of the Society for Gynecologic Investigation | 1999 |
Tissue Quantification of CA 125 in Epithelial Ovarian Cancer
RD Cuesta, ML Maestro, J Solana, JA Vidart, M Escudero, E Iglesias, R Valor |
The International Journal of Biological Markers | 1999 |
Nuclear Oncology
C Aktolun, WN Tauxe |
Nuclear Oncology | 1999 |
Kinetics of Serum Tumor Marker Concentrations and Usefulness in Clinical Monitoring
JM Bidart, F Thuillier, C Augereau, J Chalas, A Daver, N Jacob, F Labrousse, H Voitot |
Clinical chemistry | 1999 |
Comparison of Glycoprotein Expression Between Ovarian and Colon Adenocarcinomas
HA Multhaupt, CP Arenas-Elliott, MJ Warhol |
Archives of pathology & laboratory medicine | 1999 |
Monoclonal antibodies in solid tumours: approaches to therapy with emphasis on gynaecological cancer
G Fleckenstein, R Osmers, J Puchta |
Medical Oncology | 1998 |
Immunoscreening protocols for the identification of clinically useful antibodies and antigens
S Mukerjee, ME McKnight, MC Glassy |
Expert Opinion on Investigational Drugs | 1998 |
Elevated Ovarian Cancer Marker(CA-125) in Cirrhotic Patients With Intractable Ascites
D Zamir, J Jarchovsky, C Singer, P Weiner |
Journal of Clinical Gastroenterology | 1998 |
Determination of a Normal Level of Serum CA125 in Postmenopausal Women as a Tool for Preoperative Evaluation and Postoperative Surveillance of Endometrial Carcinoma
T Kurihara, H Mizunuma, M Obara, K Andoh, Y Ibuki, T Nishimura |
Gynecologic Oncology | 1998 |
Immunohistochemical and Molecular Studies on Malignant Transformation in Mature Cystic Teratoma of the Ovary
T Yoshioka, T Tanaka |
Journal of Obstetrics and Gynaecology Research | 1998 |
Establishment and characterization of a novel cancer cell line (SMOV-1), derived from the ascitic fluid of a woman with ovarian cancer who had never responded to chemotherapeutic drugs
T Iida, K Yonamine, H Takeuchi, K Hayashi, T Meguro, T Shinagawa, A Amemiya |
International Journal of Clinical Oncology | 1998 |
Human tetranectin: Methodological and clinical studies
CK Høgdall |
APMIS | 1998 |
Elevated Ovarian Cancer Marker(CA-125) in Cirrhotic Patients With Intractable Ascites:
D Zamir, J Jarchovsky, C Singer, P Weiner |
Journal of Clinical Gastroenterology | 1998 |
Tracing the origin of adenocarcinomas with unknown primary using immunohistochemistry: Differential diagnosis between colonic and ovarian carcinomas as primary sites
JH Lagendijk, H Mullink, PJ van Diest, GA Meijer, CJ Meijer |
Human Pathology | 1998 |
Improved stability and yield of a Fv-toxin fusion protein by computer design and protein engineering of the Fv
PS Chowdhury, G Vasmatzis, R Beers, B Lee, I Pastan |
Journal of Molecular Biology | 1998 |
Intraoperative and postoperative kinetics of serum tumor markers in patients with oral carcinoma
J Hoffmann, A Munz, M Krimmel, G Alfter |
Journal of Oral and Maxillofacial Surgery | 1998 |
CA-125 concentrations in the serum and pregnancy outcome in IVF cycles
AW Brandenberger, NA Bersinger, PR Huber, E Berger, P Glanzmann, MH Birkhaeuser |
Journal of Assisted Reproduction and Genetics | 1998 |
Serum CA 125 level as a predictor of peritoneal dissemination in patients with gastric carcinoma
B Nakata, KH Chung, Y Kato, Y Yamashita, K Maeda, N Onoda, T Sawada, M Sowa |
Cancer | 1998 |
CA 125: The past and the Future
RC Bast, FJ Xu, YH Yu, S Barnhill, Z Zhang, GB Mills |
The International Journal of Biological Markers | 1998 |
CA 125 - Epitopes and Molecular Size
K Nustad, M Onsrud, B Jansson, D Warren |
The International Journal of Biological Markers | 1998 |
CA 125 Production and Release by Ovarian Cancer Cells In Vitro
EP Beck, A Moldenhauer, E Merkle, F Kiesewetter, W Jäger, L Wildt, N Lang |
The International Journal of Biological Markers | 1998 |
CA 125 in Benign Gynecological Conditions
H Meden, A Fattahi-Meibodi |
The International Journal of Biological Markers | 1998 |
Immunohistochemistry of CA 125: Unusual expression in normal tissues, distribution in the human fetus and questions around its application in diagnostic pathology
M Nap |
The International Journal of Biological Markers | 1998 |
CA 125 in Ovarian Cancer: Advances and Controversy
HA Fritsche, RC Bast |
Clinical chemistry | 1998 |
Interferences with Two-site Immunoassays by Human Anti-mouse Antibodies Formed by Patients Treated with Monoclonal Antibodies: Comparison of Different Blocking Reagents
J Reinsberg |
Clinical chemistry | 1998 |
Comparison of seven immunoassays for the quantification of CA 125 antigen in serum
EM Davelaar, GJ van Kamp, RA Verstraeten, P Kenemans |
Clinical chemistry | 1998 |
Serum CA 125 levels and survival in advanced ovarian cancer
K Münstedt, M Krisch, S Sachsse, H Vahrson |
Archives of Gynecology and Obstetrics | 1997 |
Serum concentrations of cancer antigen 125, placental alkaline phosphatase, cancer-associated serum antigen and free beta human chorionic gonadotrophin as prognostic markers for epithelial ovarian cancer
T Ind, R Iles, J Shepherd, T Chard |
BJOG: An International Journal of Obstetrics and Gynaecology | 1997 |
The ratio between carcinoma antigen-125 levels in the seminal plasma and serum may be a marker for fertilization in intracytoplasmic sperm injection
E Geva, J Arava, L Lerner-Geva, M Hareuveni, JB Lessing, S Ballas, A Amit |
Fertility and Sterility | 1997 |
What should be the cut-off level of serum CA125 to evaluate the disease status before second-look laparotomy in epithelial ovarian carcinoma?
T Bese, F Demirkiran, M Arvas, AU oz, D Kosebay, E Erkun |
International Journal of Gynecological Cancer | 1997 |
Serum CA 125 concentrations in women of different ages, hormonal statuses, orclinical conditions
NP Koper, CM Thomas, LF Massuger, MJ van der Mooren, LA Kiemeney, AL Verbeek |
International Journal of Gynecological Cancer | 1997 |
Isolation and characterization of ovarian cancer antigen CA 125 using a new monoclonal antibody (VK-8): identification as a mucin-type molecule
KO Lloyd, BW Yin, V Kudryashov |
International Journal of Cancer | 1997 |
Utility of tumour markers in the diagnosis of neoplastic pleural effusion
ME Jose, D Alvarez, L Valdes, A Sarandeses, JM Valle, P Penela |
Clinica Chimica Acta | 1997 |
Establishment and Characterization of Human Ovarian Carcinoma Cell Lines
Y Yuan, WH Kim, HS Han, JH Lee, HS Park, JK Chung, SB Kang, JG Park |
Gynecologic Oncology | 1997 |
Preevacuation Serum CA 125 in Complete Hydatidiform Mole
S Tangtrakul, S Srisupandit, LO Chailurkit, R Rajatanavin |
Gynecologic Oncology | 1997 |
In vitro expression of the diphtheria toxin A-chain gene under the control of human chorionic gonadotropin gene promoters as a means of directing toxicity to ovarian cancer cell lines
YJ Lidor, WE Lee, JH Nilson, H Maxwell, LJ Su, E Brand, LM Glode |
American Journal of Obstetrics and Gynecology | 1997 |
Immunological Responses to the Tumor-Associated Antigen CA15 in Patients with Advanced Ovarian Cancer Induced by the Murine Monoclonal Anti-idiotype Vaccine ACA125
U Wagner, H Schlebusch, S Köhler, J Schmolling, U Grünn, D Krebs |
Hybridoma | 1997 |
Anti-TAG-72 Antibody B72.3—Immunological and Clinical Effects in Ovarian Carcinoma
J Schmolling, J Reinsberg, U Wagner, D Krebs |
Hybridoma | 1997 |
Are Human Anti-Idiotypic Anti-OC125 Antibodies Formed after Immunization with the Anti-CA125 Antibody B43.13?
J Reinsberg, D Krebs |
Hybridoma | 1997 |
Ascites with a raised CA 125
DJ D'Souza, EJ Walker |
Journal of the Royal Society of Medicine | 1997 |
Idiotypes in Medicine: Autoimmunity, Infection and Cancer
TJ Kunicki, DJ Nugent |
Idiotypes in Medicine: Autoimmunity, Infection and Cancer | 1997 |
Clinical Significance of Preoperative Serum Levels of CA 125 and TAG-72 in Ovarian Carcinoma
A Gonzalez, F Vizoso, J Vázquez, A Ruibal, JL Balibrea |
The International Journal of Biological Markers | 1997 |
How to Overcome the Disturbing Effects of Human Anti-Mouse Antibodies (Hama) on in Vitro Assays
JB Oltrogge, RP Baum, KN Lema, B Donnerstag, G Hör |
The International Journal of Biological Markers | 1997 |
Ovca (CA125) Second Generation: Technical Aspects and Serum Levels in Controls, Patients with Liver Disease, Pregnant Women and Patients with Ovarian Disease
M Cioffi, M Fratta, P Gazzerro, BD Finizio, A Tucci, AM Molinari |
TUMORI | 1997 |
Radiation Oncology of Gynecological Cancers
HW Vahrson |
1997 | |
Ovarian Vein vs Peripheral Blood CA125 Serum Levels: A Comparative Study
YD Podnos, G Gamboa, T Kurosaki, R Buller, JL Walker, A Manetta |
Gynecologic Oncology | 1997 |
The Role of CA‐125 in the Management of Ovarian Cancer
M Markman |
The oncologist | 1997 |
Clinical evaluation of the Byk LIA-mat CA125 II assay: discussion of a reference value
JM Bonfrer, CM Korse, RA Verstraeten, GJ van Kamp, GA Hart, P Kenemans |
Clinical chemistry | 1997 |
Tumor Markers in Ovarian Malignancies
K Eagle, JA Ledermann |
The oncologist | 1997 |
Sensitivity of Breast and Ovarian Cancer Cells for Interferons (IFNs) and Retinoids
G Daxenbichler, M Widschwendter, C Marth |
Annals of the New York Academy of Sciences | 1996 |
Transforming growth factor-α promotes tumor markers secretion from human ovarian cancers in vitro
H Kurachi, H Adachi, K Morishige, K Adachi, T Takeda, H Homma, T Yamamoto, A Miyake |
Cancer | 1996 |
Serum tumor markers and cyst fluid analysis are useful for the diagnosis of pancreatic cystic tumors
C Sperti, C Pasquali, P Guolo, R Polverosi, G Liessi, S Pedrazzoli |
Cancer | 1996 |
Serological and immunochemical analysis of Lewis Y (Ley) blood group antigen expression in epithelial ovarian cancer
BW Yin, CL Finstad, K Kitamura, MG Federici, M Welshinger, V Kudryashov, WJ Hoskins, S Welt, KO Lloyd |
International Journal of Cancer | 1996 |
Immunohistochemical Study of Colorectal Polyps with Antibodies against CEA, CA19-9, CA125, CA15-3 (DF3), PCNA and p53
K SAITO, A OGAWA, I OHKI |
Digestive Endoscopy | 1996 |
Use of Immunocytochemistry in the Diagnosis of Metastatic Carcinoma
P Matthews, IO Ellis |
Annals of Medicine | 1996 |
Pharmacokinetics and biodistribution of samarium-153-labelled OC125 antibody coupled to CITCDTPA in a xenograft model of ovarian cancer
F Kraeber-Bodéré, A Mishra, P Thédrez, A Faivre-Chauvet, M Bardiès, S Imai, J Boterff, JF Chatal |
European Journal of Nuclear Medicine | 1996 |
Use of Tetranectin, CA-125 and Casa to Predict Residual Tumor and Survival at Second- and Third-Look Operations for Ovarian Cancer
CK Høgdall, EV Høgdall, U Hørding, K Toftager-Larsen, J Arends, B Nørgaard-Pedersen, I Clemmensen |
Acta Oncologica | 1996 |
Risk of diagnosis of ovarian cancer after raised serum CA 125 concentration: a prospective cohort study
IJ Jacobs, S Skates, AP Davies, RP Woolas, A Jeyerajah, P Weidemann, K Sibley, DH Oram |
BMJ (Clinical research ed.) | 1996 |
Treatment of ovarian cancer with photodynamic therapy and immunoconjugates in a murine ovarian cancer model
BA Goff, J Blake, MP Bamberg, T Hasan |
British Journal of Cancer | 1996 |
Clinical relevance of serological markers in the detection and follow-up of pancreatic adenocarcinoma
RA Audisio, P Veronesi, P Maisonneuve, A Chiappa, B Andreoni, E Bombardieri, JG Geraghty |
Surgical Oncology | 1996 |
Maternal serum CA 125 is of prognostic value in patients with uterine bleeding in the detection of small-for-gestational-age neonates
M Mazor, A Bashiri, F Ghezzi, E Maymon, O Kuperman, G Kopernik, JR Leiberman |
European Journal of Obstetrics & Gynecology and Reproductive Biology | 1996 |
Evaluation des dosages du CA 19-9, du CA 125II et du CA 15 3 sur l'automate RIA-MAT 280TM
L Nonnenmacher, Y Fulla |
Immuno-analyse & Biologie Spécialisée | 1996 |
Magnetic resonance imaging, OC125 immunoscintigraphy and serum CA125 levels in the management of patients with suspected primary or recurrent ovarian carcinoma
Q Davies, IM Symonds, AC Perkins, RW Kerslake, ML Wastie, BS Worthington, EM Symonds |
Journal of Obstetrics & Gynaecology | 1996 |
Immunologic Characterization of Tumor Markers in Human Ovarian Cancer Cell Lines
WH Kutteh, DS Miller, JM Mathis |
Journal of the Society for Gynecologic Investigation | 1996 |
Neurocutaneous Melanosis With Dandy-Walker Malformation Complicated by Primary Spinal Leptomeningeal Melanoma
RD Craver, SE Golladay, RP Warrier, AJ Gates, JS Nelson |
Journal of child neurology | 1996 |
Generation of Human Monoclonal Anti-idiotypic Antibodies with Specificity to the Murine Monoclonal Anti-CA 125 Antibody B43.13
JB Oltrogge, B Donnerstag, RP Baum, AA Noujaim, L Träger |
The International Journal of Biological Markers | 1996 |
An antibody-lectin sandwich assay for the determination of CA125 antigen in ovarian cancer patients
R Madiyalakan, M Kuzma, AA Noujaim, MR Suresh |
Glycoconjugate Journal | 1996 |
Serum and tissue measurements of CA72-4 in patients with endometrial carcinoma
H Hareyama, N Sakuragi, S Makinoda, S Fujimoto |
Journal of clinical pathology | 1996 |
The Clinical Value of Tumour Markers in the Management of Ovarian Cancer
GJ Rustin |
Annals of Clinical Biochemistry | 1996 |
Pharmacokinetics and biodistribution of samarium-153-labelled OC125 antibody coupled to CITCDTPA in a xenograft model of ovarian cancer
F Kraeber-Bodéré, A Mishra, P Thédrez, A Faivre-Chauvet, M Bardiès, S Imai, JL Boterff, JF Chatal |
European Journal of Nuclear Medicine | 1996 |
Involvement of ovarian factors magnified by pharmacological induction of multiple follicular development (MFD) in the increase in Ca125 occurring during the luteal phase and the first 12 weeks of induced pregnancies
AM Paoletti, GG Serra, V Mais, S Ajossa, S Guerriero, M Orrú, GB Melis |
Journal of Assisted Reproduction and Genetics | 1995 |
Superiority of CA 125 over CA 19-9 and CEA for epithelial ovarian malignancies
A Saraswathi, T Malati |
Indian Journal of Clinical Biochemistry | 1995 |
High serum level of CA125 in malignant peritoneal mesothelioma
H Simsek |
European Journal of Cancer | 1995 |
Limited loss of nine tumor-associated surface antigenic determinants after tryptic cell dissociation
WE Corver, CJ Cornelisse, J Hermans, GJ Fleuren |
Cytometry | 1995 |
Clinical validation of the new ELSA-CA 125 II assay: Report of a european multicentre evaluation
M Clement, P Bischof, C Gruffat, G Ricolleau, E Auvray, V Quilien, C Pacheco, M Torres, M Ferdeghini |
International Journal of Cancer | 1995 |
Serum CA 125 levels and spontaneous abortion
MD Hornstein, JH Check, JA Hill |
American Journal of Obstetrics and Gynecology | 1995 |
The Second Generation CA125 Assays
P Kenemans, AA Verstraeten, GJ van Kamp, S Mensdorff-Pouilly |
Annals of Medicine | 1995 |
A Monoclonal Antiidiotypic Antibody ACA 125 Mimicking the Tumor-Associated Antigen CA 125 for Immunotherapy of Ovarian Cancer
H Schlebusch, U Wagner, U Grünn, B Schultes |
Hybridoma | 1995 |
Antiidiotypic Antibodies in Ovarian Cancer Patients Treated with the Monoclonal Antibody B72.3
J Schmolling, J Reinsberg, U Wagner, D Krebs |
Hybridoma | 1995 |
Radioimmunotherapy of Ovarian Cancer
K Syrigos, A Epenetos |
Hybridoma | 1995 |
Is Ca 125 Actually a Tumor Marker for Ovarian Cancer?
J Collazos |
Acta Oncologica | 1995 |
Cancer Therapy With Radiolabeled Antibodies An Overview
S Bruland |
Acta Oncologica | 1995 |
Tumor markers in the management of patients with ovarian cancer
MK Tuxen, G Sölétormos, P Dombernowsky |
Cancer Treatment Reviews | 1995 |
Can you screen for ovarian cancer?
ML Hicks, G Parham |
Journal of the National Medical Association | 1995 |
Radiosensitivity of multicellular tumour spheroids obtained from human ovarian cancers
G Griffon, C Marchal, JL Merlin, S Marchal, RM Parache, P Bey |
European Journal of Cancer | 1995 |
Evaluation of second generation CA 125 assays
EV Cosmi, G Atlante, C Donadio, L Mariani, A Barbati |
European Journal of Obstetrics & Gynecology and Reproductive Biology | 1995 |
Serum CA 125 and first trimester abortion
F Scarpellini, M Mastrone, M Sbracia, L Scarpellini |
International Journal of Gynecology & Obstetrics | 1995 |
Predictive value of combined assays of urinary gonadotropin fragment (UGF) and CA 125 for ovarian carcinoma in patients with pelvic masses
NC Gleeson, MS Hoffman, JV Fiorica, WS Roberts, D Cavanagh |
Journal of Obstetrics & Gynaecology | 1995 |
Tumor Markers in the Diagnosis, Monitoring and Therapy of Pancreatic Cancer: State of the Art
M Plebani, D Basso, MP Panozzo, P Fogar, GD Favero, R Naccarato |
The International Journal of Biological Markers | 1995 |
CA125 Serum levels in tubercolosis patients
JF Quirós, M Telenti, PS Leiva, BF Llana, MT Allende, AR Morell |
The International Journal of Biological Markers | 1995 |
False changes in CA 125 levels in ovarian cancer patients after infusion of OC125 fragments for diagnostic and therapeutic purpose
J Reinsberg, U Wagner, D Krebs |
Archives of Gynecology and Obstetrics | 1994 |
Differential expression of the cell-cell adhesion molecule E-cadherin in ascites and solid human ovarian tumor cells
AL Veatch, LF Carson, S Ramakrishnan |
International Journal of Cancer | 1994 |
Prognostic significance of serum ca 125 antigen assay in patients with non-small cell lung cancer
M Diez, J Granell, A Torres, A Gomez, JL Balibrea, M Pollán, D Ortega, ML Maestro |
Cancer | 1994 |
Serum albumin and CA125 are powerful predictors of survival in epithelial ovarian cancer
D Parker, C Bradley, SM Bogle, J Lay, M Masood, AK Hancock, B Naylor, JJ Price |
BJOG: An International Journal of Obstetrics and Gynaecology | 1994 |
Molecular cloning and expression of a cDNA encoding a protein detected by the ki antibody from an ovarian carcinoma (OVCAR-3) cell line
K Chang, I Pastan |
International Journal of Cancer | 1994 |
Modulation of associated ovarian carcinoma antigens by 5 cytokines used as single agents or in combination
BM Imbert-Marcille, P Thëdrez, C Saï-Maurel, C Francois, JL Auget, J Benard, Y Jacques, S Imai, JF Chatal |
International Journal of Cancer | 1994 |
Secretion of extracellular matrix-degrading proteinases is increased in epithelial ovarian carcinoma
TL Moser, TN Young, GC Rodriguez, SV Pizzo, RC Bast, MS Stack |
International Journal of Cancer | 1994 |
Distribution of VRA09, an ovarian tumor-associated antigen, distinguishing borderline serous tumors
T Voeltzel, P Duvillard, P Ghillani, J Bénard, C Bohuon, D Bellet, JM Bidart |
International Journal of Cancer | 1994 |
Color Doppler ultrasonography and serum CA 125 in the differentiation of benign and malignant ovarian tumors
CY Chou, CH Chang, BL Yao, HC Kuo |
Journal of Clinical Ultrasound | 1994 |
Immunocytochemical and serological expression of CA 125: a clinicopathological study of 40 malignant ovarian epithelial tumours
J Leake, R Woolas, J Daniel, D Oram, C Brown |
Histopathology | 1994 |
CA125-producing adenocarcinoma of the seminal vesicle
T Ohmori, K Okada, R Tabei, K Sugiura, S Nabeshima, H Ohoka, M Okamoto |
Pathology International | 1994 |
Construction and Expression of Chimeric Antibodies by a Simple Replacement of Heavy and Light Chain V Genes into a Single Cassette Vector
H Kanda, K Mori, H Koga, K Taniguchi, H Kobayashi, H Sakahara, J Konishi, K Endo, T Watanabe |
Hybridoma | 1994 |
Serum Tumor Markers for Detection of Bone Metastasis in Breast Cancer Patients
A Aydiner, E Topuz, R Discli, V Yasasever, M Dincer, K Dincol, N Bilge |
Acta Oncologica | 1994 |
A Comparison of Ovarian Cyst Aspirate Cytology and Histology. The Case Against Aspiration of Cystic Pelvic Masses
JL Nicklin, M Eijkeren, P Athanasatos, GV Wain, NF Hacker |
The Australian and New Zealand Journal of Obstetrics and Gynaecology | 1994 |
Circulating levels of colony-stimulating factor 1 as a prognostic indicator in 82 patients with epithelial ovarian cancer
SM Scholl, CH Bascou, V Mosseri, R Olivares, H Magdelenat, T Dorval, T Palangié, P Validire, P Pouillart, ER Stanley |
British Journal of Cancer | 1994 |
Photoimmunotherapy and biodistribution with an OC125-chlorin immunoconjugate in an in vivo murine ovarian cancer model
BA Goff, U Hermanto, J Rumbaugh, J Blake, M Bamberg, T Hasan |
British Journal of Cancer | 1994 |
Characterisation of the differential expression of marker antigens by normal and malignant endometrial epithelium
E Chatzaki, CJ Gallagher, RK Iles, TE Ind, AM Nouri, CM Bax, JG Grudzinskas |
British Journal of Cancer | 1994 |
Decreased kidney uptake of technetium-99m-labelled Fab′ fragments in ovarian carcinoma bearing nude mice using a cleavable chelator
JG Tibben, LF Massuger, OC Boerman, RA Claessens, GF Borm, KY Pak, EB Koenders, FH Corstens |
Nuclear Medicine and Biology | 1994 |
A comparison study of IFN-γ, ADA, and CA125 as the diagnostic parameters in tuberculous pleuritis
Y Aoki, O Katoh, Y Nakanishi, S Kuroki, H Yamada |
Respiratory Medicine | 1994 |
Biological markers and ovarian carcinomas: Galactosyltransferase, CA 125, isoenzymes of amylase and alkaline phosphatase
F Sichel, V Salaün, E Bara, P Gauduchon, JP Malas, J Goussard, JY Talaër |
Clinica Chimica Acta | 1994 |
Performances analytiques d'un nouvel automate d'immunoanalyse : le LIA-mat S300
C Bogard, G Glikmanas, M Bogard, F Thuillier, Y Gourmelin |
Immuno-analyse & Biologie Spécialisée | 1994 |
Antibody-directed enzyme prodrug therapy (ADEPT): A three-phase study in ovarian tumor xenografts
SK Sharma, JA Boden, CJ Springer, PJ Burke, KD Bagshawe |
Cell Biochemistry and Biophysics | 1994 |
In vitro activity of immunoconjugates between cisplatin and an anti-CA125 monoclonal antibody on ovarian cancer cell lines
E Beck, M Hofmann, G Bernhardt, W Jäger, L Wildt, N Lang |
Cell Biochemistry and Biophysics | 1994 |
Atlas of Human Tumor Cell Lines
YC Hung, PG Satyaswaroop, S Tabibzadeh |
Atlas of Human Tumor Cell Lines | 1994 |
CA-125 levels in cervical mucus during the menstrual cycle*
AR Martinez, CM Thomas, MF Segers, J Schoemaker, TK Eskes |
Fertility and Sterility | 1994 |
Epidermal Growth Factor Enhances Secretion of the Ovarian Tumor-Associated Cancer Antigen CAI25 From the Human Amnion WISH Cell Line
I Konishi, JL Fendrick, TH Parmley, JG Quirk, TJ O'Brien |
Journal of the Society for Gynecologic Investigation | 1994 |
Cyfra 21–1 in Lung Cancer: Comparison with Cea, Ca 125, Scc and Nse Serum Levels
R Molina, C Agusti, JM Mañe, X Filella, J Jo, J Joseph, N Giménez, J Estapé, AM Ballesta |
The International Journal of Biological Markers | 1994 |
Expression of the Tumor-Associated Glycoproteins Mca, Ca 125 and Bw 495/36-P in Epithelial Tumors of the Kidney and the Urinary Bladder
A Ammon, MH Weber, I Wallner, N Marschner, M Droese, HJ Gröne, W Hiddemann |
The International Journal of Biological Markers | 1994 |
Relation between Ovarian Carcinoma-Associated Antigens in Tumor Tissue and Detached Cyst Fluid Cells of Patients with Ovarian Neoplasms
JK Bar, A Harłtozińska, E Sobańska, M Cislo |
TUMORI | 1994 |
Regulation of tumour necrosis factor-α processing by a metalloproteinase inhibitor
GM McGeehan, JD Becherer, RC Bast, CM Boyer, B Champion, KM Connolly, JG Conway, P Furdon, S Karp, S Kidao, AB McElroy, J Nichols, KM Pryzwansky, F Schoenen, L Sekut, A Truesdale, M Verghese, J Warner, JP Ways |
Nature | 1994 |
Immunohistochemical characterization of undifferentiated carcinomas of the ovary
Y Kuwashima, T Uehara, K Kishi, K Shiromizu, M Matsuzawa, S Takayama |
Journal of Cancer Research and Clinical Oncology | 1994 |
Cancer Treatment An Update
P Banzet, JF Holland, D Khayat, M Weil |
1994 | |
Blaustein’s Pathology of the Female Genital Tract
RJ Kurman |
1994 | |
CA 125 secretion by peritoneal mesothelial cells
AM Zeillemaker, HA Verbrugh, AA van Papendrecht, P Leguit |
Journal of clinical pathology | 1994 |
Atlas of Exocrine Pancreatic Tumors
PM Pour, Y Konishi, G Klöppel, DS Longnecker |
1994 | |
Adenocarcinoma of the submandibular gland with positive serum and tissue immunohistochemical staining for both CEA and CA 125: report of a case
Y Kasuga, A Nakai, Y Matsunaga, M Toi, H Goto, Y Nimura, R Kurasawa, S Moriyama |
The Journal of Laryngology & Otology | 1994 |
TUMOR MARKERS IN EPITHELIAL OVARIAN CANCER
RE Hempling |
Obstetrics and Gynecology Clinics of North America | 1994 |
Cancer Antigen 1251S Locally Produced in the Peritoneal Cavity during Continuous Ambulatory Peritoneal Dialysis
GC Koomen, MG Betjes, O Zemel, RT Krediet, FJ Hoek |
Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis | 1994 |
Alkylating agents and immunotoxins exert synergistic cytotoxic activity against ovarian cancer cells. Mechanism of action
YJ Lidor, KC O'Briant, FJ Xu, TC Hamilton, RF Ozols, RC Bast |
Journal of Clinical Investigation | 1993 |
Quantitative and qualitative assessment of CA-125 production by human endometrial epithelial cells: Comparison of eutopic and heterotopic epithelial cells
H Kobayashi, W Ida, T Terao, Y Kawashima |
International Journal of Cancer | 1993 |
Immunohistochemical markers of uterine receptivity in the human endometrium
AO Ilesanmi, DA Hawkins, BA Lessey |
Microscopy Research and Technique | 1993 |
Elevated serum ca 125 secondary to tuberculous peritonitis
SA Candocia, GY Locker |
Cancer | 1993 |
Evaluation of human carcinoembryonic-antigen (CEA)-transduced and non-transduced murine tumors as potential targets for anti-CEA therapies
PH Hand, PF Robbins, ML Salgaller, DJ Poole, J Schlom |
Cancer Immunology Immunotherapy | 1993 |
mAb-Labeled Liposomes in Breast Cancer Cell Targeting
G Rombi, F Cossu, G Melis |
Annals of the New York Academy of Sciences | 1993 |
Predictive value of serum CA125 following optimal cytoreductive surgery during weekly cisplatin induction therapy for advanced ovarian cancer
RE Hempling, MS Piver, N Natarajan, TR Baker, JM Thompson, ML Hicks, CJ Mettlin |
Journal of Surgical Oncology | 1993 |
Immunocytodiagnosis of solid tumors employing panels of monoclonal antibodies
M Mottolese, I Venturo, M Salzano, M Benevolo, A Bigotti, PG Natali |
Journal of Clinical Laboratory Analysis | 1993 |
Falsely Low Results in CA 125 Determination Due to Anti-Idiotypic Antibodies Induced by Infusion of [131I]F(ab′)2 Fragments of the OC125 Antibody
J Reinsberg, W Nocke |
Clinical Chemistry and Laboratory Medicine | 1993 |
Cancer in the elderly
A Byrne, DN Carney |
Current Problems in Cancer | 1993 |
Ovarian cancer screening
JR van Nagell, PD Depriest, HH Gallion, EJ Pavlik |
Cancer | 1993 |
Monoclonal antibodies in the management of ovarian cancer: A clinical perspective
SC Rubin |
Cancer | 1993 |
Idiotypic Cascades After MAb OC 125 Application
J Reinsberg |
Hybridoma | 1993 |
In vitro cytotoxic activity of taxol' and taxotere on primary cultures and established cell lines of human ovarian cancer
R Silvestrini, N Zaffaroni, L Orlandi, S Oriana |
Stem Cells | 1993 |
Limitations of CA125 in the Preoperative Evaluation of a Pelvic Mass: Struma Ovarii and Ascites
YC Leung, IG Hammond |
The Australian and New Zealand Journal of Obstetrics and Gynaecology | 1993 |
Women with a Pelvic Mass - When to Perform an Ultrasound
JR Dowd, MA Quinn, R Rome, H Koh |
The Australian and New Zealand Journal of Obstetrics and Gynaecology | 1993 |
Origin of CA125 and SCC Antigen in Human Amniotic Fluid*
N Takeshima, Y Suminami, O Takeda, H Abe, H Kato |
Asia-Oceania Journal of Obstetrics and Gynaecology | 1993 |
The value of the human milk fat globule membrane antigen HMFG2 in epithelial ovarian cancer monitoring: comparison with CA125
J Fisken, JE Roulston, C Sturgeon, RA Badley, I Jönrup, L Aspinall, RC Leonard |
British Journal of Cancer | 1993 |
Trophoblast and ovarian cancer antigen LK26. Sensitivity and specificity in immunopathology and molecular identification as a folate-binding protein
P Garin-Chesa, I Campbell, PE Saigo, JL Lewis, LJ Old, WJ Rettig |
The American Journal of Pathology | 1993 |
Characterisation and clinical usefulness of CA130 antigen recognised by monoclonal antibodies, 130-22 and 145-9, in ovarian cancers
H Kobayashi, H Ohi, T Fujii, T Terao |
British Journal of Cancer | 1993 |
Changes in expression of differentiation markers between normal ovarian cells and derived tumors
CC van Niekerk, FC Ramaekers, AG Hanselaar, J Aldeweireldt, LG Poels |
The American Journal of Pathology | 1993 |
Cancer of the Ovary
SA Cannistra |
New England Journal of Medicine | 1993 |
Clinical evaluation of new cancer-associated antigen CA125 II in epithelial ovarian cancers: Comparison with CA125
H Kobayashi, M Tamura, T Satoh, T Terao |
Clinical Biochemistry | 1993 |
Characterization of CA 125 antigen identified by monoclonal antibodies that recognize different epitopes
H Kobayashi, H Ohi, N Moniwa, H Shinohara, T Terao |
Clinical Biochemistry | 1993 |
mAb-Labeled Liposomes in Breast Cancer Cell Targeting.: Therapeutics and Diagnostic Use of Polyspecific Artificial Carriers
G Rombi, F Cossu, G Melis |
Annals of the New York Academy of Sciences | 1993 |
Falsely Low Results in CA 125 Determination Due to Anti-Idiotypic Antibodies Induced by Infusion of [ 131 I]F(ab′)2 Fragments of the OC125 Antibody
J Reinsberg, W Nocke |
Clinical Chemistry and Laboratory Medicine | 1993 |
What do we know about the origin of CA 125?
P Bischof |
European Journal of Obstetrics & Gynecology and Reproductive Biology | 1993 |
Discordant serum CA 125 values in commercial immunoassays
GJ Kamp, AA Verstraeten, P Kenemans |
European Journal of Obstetrics & Gynecology and Reproductive Biology | 1993 |
Que peut attendre le clinicien aujourd'hui du dosage du CA125 ?
PF Vallino |
Immuno-analyse & Biologie Spécialisée | 1993 |
4 Markers for endometriosis
JL Evers, GA Dunselman, PJ der Linden |
Baillière's Clinical Obstetrics and Gynaecology | 1993 |
Molecular characteristics of the CA 125 antigen produced by human endometrial epithelial cells: Comparison between eutopic and heterotopic epithelial cells
H Kobayashi, W Ida, T Terao, Y Kawashima |
American Journal of Obstetrics and Gynecology | 1993 |
Determinación de marcadores tumorales séricos (CEA, SCC y CA 125) en pacientes con cáncer de pulmón. I. Análisis pretratamiento
M Díez, A Torres, MD Ortega, ML Maestro, A Gómez, A Cidoncha, F Hernando, J Granell, JL Balibrea |
Archivos de Bronconeumología | 1993 |
In vitro CA-125 secretion by endometrium from women with advanced endometriosis
JH McBean, JR Brumsted |
Fertility and Sterility | 1993 |
Tumor marker CA-125 in tissues of the female reproductive tract and in serum during the normal menstrual cycle
AG Zeimet, E Müller-Holzner, C Marth, G Daxenbichler, O Dapunt |
Fertility and Sterility | 1993 |
Serum and Tissue Levels of CEA, TPA, CA 125 and CA 15.3 in Patients with Lung Cancer
V Macchia, D Paduano, AD Carlo, A Mariano, C Cecere, G Ferrante |
The International Journal of Biological Markers | 1993 |
Production and Characterization of a Tumor-Specific Monoclonal Antibody Act19 Recognizing an Epitope Distinctive from Sialosyl-Tn on the TAG72 Antigen
J Xiang, T Moyana, Z Chen, W Han, T Ping, E Li |
TUMORI | 1993 |
Characterization of OM-B monoclonal antibody-defined antigen associated with mucinous type human ovarian tumor
K Nishida, R Ueda, K Sakakibara, Y Minoura, M Ohta, Y Ariyoshi, T Takahashi |
Japanese journal of cancer research : Gann | 1993 |
A human/mouse chimeric monoclonal antibody against CA125 for radioimmunoimaging of ovarian cancer
H Kobavashi, H Sakahara, T Saga, M Hosono, M Shirato, H Kanda, K Ishibashi, T Watanabe, K Endo, I Ishiwata, J Konishi |
Cancer Immunology, Immunotherapy | 1993 |
Office Gynecology
JV Knaus, JH Isaacs |
1993 | |
Serum CA 125 levels in patients with non-malignant liver diseases without ascites
J Collazos, J Genolla, MT Allende, A Ruibal |
The Clinical Investigator | 1993 |
Evaluation of human carcinoembryonic-antigen (CEA)-transduced and non-transduced murine tumors as potential targets for anti-CEA therapies
PH Hand, PF Robbins, ML Salgaller, DJ Poole, J Schlom |
Cancer Immunology, Immunotherapy | 1993 |
Characterization of OM‐B Monoclonal Antibody‐defined Antigen Associated with Mucinous Type Human Ovarian Tumor
Nishida K, Ueda R, Sakakibara K, Minoura Y, Ohta M, Ariyoshi Y, Takahashi T |
Japanese journal of cancer research : Gann | 1993 |
Tumour markers in oncology: past, present and future
H Magdelénat |
Journal of Immunological Methods | 1992 |
CA-125 as a maternal serum marker for Down's syndrome in the first and second trimesters
CK Høgdall, EV Høgdall, J Arends, B Nørgaard-Pedersen, S Smidt-Jensen, SO Larsen |
Prenatal Diagnosis | 1992 |
Use of multi-cell spheroids of ovarian carcinoma as an intraperitoneal radio-immunotherapy model: Uptake, retention kinetics and dosimetric evaluation
M Bardiès, P Thedrez, JF Gestin, BM Marcille, D Guerreau, A Faivre-Chauvet, M Mahe, C Sai-Maurel, JF Chatal |
International Journal of Cancer | 1992 |
Fibronectin is an immunosuppressive substance associated with epithelial ovarian cancer
G Olt, A Berchuck, AP Soisson, CM Boyer, RC Bast |
Cancer | 1992 |
Different antigenic nature in apparently healthy women with high serum CA 125 levels compared with typical patients with ovarian cancer
MN Hosono, K Endo, H Sakahara, Y Watanabe, T Saga, T Nakai, M Hosono, T Nakajima, Y Onoyama, J Konishi |
Cancer | 1992 |
Multivariate analysis of serum tumor markers for diagnosis of skeletal metastases
T Shinozaki, M Chigira, K Kato |
Cancer | 1992 |
Studies of a tumor-associated antigen, COX-1, recognized by a monoclonal antibody
CY Lee, KW Chen, FS Sheu, A Tsang, KC Chao, HT Ng |
Cancer Immunology Immunotherapy | 1992 |
In search of specific cytotoxic T lymphocytes infiltrating or accompanying human ovarian carcinoma
M Apiranthitou-Drogari, C Paganin, S Bernasconi, G Losa, A Maneo, N Colombo, A Mantovani, P Allavena |
Cancer Immunology Immunotherapy | 1992 |
Effects of dexamethasone on the growth and epidermal growth factor receptor expression of the OVCA 433 ovarian cancer cells
G Ferrandina, G Scambia, PB Panici, G Bonanno, RD Vincenzo, C Rumi, S Bussa, M Genuardi, VS Romano, S Mancuso |
Molecular and Cellular Endocrinology | 1992 |
Selected monoclonal antibodies can increase the accuracy of cytodiagnosis of neoplastic effusions of cryptic origin expanded in a short term culture
M Mottolese, A Cianciulli, I Venturo, RP Donnorso, M Salzano, M Benevolo, G Bigotti, PG Natali |
Diagnostic Cytopathology | 1992 |
Isolation and characterization of a monoclonal antibody, K1, reactive with ovarian cancers and normal mesothelium
K Chang, I Pastan, MC Willingham |
International Journal of Cancer | 1992 |
Second-trimester cancer antigen 125 and Down's syndrome
MV Blerk, J Smitz, LD Catte, C Kumps, JV der Elst, AC van Steirteghem |
Prenatal Diagnosis | 1992 |
Monoclonal antibody-based ELISA to detect glycoprotein tumor-associated-antigen-specific immune complexes in cancer patients
RK Gupta, DL Morton |
Journal of Clinical Laboratory Analysis | 1992 |
An immunoenzymometric assay for a CA 125-like antigen, CA602
H Mochizuki, I Sato, K Nagoya, S Furusako, T Yamauchi, H Masuko, H Sato, H Morishita, M Yajima, H Sasaki, Y Udagawa, S Nozawa |
Journal of Clinical Laboratory Analysis | 1992 |
The concomitant determination of different tumor markers in patients with epithelial ovarian cancer and benign ovarian masses: Relevance for differential diagnosis
A Gadducci, M Ferdeghini, C Prontera, L Moretti, G Mariani, R Bianchi, P Fioretti |
Gynecologic Oncology | 1992 |
CA125 in peritoneal fluid of ovarian cancer patients
IB Vergote, M Onsrud, OP Børmer, BM Sert, M Moen |
Gynecologic Oncology | 1992 |
Characterization and clinical evaluation of tumor-associated antigen CA54/61 identified by monoclonal antibodies MA54 and MA61 in epithelial ovarian cancer
H Kobayashi, H Ohi, M Sugimura, H Shinohara, T Terao |
Gynecologic Oncology | 1992 |
Seven tumor markers in benign and malignant germ cell tumors of the ovary
M Kawai, T Kano, F Kikkawa, Y Morikawa, H Oguchi, N Nakashima, T Ishizuka, K Kuzuya, M Ohta, Y Arii, Y Tomoda |
Gynecologic Oncology | 1992 |
Histopathologic Diagnostic and Histogenetic Problems in Malignant Soft Tissue Tumors
S Ushigome, T Shimoda, T Nikaido, S Takasaki |
Pathology International | 1992 |
Significance of the Serum CA125 Level in Recurrent Ovarian Cancer
H Nishimura, M Tashiro, K Hamaguchi, Y Kiyozuka, H Ide, N Tateno, T Miyoshi, M Yakushiji |
Asia-Oceania Journal of Obstetrics and Gynaecology | 1992 |
CA 125 serum levels in patients with non-neoplastic liver diseases. A clinical and laboratory study
J Collazos, J Genolla, A Ruibal |
Scandinavian Journal of Clinical & Laboratory Investigation | 1992 |
The prognostic implications of low serum CA 125 levels prior to the second-look operation for stage III and IV epithelial ovarian cancer
HH Gallion, JE Hunter, JR Nagell, HE Averette, JM Cain, LJ Copeland, RV Higgins, N Husseinzadeh, WA Nahhas, EE Partridge, SH Pursell |
Gynecologic Oncology | 1992 |
Heterophile Antigens in Serous Cystadenocarcinoma of the Human Ovary
M Kamada, T Mori, Y Sakamoto, T Daitoh, H Furumoto, M Irahara, T Aono, T Mori |
Asia-Oceania Journal of Obstetrics and Gynaecology | 1992 |
Effect of Menstruation on Serum CA125 Levels
YY Kan, SH Yeh, HT Ng, CM Lou |
Asia-Oceania Journal of Obstetrics and Gynaecology | 1992 |
Sensitivity and specificity of CA242 in gastro-intestinal cancer. A comparison with CEA, CA50 and CA 19-9
O Nilsson, C Johansson, B Glimelius, B Persson, B Nørgaard-Pedersen, A Andrén-Sandberg, L Lindholm |
British Journal of Cancer | 1992 |
Comparison of the pharmacokinetics, biodistribution and dosimetry of monoclonal antibodies OC125, OV-TL 3, and 139H2 as IgG and F(ab')2 fragments in experimental ovarian cancer
CF Molthoff, HM Pinedo, HM Schlüper, HW Nijman, E Boven |
British Journal of Cancer | 1992 |
An independent evaluation of the potential clinical usefulness of proposed CA-125 indices previously shown to be of prognostic significance in epithelial ovarian cancer
DJ Cruickshank, J Paul, CR Lewis, EJ McAllister, SB Kaye |
British Journal of Cancer | 1992 |
Antigenic modulation of metastatic breast and ovary carcinoma cells by intracavitary injection of IFN-alpha
P Giacomini, M Mottolese, R Fraioli, M Benevolo, I Venturo, PG Natali |
British Journal of Cancer | 1992 |
Management of patients with ovarian cancer using monoclonal antibodies
S Lastoria, N Panza, G Esposito, E Vergara, L Castelli, C Caraco, C Battista, G Pacilio, M Salvatore |
Biomedicine & Pharmacotherapy | 1992 |
Modulation of tumour marker CA-125 expression in cultured ovarian carcinoma cells
C Marth, AG Zeimet, G Böck, G Daxenbichler |
European Journal of Cancer | 1992 |
Metastatic ovarian or colonic cancer: A clinical challenge
BG Taal, FC Jager, PC Hageman, JF Delemarre, JM Bonfrèr |
European Journal of Cancer | 1992 |
The prognostic significance of maternal serum CA125 measurement in threatened abortion
F Öçer, T Beşe, E Saridoǧan, K Aydinli, T Atasü |
European Journal of Obstetrics & Gynecology and Reproductive Biology | 1992 |
Stimulation of ovarian tumor cell proliferation with monocyte products including interleukin-1, interleukin-6, and tumor necrosis factor-α
S Wu, K Rodabaugh, O Martinez-Maza, JM Watson, DS Silberstein, CM Boyer, WP Peters, JB Weinberg, JS Berek, RC Bast |
American Journal of Obstetrics and Gynecology | 1992 |
Menstrual cyclicity of CA-125 in patients with endometriosis**Presented in part at the 47th Annual Meeting of The American Fertility Society, Orlando, Florida, October 19 to 24, 1991.††Supported in part by a grant from Centocor, Inc., Malvern, Pennsylvania, and by General Clinical Research Center grant 5-Mol-RR-02635, Brigham and Women’s Hospital, Boston, Massachusetts.‡‡Data organization and analysis assisted by the Computerized Data Base Management and Analysis System
MD Hornstein, PP Thomas, RE Gleason, RL Barbieri |
Fertility and Sterility | 1992 |
CA-125 is present in significant concentrations in periovulatory follicles of in vitro fertilization patients
N Mordel, SO Anteby, G Zajicek, I Roisman, A Treves, V Barak |
Fertility and Sterility | 1992 |
CA-125 levels in human uterine fluid**Presented in part at the 46th Annual Meeting of The American Fertility Society, Washington, D.C., October 13 to 18, 1990
M Abaé, M Gibson, J Chapitis, DH Riddick, JR Brumsted |
Fertility and Sterility | 1992 |
Characterization of human purified epithelial and stromal cells from endometrium and endometriosis in tissue culture**Supported by the Wellcome Trust, London, United Kingdom, and the University of Newcastle upon Tyne Research Committee, Newcastle upon Tyne, United Kingdom
CJ Matthews, CP Redfern, BH Hirst, EJ Thomas |
Fertility and Sterility | 1992 |
Unsettled questions regarding ovarian cancer
C Tropé, A Makar |
Acta Obstetricia et Gynecologica Scandinavica | 1992 |
What do CA 125 and other antigens tell us about ovarian cancer biology?
CE Welander |
Acta Obstetricia et Gynecologica Scandinavica | 1992 |
Biologic and Immunologic Therapy of Ovarian Cancer
MA Bookman, JS Berek |
Hematology/Oncology Clinics of North America | 1992 |
Establishment of an enzyme immunoassay using monoclonal antibody (HG1-219) and its application for the diagnosis of hepatocellular carcinoma
T Hada, Y Kinoshita, Y Ichimori, H Imanishi, K Umeyama, Y Amuro, A Toyosaka, E Okamoto, K Higashino |
Japanese journal of cancer research : Gann | 1992 |
Serological Cancer Markers
S Sell |
1992 | |
Tumormarker und Immunszintigraphie in der gynäkologischen Onkologie
D Elling, V Pink |
1992 | |
Chirurgische Therapie von Kopf-Hals-Karzinomen
K Vinzenz, HW Waclawiczek |
1992 | |
TUMOR MARKERS
MJ Seleznick |
Primary care | 1992 |
SCREENING FOR GYNECOLOGIC CANCER
KL Hall, MA Dewar, J Perchalski |
Primary care | 1992 |
Studies of a tumor-associated antigen, COX-1, recognized by a monoclonal antibody
CY Lee, KW Chen, FS Sheu, A Tsang, KC Chao, HT Ng |
Cancer Immunology, Immunotherapy | 1992 |
In search of specific cytotoxic T lymphocytes infiltrating or accompanying human ovarian carcinoma
M Apiranthitou-Drogari, C Paganin, S Bernasconi, G Losa, A Maneo, N Colombo, A Mantovani, P Allavena |
Cancer Immunology, Immunotherapy | 1992 |
Establishment of an Enzyme Immunoassay Using Monoclonal Antibody (HG1‐219) and Its Application for the Diagnosis of Hepatocellular Carcinoma
Hada T, Kinoshita Y, Ichimori Y, Imanishi H, Umeyama K, Amuro Y, Toyosaka A, Okamoto E, Higashino K |
Japanese journal of cancer research : Gann | 1992 |
Clinical use of tumor markers in oncology
EL Jacobs, CM Haskell |
Current Problems in Cancer | 1991 |
Immunohistochemical differentiation between ovarian granulosa cell tumors and ovarian carcinomas
G Gitsch, P Kohlberger, E Hanzal, H Kölbl, G Breitenecker |
Archives of Gynecology and Obstetrics | 1991 |
Carcinoma-associated mucin serum markers CA M26 and CA M29: Efficacy in detecting and monitoring patients with cancer of the breast, colon, ovary, endometrium and cervix
KA Yedema, P Kenemans, T Wobbes, GJ van Kamp, HW de Bruijn, CM Thomas, LF Massuger, CP Schuf, GG Bon, JB Vermorken, F Voorhorst, J Hilgers |
International Journal of Cancer | 1991 |
Human ovarian cancer xenografts in nude mice: Characterization and analysis of antigen expression
CF Molthoff, JJ Calame, HM Pinedo, E Boven |
International Journal of Cancer | 1991 |
Drug effects on CA125 antigen expression and antibody binding to cancer cells
T Nakai, K Endo, M Hosono, T Saga, Y Watanabe, H Sakahara, K Imai, A Yachi, Y Kivozuka, I Ishiwata, J Konishi |
International Journal of Cancer | 1991 |
Synergistic cytotoxicity of different alkylating agents for epithelial ovarian cancer
YJ Lidor, EJ Shpall, WP Peters, RC Bast |
International Journal of Cancer | 1991 |
Evaluation of serum ca 125 as a tumor marker in non-small cell lung cancer
M Diez, FJ Cerdàn, MD Ortega, A Torres, A Picardo, JL Balibrea |
Cancer | 1991 |
Monitoring patients with ovarian carcinoma: the relationship of serum CA125 levels to CT scanning
E Moskovic, E Wiltshaw, P Blake, C Parsons |
International Journal of Gynecological Cancer | 1991 |
Elevated tissue concentrations of sialyl lex-i in cancerous tissues compared with those in noncancerous tissues of various organs
K Nishida, H Yamamoto, T Ohtsuki, M Matsuba, S Mukai, Y Naito, T Yoshikawa, M Kondo |
Cancer | 1991 |
CA125 parameters in survivors and non-survivors with epithelial ovarian cancer
D Cruickshank |
International Journal of Gynecological Cancer | 1991 |
Histochemical distribution of CA-125 as a prognostic indicator in patients with serous ovarian cancer
P Bichel, A Jakobsen, T Ørntoft |
International Journal of Gynecological Cancer | 1991 |
Presence of epidermal growth factor (EGF) receptor and proliferative response to EGF in six human ovarian carcinoma cell lines
G Scambia, PB Panici, F Battaglia, G Ferrandina, C Gaggini, S Mancuso |
International Journal of Gynecological Cancer | 1991 |
Is CA-125 monitoring useful in patients with epithelial ovarian carcinoma and preoperative negative CA-125 serum levels?
P Sevelda, A Rosen, U Denison, M Barrada, J Spona, H Salzer |
Gynecologic Oncology | 1991 |
Establishment and characterization of a cell line (OMC-3) originating from a human mucinous cystadenocarcinoma of the ovary
T Yamada, M Ueda, Y Otsuki, M Ueki, O Sugimoto |
Gynecologic Oncology | 1991 |
Effect of differentiation agents on expression of CA 125, alkaline phosphatase, and cytokeratins in human ovarian adenocarcinoma cells (OVCA 433)
SE Brooks, J Timmerman, CC Lau, SW Tsao, RC Knapp, EE Sheets |
Gynecologic Oncology | 1991 |
Two Cases of Peritoneal Serous Papillary Adenocarcinoma
T Tsujimura, M Takeda, N Terada, H Uramoto |
Pathology International | 1991 |
S-100 Protein in Ovarian Tumors
M Lin, J Hanai, A Wada, M Ozaki, K Nasu, S Okamoto, K Matsumoto |
Pathology International | 1991 |
Comparison of Tumor-Associated Trypsin Inhibitor (Tati) with Ca125 as a Marker for Diagnosis and Monitoring of Epithelial Ovarian Cancer
A Gadducci, M Ferdeghini, G Rispoli, C Prontera, R Bianchi, P Fioretti |
Scandinavian Journal of Clinical & Laboratory Investigation | 1991 |
Tumour marker CA 125 in patients with digestive tract malignancies
C Haglund, P Kuusela, P Roberts, H Jalanko |
Scandinavian Journal of Clinical & Laboratory Investigation | 1991 |
Serial Changes of Serum CA125 Levels during Menstrual Cycles
H Nonogaki, S Fujii, I Konishi, Y Nanbu, F Kobayashi, T Mori |
Asia-Oceania Journal of Obstetrics and Gynaecology | 1991 |
Antigenic Studies on an Enzymatically Sialylated Carbohydrate: NeuAc(α2-3)Gal(β1-3)[GlcNAc(131-6)]GalNAc
DJ Handley, KL Matta, MS Piver, KR Diakun |
Immunological Investigations | 1991 |
Development of intrapancreatic transplantable model of pancreatic duct adenocarcinoma in Syrian golden hamsters
H Egami, T Tomioka, M Tempero, D Kay, PM Pour |
The American Journal of Pathology | 1991 |
Marker profile of different phases in the transition of normal human ovarian epithelium to ovarian carcinomas
CC van Niekerk, OC Boerman, FC Ramaekers, LG Poels |
The American Journal of Pathology | 1991 |
Early detection of ovarian cancer: background, rationale, and structure of the Yale Early Detection Program
PE Schwartz, JT Chambers, KJ Taylor, J Pellerito, L Hammers, LA Cole, TL Yang-Feng, P Smith, ST Mayne, R Makuch |
The Yale journal of biology and medicine | 1991 |
Monoclonal antibodies against CA125-bearing antigenic molecule fragments; reactivity with mucinous ovarian tumours and lung cancers
S Imai, H Maeda, Y Kiyozuka, J Morimoto, S Haga, T Noda, S Hiroishi, J Hilgers |
Molecular and Cellular Probes | 1991 |
Prechemotherapy serum CA125 level as a predictor of survival outcome in epithelial carcinoma of the ovary
NG Davidson, S Khanna, PH Kirwan, D Bircumshaw |
Clinical Oncology | 1991 |
Malignant ileal carcinoid with metastasis to adenocarcinoma of the ovary
WG Finn, MS Rao |
Human Pathology | 1991 |
Detection and localization of ovarian cancer with radiolabeled monoclonal antibodies
LF Massuger, P Kenemans, RA Claessens, RH Verheijen, FH Corstens |
European Journal of Obstetrics & Gynecology and Reproductive Biology | 1991 |
Immunocytochemical markerprofile of endometriotic epithelial, endometrial epithelial, and mesothelial cells: a comparative study
RF Kruitwagen, LG Poels, WN Willemsen, PH Jap, IJ de Ronde, TG Hanselaar, R Rolland |
European Journal of Obstetrics & Gynecology and Reproductive Biology | 1991 |
Identification of an ectopic developmental antigen that appears in malignant ascitic fluid
M Nakai, M Ishikawa, H Kawauchi |
European Journal of Obstetrics & Gynecology and Reproductive Biology | 1991 |
Primary diagnosis and follow-up of ovarian cancer: Radioimmunoscintigraphy with iodine-131 labeled OC 125 monoclonal antibodies versus computed tomography and “second look”
G Barzen, J Hierholzer, M Cordes, W Friedmann, R Felix |
International Journal of Radiation Applications and Instrumentation. Part B. Nuclear Medicine and Biology | 1991 |
Increased serum levels of macrophage colony-stimulating factor in ovarian cancer
FJ Xu, S Ramakrishnan, L Daly, JT Soper, A Berchuck, D Clarke-Pearson, RC Bast |
American Journal of Obstetrics and Gynecology | 1991 |
Secondary müllerian system and endometriosis
S Fujii |
American Journal of Obstetrics and Gynecology | 1991 |
New monoclonal antibodies identify the glycoprotein carrying the CA 125 epitope
TJ O'Brien, LM Raymond, GA Bannon, DH Ford, H Hardardottir, FC Miller, JG Quirk |
American Journal of Obstetrics and Gynecology | 1991 |
Tumour Markers in Gynaecologic Oncology
M Onsrud |
Scandinavian Journal of Clinical & Laboratory Investigation | 1991 |
High CA-125 concentrations in peritoneal fluid of normal cyclic women with various infertility-related factors as demonstrated with two-step immunoradiometric assay
RF Kruitwagen, C Thomas, LG Poels, AM Koster, WN Willemsen, R Rolland |
Fertility and Sterility | 1991 |
Clinical chemistry
DJ Anderson, FV Lente, FS Apple, SC Kazmierczak, JA Lott, MK Gupta, N McBride, WE Katzin, RE Scott, al. |
Analytical Chemistry | 1991 |
The Potential Value of CA125 as a Tumour Marker in Small Volume, Non-Evaluable Epithelial Ovarian Cancer
DJ Cruickshank, PB Terry, WT Fullerton |
The International Journal of Biological Markers | 1991 |
A new CA125-like antigen (CA602) recognized by two monoclonal antibodies against a newly established ovarian clear cell carcinoma cell line (RMG-II)
S Nozawa, M Yajima, H Sasaki, K Tsukazaki, D Aoki, M Sakayori, Y Udagawa, T Kobayashi, I Sato, S Furusako |
Japanese journal of cancer research : Gann | 1991 |
Gynäkologie und Geburtshilfe 1990
EJ Hickl, D Berg |
1991 | |
OC-125 as a diagnostic aid in the cytological evaluation of ascitic cells in patients with ovarian carcinoma
RV Skov, P Bichel |
Virchows Archiv A Pathological Anatomy and Histopathology | 1991 |
A New CA125‐like Antigen (CA602) Recognized by Two Monoclonal Antibodies against a Newly Established Ovarian Clear Cell Carcinoma Cell Line (RMG‐II)
Nozawa S, Yajima M, Sasaki H, Tsukazaki K, Aoki D, Sakayori M, Udagawa Y, Kobayashi T, Sato I, Furusako S, Mochizuki H |
Japanese journal of cancer research : Gann | 1991 |
Preoperative diagnosis of fallopian tube carcinoma by transvaginal sonography and CA-125
S Kol, D Gal, M Friedman, E Paldi |
Gynecologic Oncology | 1990 |
A Simple Procedure for Isolation of Tumor-Associated Antigens by Affinity Chromatography Using Fucose-SpecificAleuria aurantiaLectin
S Yazawa, N Kochibe, T Asao |
Immunological Investigations | 1990 |
Imaging of ovarian cancer with radiolabelled monoclonal antibodies
DL Kranenburg, MJ Kroonenburgh, JB Trimbos, GJ Fleuren, EK Pauwels |
Archives of Gynecology and Obstetrics | 1990 |
Six new monoclonal antibodies to serous, mucinous, and poorly differentiated ovarian adenocarcinomas
L Mettler, HJ Radzun, A Salmassi, W Köchling, MR Parwaresch |
Cancer | 1990 |
Cancer antigen 125, carcinoembryonic antigen, and carbohydrate determinant 19-9 in ovarian tumors
T Motoyama, H Watanabe, S Takeuchi, T Watanabe, S Gotoh, E Okazaki |
Cancer | 1990 |
Ovarian carcinoma.Advances in diagnosis, staging, and treatment
HE Averette, DM Donato |
Cancer | 1990 |
Normal bronchial mucus contains high levels of cancer-associated antigens, CA125, CA19-9, and carcinoembryonic antigen
Y Matsuoka, K Endo, Y Kawamura, T Yoshida, T Saga, Y Watanabe, M Koizumi, T Nakashima, J Konishi, N Yamaguchi, R Yatani |
Cancer | 1990 |
Adrenal Steroids and Tumor Antigens in Plasma and Cyst Fluid of Women with Gross Cystic Breast Disease
P Inaudi, V Leo, S Baldini, N D'Antona |
Annals of the New York Academy of Sciences | 1990 |
Gonadotrophin releasing hormone agonist (buserelin) in the treatment of endometriosis: changes in the extent of the disease and in CA 125 serum levels after 6-month therapy
R Marana, L Muzh, P Muscatello, A Lanzone, A Caruso, S Dell'acqua, S Mancuso |
BJOG: An International Journal of Obstetrics and Gynaecology | 1990 |
Antigenic heterogeneity in human ovarian cancer
WR Welch, JM Niloff, D Anderson, A Battaile, S Emery, RC Knapp, RC Bast |
Gynecologic Oncology | 1990 |
Gynecologic tumor markers
GJ Olt, A Berchuck, RC Bast |
Seminars in Surgical Oncology | 1990 |
Combined immunohistochemical study of tissue polypeptide antigen and cancer antigen 125 in human ovarian tumours
M Ghazizadeh, Y Sasaki, T Oguro, K Aihara, H Tenjin, T Araki |
Histopathology | 1990 |
Pretreatment serum levels of CA-125, carcinoembryonic antigen, tissue polypeptide antigen, and placental alkaline phosphatase, in patients with ovarian carcinoma, borderline tumors, or benign adnexal masses: Relevance for differential diagnosis
B Tholander, A Taube, A Lindgren, O Sjöberg, U Stendahl, A Kiviranta, K Hallman, L Holm, E Weiner, L Tamsen |
Gynecologic Oncology | 1990 |
Establishment and characterization of a new human cell line derived from ovarian clear cell carcinoma
WS Wong, YF Wong, YT Ng, PD Huang, EC Chew, TH Ho, MZ Chang |
Gynecologic Oncology | 1990 |
Immunoscintigraphy of endometriosis
SH Kennedy, OA Mojiminiyi, ND Soper, BJ Shepstone, DH Barlow |
BJOG: An International Journal of Obstetrics and Gynaecology | 1990 |
Serial measurement of CA 125 in patients with primary carcinoma of the fallopian tube
T Tokunaga, K Miyazaki, S Matsuyama, H Okamura |
Gynecologic Oncology | 1990 |
Clinical value of sialyl SSEA-1 antigen in patients with ovarian cancer
M Suzuki, M Ohwada, T Tamada |
Gynecologic Oncology | 1990 |
CA 125 in peritoneal fluid and serum from patients with benign gynecologic conditions and ovarian cancer
VJ Hunter, JB Weinberg, AF Haney, JT Soper, P Lavin, L Metsch, RC Knapp, RC Bast |
Gynecologic Oncology | 1990 |
CA 19-9 and CA 125 Determination by Immunoluminometric Assay
M Plebani, D Faggian, M Masiero, A Giacomini, A Burlina |
Clinical Chemistry and Laboratory Medicine | 1990 |
α-Fetoprotein in malignant germ cell tumors of the ovary
M Kawai, Y Furuhashi, T Kano, T Misawa, N Nakashima, S Hattori, Y Okamoto, I Kobayashi, M Ohta, Y Arii, Y Tomoda |
Gynecologic Oncology | 1990 |
Predictive value of CA 125 during early chemotherapy of advanced ovarian cancer
O Mogensen, B Mogensen, A Jakobsen |
Gynecologic Oncology | 1990 |
Immunohistochemical Localization of CA130 in Fetal Tissues, and in Normal and Neoplastic Tissues of the Female Genital Tract
Y Nanbu, S Fujii, I Konishi, H Nonogaki, N Sagawa, F Kobayashi, T Mori, T Saga, K Endo |
Asia-Oceania Journal of Obstetrics and Gynaecology | 1990 |
Human ovarian cancers specifically bind daunorubicin-OC-125 conjugate: An immunofluorescence study
B Dezsö, I Török, LO Rosik, F Sweet |
Gynecologic Oncology | 1990 |
Construction of An Immunoradiometric Ay for Ovarian Cancer Associated Antigen Ca125 Recognizing Different Antigenic Determinant
T Saga, K Endo, T Nakashima, T Awaji, M Koizumi, Y Kawamura, Y Watanabe, J Konishi, H Nonogaki, Y Nanbu, S Fujii, T Mori |
Acta Obstetricia et Gynecologica Scandinavica | 1990 |
Expression of human tumor-associated antigens in pancreatic cancer induced in Syrian hamsters
Y Takiyama, H Egami, PM Pour |
The American Journal of Pathology | 1990 |
Tumour-associated trypsin inhibitor (TATI) and cancer antigen 125 (CA 125) in mucinous ovarian tumours
O Mogensen, B Mogensen, A Jakobsen |
British Journal of Cancer | 1990 |
Serum CA125 level is a good prognostic indicator in lung cancer
Y Kimura, T Fujii, K Hamamoto, N Miyagawa, M Kataoka, A Iio |
British Journal of Cancer | 1990 |
Immunohistochemical identification of CA125 and the F(ab')2 fragments of the murine monoclonal antibody OC125 in ovarian cancer tissue
G Ronay, W Jäger, K Weiss, H Feistel, F Wolf, AH Tulusan, N Lang |
The British journal of cancer. Supplement | 1990 |
Use of MoAb D612 in combination with a panel of MoAb for the immunocytochemical identification of metastases from colon-rectum carcinoma
M Mottolese, I Venturo, G Digiesi, RP Donnorso, A Bigotti, R Muraro, A Aluffi, PG Natali |
British Journal of Cancer | 1990 |
OC125 immunoscintigraphy in ovarian carcinoma: A comparison with alternative methods of assessment
TS Maughan, B Haylock, M Hayward, P Facey, WD Evans, MD Shelley, RG Fish, M Adams |
Clinical Oncology | 1990 |
Serum placental alkaline phosphatase (PLAP) in gynecologic malignancies — with special reference to the combination of PLAP and CA54/61 assay
S Nozawa, Y Udagawa, H Ohkura, Y Negishi, K Akiya, N Inaba, H Takamizawa, E Kimura, Y Terashima |
Clinica Chimica Acta | 1990 |
A Simple Procedure for Isolation of Tumor-Associated Antigens by Affinity Chromatography Using Fucose-Specific Aleuria aurantia Lectin
S Yazawa, N Kochibe, T Asao |
Immunological Investigations | 1990 |
Comparative study of RIS with the 131I-OC 125 F(ab′)2 Mab and CT scan prior to second look operation for ovarian cancer
V Papazefkos, S Michalas, V Papantoniou, J Datseris, P Athanasiadis, T Akrivos, A Leonti, A Xygakis, D Aravantinos |
European Journal of Obstetrics & Gynecology and Reproductive Biology | 1990 |
Predictive values of CA 125 antigen levels and CT scan in second-look procedures for ovarian cancer
D Aravantinos, S Michalas, V Papazefkos, M Christoforaki, A Stypsaneli, G Vlachos, P Athanasiadis |
European Journal of Obstetrics & Gynecology and Reproductive Biology | 1990 |
Monoclonal antibodies that discriminate between human ovarian carcinomas and benign ovarian tumours
OC Boerman, WK Makkink, CM Thomas, AG Hanselaar, CA Yedema, P Kenemans, LG Poels |
European Journal of Cancer and Clinical Oncology | 1990 |
Separation and biochemical characterization of blood group N antigen precursor glycoproteins with thomsen-friedenreich (T) activity, T-active glycoproteins and N antigen precursor glycoproteins from ascites of primary ovarian cancer patients
H Shigemi, O Kunio, Y Khomei, Y Toshio, W Hajime, H Shun, O Seiichi |
International Journal of Biochemistry | 1990 |
Distribution of CA 125 in embryonic tissues and adult derivatives of the fetal periderm
H Hardardottir, TH Parmley, JG Quirk, MM Sanders, FC Miller, TJ O'Brien |
American Journal of Obstetrics and Gynecology | 1990 |
Heterogeneity of antigen expression in advanced epithelial ovarian cancer
A Berchuck, GJ Olt, AP Soisson, A Kamel, JT Soper, CM Boyer, DL Clarke-Pearson, DS Leslie, RC Bast |
American Journal of Obstetrics and Gynecology | 1990 |
CA 125 is released by human amnion cells in culture
A Barbati, MM Anceschi, L Broccucci, EV Cosmi |
American Journal of Obstetrics and Gynecology | 1990 |
Correlation between peripheral CA-125 levels and ovarian activity**Supported in part by the Abbott Diagnostics Division, Ottignies, Belgium
A Zweers, JD Boever, R Serreyn, D Vandekerckhove |
Fertility and Sterility | 1990 |
Reactivity of Polyclonal and Two Monoclonal Antibodies with Cell Subsets Isolated from Cystic Fluids of Ovarian Serous Neoplasms
A Hartozińska, JK Bar, J Rabczyński, RC Bast, R Richter, M Cisto |
TUMORI | 1990 |
Clinical Value of Radioimmunoscintigraphy in the follow-up of Ovarian Carcinoma: A Prospective Study
F Crippa, M Presti, A Marini, B D'Onofrio, G Bolis, GL Buraggi |
The International Journal of Biological Markers | 1990 |
MCA in Patients with Breast Cancer: Correlation with CEA and CA15-3
R Molina, X Filella, P Mengual, M Prats, G Zanon, M Daniels, AM Ballesta |
The International Journal of Biological Markers | 1990 |
An antibody-tumor model for the targeting of CA125-producing gynecologic malignancies
T Saga, I Ishiwata, K Endo, H Sakahara, M Koizumi, Y Watanabe, T Nakai, M Hosono, H Ishikawa, M Sawada |
Japanese journal of cancer research : Gann | 1990 |
Diagnostic value of serum tumor markers in skeletal metastasis of carcinomas
M Chigira, T Shinozaki |
Archives of Orthopaedic and Trauma Surgery | 1990 |
Endometrial Carcinoma
S Li, E Wang |
1990 | |
From Clone to Clinic
DJ Crommelin, H Schellekens |
1990 | |
Diagnostic significance of the tumour markers CEA, CA 15–3 and CA 125 in malignant effusions in breast cancer
K Kandylis, M Vassilomanolakis, N Baziotis, A Papadimitriou, S Tsoussis, A Ferderigou, AP Efremidis |
Annals of Oncology | 1990 |
Screening for Gynecologic Cancer
MJ Campion, R Reid |
Obstetrics and Gynecology Clinics of North America | 1990 |
Imaging of ovarian cancer with radiolabelled monoclonal antibodies
DL van Kranenburg, MJ van Kroonenburgh, JB Trimbos, GJ Fleuren, EK Pauwels |
Archives of Gynecology and Obstetrics | 1990 |
An Antibody‐Tumor Model for the Targeting of CA125‐producing Gynecologic Malignancies
Saga T, Ishiwata I, Endo K, Sakahara H, Koizumi M, Watanabe Y, Nakai T, Hosono M, Ishikawa H, Sawada M, Konishi J |
Japanese journal of cancer research : Gann | 1990 |
Constitutive production of macrophage colony-stimulating factor by human ovarian and breast cancer cell lines
S Ramakrishnan, FJ Xu, SJ Brandt, JE Niedel, RC Bast, EL Brown |
Journal of Clinical Investigation | 1989 |
Present status of serum markers
JP Minton, A Chevinsky |
Seminars in Surgical Oncology | 1989 |
CA 125 as a tumour marker in epithelial ovarian cancer
JD Sheehan, MJ Duffy, MA Allen, JJ Fennelly |
Irish Journal of Medical Science | 1989 |
The prognostic value of post chemotherapy serum CA 125 in epithelial ovarian cancer
M Teeling, P McGing, DN Carney |
Irish Journal of Medical Science | 1989 |
Alpha1-acid glucoprotein in ovarian cancer with a reference to immunosuppressive acidic protein and cancer antigen 125
O Mogensen, B Mogensen, A Jakobsen |
Cancer | 1989 |
Combinations of monoclonal antibodies can distinguish primary lung tumors from metastatic lung tumors sampled by fine needle aspiration biopsy
M Mottolese, I Venturo, M Rinaldi, N Campioni, A Aluffi, CG Curcio, RP Donnorso, PG Natali |
Cancer | 1989 |
Die Bedeutung des Markers CA 125 für die Nachsorge des Ovarialkarzinoms
K Engel, T Piotrowski, H Schmid, W Kühn, M Kaufmann |
Archives of Gynecology and Obstetrics | 1989 |
Simultaneous stimulation of urokinase and tissue-type plasminogen activators by phorbol esters in human ovarian carcinoma cells
V Band, BY Karlan, VR Zurawski, BA Littlefield |
Journal of Cellular Physiology | 1989 |
Serum CA 125 in acute pelvic inflammatory disease
J Paavonen, A Miettinen, PK Heinonen, RK Aaran, K Teisala, R Aine, R Punnonen, S Laine, OP Kallioniemi, M Lehtinen |
BJOG: An International Journal of Obstetrics and Gynaecology | 1989 |
Marker profile of mesothelial cellsversus ovarian carcinoma cells
CC van Niekerk, PH Jap, CM Thomas, DF Smeets, FC Ramaekers, LG Poels |
International Journal of Cancer | 1989 |
ETN-1: A new human endometrial carcinoma cell line producing ascites and distant metastases in nude mice
RF Kruitwagen, LG Poels, WN Willemsen, HJ Croes, DF Smeets, JL Beck, AG Hanselaar, FC Ramaekers, R Rolland, PH Jap |
International Journal of Cancer | 1989 |
CA 19-9, CA 125 and CEA in the endometrial mucosa during the menstrual cycle, in atypical hyperplasia and endometrial carcinoma
W Neunteufel, G Breitenecker |
Cancer Letters | 1989 |
A longitudinal study of antigen expression in epithelial ovarian cancer
SC Rubin, CL Finstad, WJ Hoskins, MG Federici, KO Lloyd, JL Lewis |
Gynecologic Oncology | 1989 |
Value of serum 125Ca levels: Does the result preclude second look?
ME Potter, M Moradi, AC To, KD Hatch, HM Shingleton |
Gynecologic Oncology | 1989 |
Characterization of two monoclonal antibodies that recognize high molecular weight colon antigens
JP Moosic, AM Mosley, K Huang, CW Taylor, LC Yeoman |
Cancer Letters | 1989 |
Prediction of the presence of ovarian cancer at surgery by an immunochemical panel: CA125 and copper-to-zinc ratio
D Gal, S Lischinsky, M Friedman, O Zinder |
Gynecologic Oncology | 1989 |
A study of the monoclonal antibody OC 125 to diagnose malignant ovarian tumors
L Xinguo, C Dixia, PE Schwartz, Y Zhan |
Gynecologic Oncology | 1989 |
Therapeutic effect of a radiolabeled monoclonal antibody on human ovarian cancer xenograft in nude mice
A Manetta, PG Satyaswaroop, T Hamilton, R Ozols, R Mortel |
Gynecologic Oncology | 1989 |
Characterization of the CA125 Antigen Secreted from a Newly Established Human Ovarian Cancer Cell Line (SHIN-3)
S Imai, H Maeda, Y Kiyozuka, T Noda, I Moriyama, M Ichijo |
Pathology International | 1989 |
Establishment and Characterization of CA 125 Producing Cell Line (OMC-2) Originating from a Human Endometrial Adenocarcinoma
T Yamada, M Ueda, T Maeda, Y Okamoto, Y Miyawaki, Y Otsuki, M Ueki, O Sugimoto |
Asia-Oceania Journal of Obstetrics and Gynaecology | 1989 |
Use of CA 125 to monitor patients with ovarian epithelial carcinomas
E Podczaski, C Whitney, A Manetta, JE Larson, J Kirk, CW Stevens, J Lyter, R Mortel |
Gynecologic Oncology | 1989 |
Characterization of a hormone-producing ovarian carcinoma cell line
LG Poels, PH Jap, FF Ramaekers, JM Scheres, CM Thomas, PG Vooijs, HJ Croes, G Mungyer |
Gynecologic Oncology | 1989 |
Daunorubicin conjugated to a monoclonal anti-CA125 antibody selectively kills human ovarian cancer cells
F Sweet, LO Rosik, GM Sommers, JL Collins |
Gynecologic Oncology | 1989 |
Tissue expression of CA 125 in benign and malignant lesions of ovary and fallopian tube: A comparison with CA 19-9 and CEA
W Neunteufel, G Breitenecker |
Gynecologic Oncology | 1989 |
Use of CA 125 monoclonal antibody to monitor patients with ovarian cancer
S Kudlacek, K Schieder, H Kölbl, W Neunteufel, C Nowotny, G Breitenecker, G Biegelmayer, M Vetterlein, B Fürlinger, M Micksche |
Gynecologic Oncology | 1989 |
Serum levels of CA 125 and histological findings at second-look laparotomy in ovarian carcinoma
W Meier, P Stieber, W Eiermann, A Schneider, A Fateh-Moghadam, H Hepp |
Gynecologic Oncology | 1989 |
Tumor Markers in Human Biopsy Material
VP Lehto, J Pontén |
Acta Oncologica | 1989 |
The clinical correlates of serum CA125 in 169 patients with epithelial ovarian carcinoma
RE Hawkins, K Roberts, E Wiltshaw, J Mundy, VR McCready |
British Journal of Cancer | 1989 |
Biological properties of ten human ovarian carcinoma cell lines: calibration in vitro against four platinum complexes
CA Hills, LR Kelland, G Abel, J Siracky, AP Wilson, KR Harrap |
British Journal of Cancer | 1989 |
Serum levels and biochemical characteristics of human ovarian carcinoma-associated antigen defined by murine monoclonal antibody, CF511
K Ohkawa, Y Tsukada, M Murae, E Kimura, K Takada, T Abe, Y Terashima, K Mitani |
British Journal of Cancer | 1989 |
Partial purification and characterization of CA19-9 antigen from the ascitic fluid of a patient with pancreatic cancer
Y Haga, S Horiuchi, Y Morino, M Akagi |
Clinical Biochemistry | 1989 |
Clinical significance of mucin-like high molecular weight glycoprotein originated from lung cancer as tumor marker
M Imokawa, H Okabe, Y Ochi, Y Kajita |
Clinica Chimica Acta | 1989 |
A new human cholangiocellular carcinoma cell line (HuCC-T1) producing carbohydrate antigen 19/9 in serum-free medium
M Miyagiwa, T Ichida, T Tokiwa, J Sato, H Sasaki |
In Vitro Cellular & Developmental Biology | 1989 |
Serum levels of CA-50, CA-19.9, CA-125, neuron specific enolase and carcinoembryonic antigen in lung cancer and benign diseases of the lung
G Berthiot, F Marechal, A Cattan, G Deltour |
Biomedicine & Pharmacotherapy | 1989 |
The use of tumour markers in clinical practice
T Cooke, CA Makin |
Bailliere's Clinical Gastroenterology | 1989 |
CA 125 levels in endometriosis patients before, during and after treatment with Danazol or LHRH agonists
P Acien, RW Shaw, L Irvine, G Burford, R Gardner |
European Journal of Obstetrics & Gynecology and Reproductive Biology | 1989 |
Locoregional immunotherapy of human ovarian cancer: Preliminary results
P Riva, M Marangolo, S Lazzari, M Agostini, G Sarti, G Moscatelli, G Franceschi, A Spinelli, G Vecchietti |
International Journal of Radiation Applications and Instrumentation. Part B. Nuclear Medicine and Biology | 1989 |
Pharmacokinetics of a radioiodinated monoclonal antibody F(ab′)2 fragment in a xenograft model with circulating antigen
MR Zalutsky, RC Bast, RC Knapp |
International Journal of Radiation Applications and Instrumentation. Part B. Nuclear Medicine and Biology | 1989 |
Labeling proteins using aryl iodide acylation agents: Influence of meta vs para substitution on in vivo stability
PK Garg, SK Slade, CL Harrison, MR Zalutsky |
International Journal of Radiation Applications and Instrumentation. Part B. Nuclear Medicine and Biology | 1989 |
Mechanism and clinical significance of elevated CA 125 levels in the sera of pregnant women
F Kobayashi, N Sagawa, K Nakamura, M Nonogaki, C Ban, S Fujii, T Mori |
American Journal of Obstetrics and Gynecology | 1989 |
Ontogeny of CA 125 antigen in pregnancy: Immunoradiometric determination in amniotic fluid and immunohistochemical localization in fetal membranes
A Barbati, MM Anceschi, P Alberti, G Pomili, GC Renzo, EV Cosmi |
American Journal of Obstetrics and Gynecology | 1989 |
Influence of human antimurine antibody on CA 125 levels in patients with ovarian cancer undergoing radioimmunotherapy or immunoscintigraphy with murine monoclonal antibody OC 125
MG Muto, EM Lepisto, AD van Abbeele, RC Knapp, AI Kassis |
American Journal of Obstetrics and Gynecology | 1989 |
CA 125 in the epithelium closely related to the embryonic ectoderm: The periderm and the amnion
Y Nanbu, S Fujii, I Konishi, H Nonogaki, T Mori |
American Journal of Obstetrics and Gynecology | 1989 |
Monoclonal antibodies reactive with human breast or ovarian carcinoma: In vivo applications
AD Thor, SM Edgerton |
Seminars in Nuclear Medicine | 1989 |
Immunohistochemical Reactivity of a Monoclonal Antibody Prepared against Human Ovarian Carcinoma on Normal and Pathological Female Genital Tissues
R Veggian, S Fasolato, S Ménard, D Minucci, P Pizzetti, M Regazzoni, E Tagliabue, MI Colnaghi |
TUMORI | 1989 |
A correlation between the expression of CD 8 antigen and specific cytotoxicity of tumor-infiltrating lymphocytes
Y Okada, G Yahata, S Takeuchi, T Seidoh, K Tanaka |
Japanese journal of cancer research : Gann | 1989 |
Abolition of in vivo platelet thrombus formation in primates with monoclonal antibodies to the platelet GPIIb/IIIa receptor. Correlation with bleeding time, platelet aggregation, and blockade of GPIIb/IIIa receptors
BS Coller, JD Folts, SR Smith, LE Scudder, R Jordan |
Circulation | 1989 |
Immunoreactive determinants of CA 125 in women with endometriosis
OA Mojiminiyi, ME Bramwell, SH Kennedy, BJ Shepstone, SM Humm, DH Barlow |
Journal of clinical pathology | 1989 |
New Cancer Markers
MJ Duffy |
Annals of Clinical Biochemistry | 1989 |
Gynäkologie und Geburtshilfe 1988
H Ludwig, D Krebs |
1989 | |
Breast Cancer Immunodiagnosis and Immunotherapy
RL Ceriani |
1989 | |
CA-125 in Women with Endometriosis
DE Pittaway |
Obstetrics and Gynecology Clinics of North America | 1989 |
Radioimmunoscintigraphy of ovarian cancer with 131-iodine labeled OC-125 antibody fragments
G Barzen, AC Mayr, M Langer, R Becker, M Cordes, C Zwicker, K Koppenhagen, R Felix |
European Journal of Nuclear Medicine | 1989 |
A new human cholangiocellular carcinoma cell line (HuCC-T1) producing carbohydrate antigen 19/9 in serum-free medium
M Miyagiwa, T Ichida, T Tokiwa, J Sato, H Sasaki |
In Vitro Cellular & Developmental Biology – Animal | 1989 |
A Correlation between the Expression of CD 8 Antigen and Specific Cytotoxicity of Tumor‐infiltrating Lymphocytes
Okada Y, Yahata G, Takeuchi S, Seidoh T, Tanaka K |
Japanese journal of cancer research : Gann | 1989 |
Monoclonal antibody against the platelet glycoprotein (GP) IIb/IIIa receptor prevents coronary artery reocclusion after reperfusion with recombinant tissue-type plasminogen activator in dogs
T Yasuda, HK Gold, JT Fallon, RC Leinbach, JL Guerrero, LE Scudder, M Kanke, D Shealy, MJ Ross, D Collen |
Journal of Clinical Investigation | 1988 |
Development of new immunoradiometric assay for CA 125 antigen using two monoclonal antibodies produced by immunizing lung cancer cells
M Kunimatsu, K Endo, T Nakashima, T Awaji, T Saga, Y Watanabe, Y Kawamura, H Ohta, M Koizumi, H Sakahara, J Konishi, S Fujii, T Mori, K Torizuka, Y Matsuoka, T Nakagawa, N Yamaguchi |
Annals of Nuclear Medicine | 1988 |
Serum levels of six tumor markers in patients with benign and malignant gynecological disease
I Fukazawa, N Inaba, Y Ota, N Sato, S Shirotake, H Iwasawa, T Sato, H Takamizawa, B Wiklund |
Archives of Gynecology and Obstetrics | 1988 |
Immunoradiometrical measurement of tissue polypeptide antigen (TPA) and cancer antigen 125 (CA125) in pregnancy and at delivery
K Itahashi, N Inaba, I Fukazawa, H Takamizawa |
Archives of Gynecology and Obstetrics | 1988 |
MULTIMODAL APPROACH TO SCREENING FOR OVARIAN CANCER
I Jacobs, J Bridges, C Reynolds, I Stabile, P Kemsley, J Grudzinskas, D Oram |
The Lancet | 1988 |
Cancer antigen 125, tissue polypeptide antigen, carcinoembryonic antigen, and beta-chain human chorionic gonadotropin as serum markers of epithelial ovarian carcinoma
N Panza, G Pacilio, L Campanella, G Peluso, C Battista, A Amoriello, W Utech, C Vacca, G Lombardi |
Cancer | 1988 |
The distribution of CA 125 in the reproductive tract of pregnant and non-pregnant women
IJ Jacobs, TN Fay, I Stabile, JE Bridges, DH Oram, JG Grudzinskas |
BJOG: An International Journal of Obstetrics and Gynaecology | 1988 |
Immunoscintigraphy of ovarian endometriosis. A preliminary study
SH Kennedy, DH Barlow, ND Soper, OA Mojiminiyi, BJ Shepstone |
BJOG: An International Journal of Obstetrics and Gynaecology | 1988 |
Use of selected combinations of monoclonal antibodies to tumor associated antigens in the diagnosis of neoplastic effusions of unknown origin
M Mottolese, I Venturo, RP Donnorso, CG Curcio, M Rinaldi, PG Natali |
European Journal of Cancer and Clinical Oncology | 1988 |
Pre-operative discrimination between benign and malignant ovarian tumors using a combination of CA125 and CA15.3 serum assays
C Yedema, L Massuger, J Hilgers, J Servaas, L Poels, C Thomas, P Kenemans |
International Journal of Cancer | 1988 |
CA 125 in the monitoring of response to chemotherapy of ovarian carcinoma
M Quaranta, V Lorusso, M Coviello, G Micelli, A Casamassima |
International Journal of Cancer | 1988 |
Characterization of a human ovarian carcinoma cell line, OTN 14, derived from a mucinous cystadenocarcinoma
CC van Niekerk, LG Poels, PH Jap, DF Smeets, CM Thomas, FC Ramaekers, GP Vooijs |
International Journal of Cancer | 1988 |
Localization of radiolabelled F(ab′)2 fragments of monoclonal antibodies in nude mice bearing intraperitoneally growing human ovarian cancer xenografts
KR Moseley, A Battaile, RC Knapp, HJ Haisma |
International Journal of Cancer | 1988 |
Human ovarian carcinoma lysis by cytotoxic t cells targeted by bispecific monoclonal antibodies: Analysis of the antibody components
D Mezzanzanica, S Canevari, S Ménard, SM Pupa, E Tagliabue, A Lanzavecchia, MI Colnaghi |
International Journal of Cancer | 1988 |
Ciliated ovarian adenocarcinoma cells in ascitic fluid cytology: Report of a case with immunocytochemical features
TK Kobayashi, S Teraoka, T Tsujioka, Y Yoshida |
Diagnostic Cytopathology | 1988 |
Serum levels of cancer-associated antigen 195, a circulating marker for colon cancer, and its relationship to carcinoembryonic antigen
KR Bray, PK Gaur |
Journal of Clinical Laboratory Analysis | 1988 |
Plasminogen activator secretion by established lines of human ovarian carcinoma cells in vitro
BY Karlan, W Amin, V Band, VR Zurawski, BA Littlefield |
Gynecologic Oncology | 1988 |
Human ovarian tumors in primary culture: Growth, characterization and initial evaluation of the response to cis platinum treatmentin vitro
G Balconi, M Brogcini, E Erba, M D'Incalci, N Colombo, C Mangioni, F Bertolero |
International Journal of Cancer | 1988 |
Reactivity of the Monoclonal Antibody B72.3 with Fetal Antigen: Correlation with Expression of TAG-72 in Human Carcinomas
D Stanick, A Schuss, Y Mishriki, S Chao, A Thor, J Lundy |
Cancer Investigation | 1988 |
Combination assay of CA125, TPA, IAP, CEA, and ferritin in serum for ovarian cancer
H Yabushita, T Masuda, A Ogawa, M Noguchi, M Ishihara |
Gynecologic Oncology | 1988 |
The role of cancer antigen 125 (CA 125) in the management of ovarian epithelial carcinomas
MM Altaras, GL Goldberg, W Levin, B Bloch, L Darge, JA Smith |
Gynecologic Oncology | 1988 |
Tumour marker immunoreactivity in adenocarcinoma
IO Ellis, A Hitchcock |
Journal of clinical pathology | 1988 |
The use of monoclonal antibody B72.3 in the management of gynecologic malignancies
J Simpson, J Schlom |
The Yale journal of biology and medicine | 1988 |
An assay for the detection of human anti-murine immunoglubulins in the presence of CA125 antigen
KR Moseley, RC Knapp, HJ Haisma |
Journal of Immunological Methods | 1988 |
Human ovarian tumors in primary culture: Growth, characterization and initial evaluation of the response to cis platinum treatment in vitro
G Balconi, M Brogcini, E Erba, M D'Incalci, N Colombo, C Mangioni, F Bertolero |
International Journal of Cancer | 1988 |
Clinical applications of monoclonal antibodies against ovarian cancer-associated antigens
P Kenemans, CA Yedema, JH Hilgers, LF Massuger, RH Verheijen, CM Thomas, LG Poels |
European Journal of Obstetrics & Gynecology and Reproductive Biology | 1988 |
Influence of circulating antigen on blood pool activity of a radioiodinated monoclonal antibody
MR Zalutsky, RC Knapp, RC Bast |
International Journal of Radiation Applications and Instrumentation. Part B. Nuclear Medicine and Biology | 1988 |
Tumor markers in non-malignant diseases
Y Touitou, A Bogdan |
European Journal of Cancer and Clinical Oncology | 1988 |
The ovarian cancer associated antigen CA 125 in patients with pleural effusions
J Lindgren, P Kuusela, PE Hellström, T Pettersson, M Klockars |
European Journal of Cancer and Clinical Oncology | 1988 |
Detection of human ovarian tumor-associated antigens by antibodies isolated from ovarian carcinoma ascitic fluid
GS Rao, P Hanjani |
American Journal of Obstetrics and Gynecology | 1988 |
CA 125 in tissues and amniotic fluid during pregnancy
JG Quirk, GL Brunson, CA Long, GA Bannon, MM Sanders, TJ O'Brien |
American Journal of Obstetrics and Gynecology | 1988 |
Clinical evaluation of ovarian tumor antigen NB/70K: monoclonal antibody assays for distinguishing ovarian cancer from other gynecologic disease
S Knauf |
American Journal of Obstetrics and Gynecology | 1988 |
Serum and peritoneal lavage fluid CA-125 levels in endometriosis
RW Moretuzzo, S DiLauro, E Jenison, SL Chen, RH Reindollar, PG McDonough |
Fertility and Sterility | 1988 |
An evaluation of CA125, CA1 and peanut lectin immunoreactivity in epithelial ovarian neoplasms: correlation with histopathological features, prognostic variables and patient outcome
M Friedlander, J Leary, P Russell |
Pathology | 1988 |
Tumor Antigen Nb/70K and Ca 125 Levels in the Blood of Preoperative Ovarian Cancer Patients and Controls: A Preliminary Report of the use of the Nb12123 and Ca 125 Radioimmunoassays Alone and in Combination
S Knauf, RC Bast |
The International Journal of Biological Markers | 1988 |
Radioimmunoscintigraphy Using Monoclonal Antibodies to CEA, CA 19-9 and CA 125
RP Baum, M Lorenz, C Hottenrott, M Albrecht, R Senekowitsch, J Happ, A Hertel, J Spitz, G Hör |
The International Journal of Biological Markers | 1988 |
Co-expression of human cancer-associated epitopes on mucin molecules
MS Lan, RS Metzgar, RC Bast, MI Colnaghi, RC Knapp, D Colcher, J Schlom |
International Journal of Cancer | 1987 |
Manipulation of the intratumor infiltrate by anti-tumor antibody conjugates
R Obrist |
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer | 1987 |
Lewis and related tumor-associated determinants on ovarian carcinoma
NG Ordonez, RS Freedman, M Herlyn |
Gynecologic Oncology | 1987 |
Characterization of human ovarian carcinoma-associated antigens defined by novel monoclonal antibodies with tumor-restricted specificity
S Miotti, S Canevari, S Ménard, D Mezzanzanica, G Porro, SM Pupa, M Regazzoni, E Tagliabue, MI Colnaghi |
International Journal of Cancer | 1987 |
Serum CA 125 and survival of mice inoculated with ovarian carcinoma and treated with antiestrogen, estrogen, or progestin
JA Holt, SE Waggoner, EY Lee, MM Hubby, TC Hamilton |
Gynecologic Oncology | 1987 |
Explanation of the limited correlation between tumor CA 125 content and serum CA 125 antigen levels in patients with ovarian tumors
GJ Fleuren, M Nap, JG Aalders, JB Trimbos, HW de Bruijn |
Cancer | 1987 |
Villin: a cytoskeletal protein and a differentiation marker expressed in some human adenocarcinomas
R Moll, S Robine, B Dudouet, D Louvard |
Virchows Archiv B Cell Pathology Including Molecular Pathology | 1987 |
Immunoradiometric assay of CA 125 in effusions comparison with carcinoembryonic antigen
MM Pinto, LH Bernstein, DA Brogan, E Criscuolo |
Cancer | 1987 |
The detection of human pancreatic cancer-associated antigen in the serum of cancer patients
YS Chung, JJ Ho, YS Kim, H Tanaka, B Nakata, A Hiura, H Motoyoshi, K Satake, K Umeyama |
Cancer | 1987 |
Elevation of CA 125 in patients with benign and malignant ascites
JF Bergmann, JM Bidart, M George, M Beaugrand, VG Levy, C Bohuon |
Cancer | 1987 |
Hepatoid carcinoma of the ovary. A newly described tumor
H Ishikura, RE Scully |
Cancer | 1987 |
The clinical significance of pre-operative serum CA 125 in ovarian cancer
D Cruickshank, WT Fullerton, A Klopper |
BJOG: An International Journal of Obstetrics and Gynaecology | 1987 |
Serum CA 125 in epithelial ovarian cancer. A longitudinal study
PA Brioschi, O Irion, P Bischof, M Bader, M Forni, F Krauer |
BJOG: An International Journal of Obstetrics and Gynaecology | 1987 |
Serum CA 125 levels in epithelial ovarian cancer: relation with findings at second-look operations and their role in the detection of tumour recurrence
MS Schtlthuis, JG Aalders, J Bouma, HW Bruijn, H Kooi, PH Willemse, GJ Fleuren |
BJOG: An International Journal of Obstetrics and Gynaecology | 1987 |
Immunochemical characterization and radioimmunometric petection of molecules shed by human ovarian cancer
F Leoni, RC Bast, S Canevari, S Menard, JT Soper, MI Colnaghi |
International Journal of Cancer | 1987 |
Antibody-antigen complex formation following injection of OC125 monoclonal antibody in patients with ovarian cancer
HJ Haisma, A Battaile, EW Stradtman, RC Knapp, VR Zurawski |
International Journal of Cancer | 1987 |
Radioimaging of human ovarian carcinoma xenograft in nude mice
A Manetta, PG Satyaswaroop, T Hamilton, R Ozols, R Mortel |
Gynecologic Oncology | 1987 |
Establishment of a murine monoclonal antibody against human clear cell carcinoma and analysis of the corresponding antigen
S Nakagawa, Y Tsuji, N Masuda, H Nishiura, S Isojima |
Gynecologic Oncology | 1987 |
Correlation of CA125 and CA19-9 serum levels with clinical course and second-look findings in patients with ovarian carcinoma
P Fioretti, A Gadducci, M Ferdeghini, T Bartolini, R Bianchi, V Facchini |
Gynecologic Oncology | 1987 |
COMBINED HEPATOCELLULAR AND CHOLANGIOCARCINOMA ARISING IN A CIRRHOTIC LIVER: Report of an Autopsy Case
H Sonobe, K Hayashi, K Takahashi, Y Ohtsuki, K Matsumoto, S Onishi, K Jinno |
Pathology International | 1987 |
Characterization of newly established human ovarian carcinoma cell line—Special reference of the effects of cis-platinum on cellular proliferation and release of CA125
I Ishiwata, C Ishiwata, M Soma, S Nozawa, H Ishikawa |
Gynecologic Oncology | 1987 |
Cytological Properties of Human Ovarian Carcinoma Cell Lines
I Ishiwata, C Ishiwata, S Nozawa, H Ishikawa |
Asia-Oceania Journal of Obstetrics and Gynaecology | 1987 |
Clinical Significance of CA125 and Its Assessement with an Enzyme Immunoassay
QY Shi, T Sakawaki, T Kasamatsu, H Ohkura |
Asia-Oceania Journal of Obstetrics and Gynaecology | 1987 |
CA125 Serum Levels and Secondary Laparotomy in Epithelial Ovarian Tumours
RM Rome, H Koh, D Fortune, M Cauchi |
The Australian and New Zealand Journal of Obstetrics and Gynaecology | 1987 |
Tumor markers in the human ovary and its neoplasms. A comparative immunohistochemical study
EJ Nouwen, PG Hendrix, S Dauwe, MW Eerdekens, ME de Broe |
The American Journal of Pathology | 1987 |
cis-platinum and ovarian carcinoma. In vitro chemosensitivity of cultured tumour cells from patients receiving high dose cis-platinum as first line treatment
AP Wilson, CH Ford, CE Newman, A Howell |
British Journal of Cancer | 1987 |
Tumour-associated trypsin inhibitor (TATI) in human ovarian cyst fluid. Comparison with CA 125 and CEA
H Halila, ML Huhtala, C Haglund, S Nordling, UH Stenman |
British Journal of Cancer | 1987 |
Epithelium-specific surface glycoprotein of Mr 34,000 is a widely distributed human carcinoma marker
G Moldenhauer, F Momburg, P Möller, R Schwartz, GJ Hämmerling |
British Journal of Cancer | 1987 |
Biologic therapy for the treatment of malignant common epithelial tumors of the ovary
TC Hamilton, RF Ozols, DL Longo |
Cancer | 1987 |
Surgical staging of gynecologic malignancies
HE Averette, DM Donato, JL Lovecchio, BU Sevin |
Cancer | 1987 |
Pros and cons of gynecologic tumor markers
RC Bast, V Hunter, RC Knapp |
Cancer | 1987 |
Enhanced melphalan cytotoxicity in human ovarian cancer in vitro and in tumor-bearing nude mice by buthionine sulfoximine depletion of glutathione
RF Ozols, KG Louie, J Plowman, BC Behrens, RL Fine, D Dykes, TC Hamilton |
Biochemical Pharmacology | 1987 |
Predictive value of serial CA 125 antigen levels in ovarian cancer evaluated by second-look laparotomy
SK Khoo, T Hurst, MJ Webb, GJ Dickie, JH Kearsley, EV Mackay |
European Journal of Cancer and Clinical Oncology | 1987 |
CA-125 in gynecological malignancies
W Meier, P Stieber, A Fateh-Moghadam, W Eiermann, H Hepp |
European Journal of Cancer and Clinical Oncology | 1987 |
The clinical value of serum CA125 levels in ovarian cancer patients receiving platinum therapy
RG Fish, MD Shelley, T Maughan, I Rocker, M Adams |
European Journal of Cancer and Clinical Oncology | 1987 |
Relation of fibrin and tumour-associated antigens to the spread of ovarian cancer
M Röbl, K Jürgensmeyer, R Hafter, R Schröck, O Wilhelm, R Babic, H Graeff |
Fibrinolysis | 1987 |
Therapeutic and diagnostic uses of modified monoclonal antibodies
LW Brady, DV Woo, ND Heindel, AM Markoe, H Koprowski |
International journal of radiation oncology, biology, physics | 1987 |
Elevated levels of CA-125 in serum of patients suffering from ovarian hyperstimulation syndrome
W Jäger, K Diedrich, L Wildt |
Fertility and Sterility | 1987 |
A combined serological and immunohistological investigation of CA 125 antigen and malignant ovarian epithelial tumours
A Hitchcock, IO Ellis, C Selby, DT Liu, RE Cotton |
Journal of Obstetrics & Gynaecology | 1987 |
Present Status of Serum Tumor Markers in Diagnosis, Prognosis, and Evaluation of Therapy
SL Cohn, ST Lincoln, ST Rosen |
Cancer Investigation | 1986 |
Ovarian cancer antigen CA 125 levels in pelvic inflammatory disease and pregnancy
H Halila, UH Stenman, M Seppälä |
Cancer | 1986 |
Monoklonale Antikörper in Diagnostik und Verlaufskontrolle des Ovarialkarzinoms. CA 125 als Tumormarker
H Kaesemann, H Caffier, FJ Hoffmann, G Crombach, H Würz, R Kreienberg, V Möbus, P Schmidt-Rhode, G Sturm |
Klinische Wochenschrift | 1986 |
Biochemical characterization of the monoclonal antibody-defined ovarian carcinoma-associated antigen SGA
TA de Kretser, HJ Thorne, D Picone, DG Jose |
International Journal of Cancer | 1986 |
Establishment and characterization of two human ovarian endometrioid carcinoma cell lines (with or without squamous cell component)
I Ishiwata, C Ishiwata, M Soma, H Ishikawa |
Gynecologic Oncology | 1986 |
The value of cancer antigen-125 as a tumor marker in malignant germ cell tumors of the ovary
MM Altaras, GL Goldberg, W Levin, L Darge, B Bloch, JA Smith |
Gynecologic Oncology | 1986 |
CA125 Production by Gynecologic Tumors in Vitro and its Modulation Induced by Dibutyl Cyclic Adenosine Monophosphate
I Ishiwata, C Ishiwata, S Nozawa, H Ishikawa |
Asia-Oceania Journal of Obstetrics and Gynaecology | 1986 |
Tumour marker antigen CA125 in pancreatic cancer: a comparison with CA19-9 and CEA
C Haglund |
British Journal of Cancer | 1986 |
Monoklonale Antikörper in Diagnostik und Verlaufskontrolle des Ovarialkarzinoms. CA 125 als Tumormarker: Eine kooperative Studie der Gynäkologischen Tumormarkergruppe (GTMG)
H Kaesemann, H Caffier, FJ Hoffmann, G Crombach, H Würz, R Kreienberg, V Möbus, P Schmidt-Rhode, G Sturm |
Klinische Wochenschrift | 1986 |
A serum test for cystic fibrosis using monoclonal antibody 19-9
DD Roberts, DL Monsein, RC Frates, MS Chernick, V Ginsburg |
Archives of Biochemistry and Biophysics | 1986 |
CA 125 in gynecologic practice
GD Malkasian, KC Podratz, CR Stanhope, RE Ritts, VR Zurawski |
American Journal of Obstetrics and Gynecology | 1986 |
CA 125 surveillance and second-look laparotomy in ovarian carcinoma
DB Atack, JA Nisker, HH Allen, ER Tustanoff, L Levin |
American Journal of Obstetrics and Gynecology | 1986 |
CA 125 antigen in human amniotic fluid and fetal membranes
TJ O'Brien, JW Hardin, GA Bannon, JS Norris, G Quirk |
American Journal of Obstetrics and Gynecology | 1986 |
The tumor marker CA 125 is a common constituent of normal cervical mucus
HW de Bruijn, TB Calkoen-Carpay, S Jager, JM Duk, JG Aalders, GJ Fleuren |
American Journal of Obstetrics and Gynecology | 1986 |
Evaluation of Serum CA125 Values in Healthy Individuals and Pregnant Women
Y Haga, K Sakamoto, H Egami, R Yoshimura, M Akagi |
The American Journal of the Medical Sciences | 1986 |
Clinical Significance of Serum CA125 Values in Patients with Cancers of the Digestive System
Y Haga, K Sakamoto, H Egami, R Yoshimura, K Mori, M Akagi |
The American Journal of the Medical Sciences | 1986 |
CA-125 in patients with endometriosis
RL Barbieri |
Fertility and Sterility | 1986 |
Tumour Markers in Pancreatic Cancer
C Haglund, PJ Roberts, P Kuusela, H Jalanko |
Scandinavian Journal of Gastroenterology | 1986 |
CA-125 levels in endometriosis
PE Patton, CS Field, RW Harms, CB Coulam |
Fertility and Sterility | 1986 |
Elevated serum concentrations of CA-125 in patients with advanced endometriosis
RL Barbieri, JM Niloff, RC Bast, E Schaetzl, RW Kistner, RC Knapp |
Fertility and Sterility | 1986 |
Monoclonal Antibodies: Their Chemistry, Functions, and Possible Uses
FR Seiler, P Gronski, R Kurrle, G L�ben, HP Harthus, W Ax, K Bosslet, HG Schwick |
Angewandte Chemie (International ed. in English) | 1985 |
Ca 125 and Ca 19-9: two cancer-associated sialylsaccharide antigens on a mucus glycoprotein from human milk
FG HANISCH, G UHLENBRUCK, C DIENST, M STOTTROP, E HIPPAUF |
European Journal of Biochemistry | 1985 |
The value of the monoclonal antibody (cancer antigen 125) in serial monitoring of ovarian cancer: a comparison with circulating immune complexes
J Dodd, JP Tyler, AJ Crandon, NJ Blumenthal, RA Fay, PJ Baird, LJ Hicks, CN Hudson |
BJOG: An International Journal of Obstetrics and Gynaecology | 1985 |
Tumour-associated antigen CA 125 in patients with ovarian cancer
PK Heinonen, K Tontti, T Koivula, P Pystynen |
BJOG: An International Journal of Obstetrics and Gynaecology | 1985 |
Production of murine monoclonal antibodies against cell-surface antigens of human ovarian carcinoma
M Bhattacharya, SK Chatterjee, A Gangopadhyay, JJ Barlow |
Journal of Surgical Oncology | 1985 |
Monoklonale Antikörper: Chemie, Funktion und Anwendungsmöglichkeiten
FR Seiler, P Gronski, R Kurrle, G Lüben, HP Harthus, W Ax, K Bosslet, HG Schwick |
Angewandte Chemie | 1985 |
Elevation of serum CA 125 prior to diagnosis of an epithelial ovarian carcinoma
RC Bast, FP Siegal, C Runowicz, TL Klug, VR Zurawski, D Schonholz, CJ Cohen, RC Knapp |
Gynecologic Oncology | 1985 |
The sebaceous gland antigen defined by the OM-1 monoclonal antibody is expressed at high density on the surface of ovarian carcinoma cells
TA de Kretser, HJ Thorne, DJ Jacobs, DG Jose |
European Journal of Cancer and Clinical Oncology | 1985 |
Practical applications of a monoclonal antibody (NDOG2) against placental alkaline phosphatase in ovarian cancer
JO Davies, ER Davies, K Howe, P Jackson, E Pitcher, B Randle, C Sadowski, GM Stirrat, CA Sunderland |
Journal of the Royal Society of Medicine | 1985 |
Characterization of the Specificity by Immunohistology of a Monoclonal Antibody to a Novel Epithelial Antigen of Ovarian Carcinomas
R Mariani-Costantini, R Agresti, MI Colnaghi, S Ménard, S Andreola, F Rilke |
Pathology - Research and Practice | 1985 |
Use of the CA 125 antigen in diagnosis and monitoring of ovarian carcinoma
RC Bast, RC Knapp |
European Journal of Obstetrics & Gynecology and Reproductive Biology | 1985 |
Prospects and applications of monoclonal antibodies in gynecological oncology
P Kenemans, RH Verheijen, AM Leloux, LG Poels |
European Journal of Obstetrics & Gynecology and Reproductive Biology | 1985 |
Reply to Davies et al
JM Niloff, RC Knapp, RC Bast |
American Journal of Obstetrics and Gynecology | 1985 |
Human lymphoblastoid interferon in the treatment of advanced epithelial ovarian malignancies: A Gynecologic Oncology Group study
G Abdulhay, PJ DiSaia, JA Blessing, WT Creasman |
American Journal of Obstetrics and Gynecology | 1985 |
Are CA125 and placental alkaline phosphatase the same antigen?
JO Davies, GM Stirrat, CA Sunderland |
American Journal of Obstetrics and Gynecology | 1985 |
Practical Applications of a Monoclonal Antibody (NDOG 2 ) against Placental Alkaline Phosphatase in Ovarian Cancer
JO Davies, P Jackson, C Sadowski, ER Davies, E Pitcher, GM Stirrat, K Howe, B Randle, CA Sunderland |
Journal of the Royal Society of Medicine | 1985 |
The localization of an anti-tumour monoclonal antibody (791T/36) in gastrointestinal tumours
NC Armitage, AC Perkins, MV Pimm, PA Farrands, RW Baldwin, JD Hardcastle |
British Journal of Surgery | 1984 |
Immunoelectronmicroscopic Demonstration of Surface Tumor Antigen Ca 125
A Blaustein |
Ultrastructural Pathology | 1984 |
Cell surface antigens of human ovarian and endometrial carcinoma defined by mouse monoclonal antibodies
MJ Mattes, C Cordon-Cardo, JL Lewis, LJ Old, KO Lloyd |
Proceedings of the National Academy of Sciences | 1984 |
Ovarian cancer antigen CA125: a prospective clinical assessment of its role as a tumour marker
PA Canney, M Moore, PM Wilkinson, RD James |
British Journal of Cancer | 1984 |
Biotechnology in medicine
AM Green |
Canadian Medical Association journal | 1984 |
Monitoring human ovarian carcinoma with a combination of CA 125, CA 19-9, and carcinoembryonic antigen
RC Bast, TL Klug, E Schaetzl, P Lavin, JM Niloff, TF Greber, VR Zurawski, RC Knapp |
American Journal of Obstetrics and Gynecology | 1984 |
Elevation of serum CA125 in carcinomas of the fallopian tube, endometrium, and endocervix
JM Niloff, TL Klug, E Schaetzl, VR Zurawski, RC Knapp, RC Bast |
American Journal of Obstetrics and Gynecology | 1984 |
Clinical Biochemistry
E Cooper, M Bowen |
Clinical Biochemistry | 1984 |
Environmental factors in the etiology of carcinoma of the human ovary: A review
CH Lingeman |
American Journal of Industrial Medicine | 1983 |
Monocyte chemotaxis mediated by formyl-methionyl-leucyl-phenylalanine conjugated with monoclonal antibodies against human ovarian carcinoma
R Obrist, R Reilly, T Leavitt, RC Knapp, RC Bast |
International Journal of Immunopharmacology | 1983 |
A Radioimmunoassay Using a Monoclonal Antibody to Monitor the Course of Epithelial Ovarian Cancer
RC Bast, TL Klug, ES John, E Jenison, JM Niloff, H Lazarus, RS Berkowitz, T Leavitt, CT Griffiths, L Parker, VR Zurawski, RC Knapp |
New England Journal of Medicine | 1983 |
Comparison of a rabbit heteroantiserum and a murine monoclonal antibody raised against a human epithelial ovarian carcinoma cell line
R Berkowitz, S Kabawat, H Lazarus, R Colvin, R Knapp, RC Bast |
American Journal of Obstetrics and Gynecology | 1983 |
Lymphocyte hybridomas
CS Foster |
Cancer Treatment Reviews | 1982 |
In vivo localization of anti-osteogenic sarcoma 791T monoclonal antibody in osteogenic sarcoma xenografts
MV Pimm, MJ Embleton, AC Perkins, MR Price, RA Robins, GR Robinson, RW Baldwin |
International Journal of Cancer | 1982 |
Recent progress in the treatment of epithelial ovarian malignancy
JS Berek, NF Hacker, LD Lagasse |
The Western journal of medicine | 1982 |
Immunohistochemical localization of murine stage-specific embryonic antigens in human testicular germ cell tumors
I Damjanov, N Fox, BB Knowles, D Solter, PH Lange, EE Fraley |
The American Journal of Pathology | 1982 |
Protides of the Biological Fluids
PA Small, RH Waldman |
Protides of the Biological Fluids | 1969 |
Ultrahigh sensitivity in liquid-crystal-based immunodetection by surface modification of the alignment layer
IC Khoo, MJ Lee, HW Su, SH Sun, W Lee |
||
Molecular forms and microheterogeneity of the oligosaccharide chains of pregnancy-associated CA125 antigen
MM Jankovic, BS Tapuskovic |
Human Reproduction | 2005 |
Human Cell Culture
MR Koller, BO Palsson, JR Masters |
2002 | |
Peritoneal Carcinomatosis: Principles of Management
PH Sugarbaker |
1996 | |
Monoclonal antibodies against native ovarian tumor cells: specificity and characterization of the antigen. A preliminary report
L Wasserman, A Neri, B Kaplan, Y Manor, M Galli, B Hardy |
Journal of Cancer Research and Clinical Oncology | 1995 |
Prevalence screening for ovarian cancer in postmenopausal women by CA 125 measurement and ultrasonography
I Jacobs, AP Davies, J Bridges, I Stabile, T Fay, A Lower, JG Grudzinskas, D Oram |
BMJ : British Medical Journal | 1993 |
Neue Entwicklungen in der Dermatologie
OP Hornstein, M Hundeiker, J Schönfeld |
1990 | |
GnRH Analogues in Cancer and Human Reproduction
BH Vickery, B Lunenfeld |
1990 | |
A prospective evaluation of OC125 and magnetic resonance imaging in patients with ovarian carcinoma
AC Perkins, MC Powell, ML Wastie, IV Scott, A Hitchcock, BS Worthington, EM Symonds |
European Journal of Nuclear Medicine | 1990 |
Preoperative and Longitudinal Serum Levels of CA 125 and CA 15.3 in Patients with Breast Cancer
YT Omar, AE Behbehani, N Al-Naqeeb, MM Motawy, MO Foudeh, AH Awwad, MY Nasralla, JJ Szymendera |
The International Journal of Biological Markers | 1989 |
Distribution of CA 125 in Placental Tissues
LC Fuith, E Müller-Holzner, C Marth, E Perkmann, A Zeimet, G Daxenbichler |
The International Journal of Biological Markers | 1989 |
CA 125 in normal tissues and carcinomas of the uterine cervix, endometrium and fallopian tube: I. Immunohistochemical detection
A Scharl, G Crombach, M Vierbuchen, H Msch, A Bolte |
Archives of Gynecology and Obstetrics | 1989 |
In vitro evaluation of cisplatin interaction with doxorubicin or 4-hydroperoxycyclophosphamide against human gynecologic cancer cell lines
MJ Xu, DS Alberts, R Liu, A Leibovitz, Y Liu |
Cancer Chemotherapy and Pharmacology | 1989 |
Radiolabeled Monoclonal Antibodies for Imaging and Therapy
SC Srivastava |
1988 | |
Experiments with tissue cultures from a human ovarian serous cystadenocarcinoma producing cancer antigen 125 (CA125), tissue polypeptide antigen (TPA) and carcinoembryonic antigen (CEA)
I Fukazawa, N Inaba, Y Ota, N Sato, S Shirotake, H Iwasawa, S Sekiya, H Takamizawa, N Suzuki, H Tokita |
Archives of Gynecology and Obstetrics | 1988 |
CA19-9, CA125 and CEA in endometrial carcinoma tissue and its relation to hormone receptor content and histological grading
W Neunteufel, C Bieglmayer, G Breitenecker |
Archives of Gynecology and Obstetrics | 1988 |
Relation between serum levels of tissue polypeptide antigen (TPA) and cancer antigen 125 (CA125) and their immunohistochemical identification in benign and malignant gynecological disease
I Fukazawa, N Inaba, Y Ota, N Sato, S Shirotake, H Iwasawa, T Sato, H Takamizawa, B Wiklund |
Archives of Gynecology and Obstetrics | 1988 |
Immunohistochemical study of tissue polypeptide antigen (TPA) and cancer antigen 125 (CA125) in the human and cynomolgus monkey placenta, umbilical cord and decidua
K Itahashi, N Inaba, I Fukazawa, H Takamizawa |
Archives of Gynecology and Obstetrics | 1988 |
Immunochemical identification of ?2-globulin in metastases of ovarian tumors
PG Prokopenko, SA Borisenko, YS Tatarinov |
Bulletin of Experimental Biology and Medicine | 1988 |
Tumour associated antigens in diagnosis of serous effusions
J Mezger, W Permanetter, AL Gerbes, W Wilmanns, R Lamerz |
Journal of clinical pathology | 1988 |
Use of statistical evaluation of antigen profiles in differential diagnosis between colonic and ovarian adenocarcinomas
SC Henzen-Logmans, NW Schipper, LG Poels, K Stolk, P Kenemans, CJ Meyer |
Journal of clinical pathology | 1988 |
New Frontiers in Cytology
K Goerttler, GE Feichter, S Witte |
1988 | |
Radiobiology in Radiotherapy
NM Bleehen |
1988 | |
The intraperitoneal delivery of radiolabeled monoclonal antibodies: studies on the regional delivery advantage
RL Wahl, J Barrett, O Geatti, M Liebert, BS Wilson, S Fisher, JG Wagner |
Cancer Immunology, Immunotherapy | 1988 |
CA 125 in the serum and tissue of patients with gynecological disease
LC Fuith, G Daxenbichler, O Dapunt |
Archives of Gynecology and Obstetrics | 1987 |
Comparative effectiveness of the tumour diagnostics, CA 19-9, CA 125 and carcinoembryonic antigen in patients with diseases of the digestive system
K Sakamoto, Y Haga, R Yoshimura, H Egami, Y Yokoyama, M Akagi |
Gut | 1987 |
Application of Monoclonal Antibodies in Tumor Pathology
DJ Ruiter, GJ Fleuren, SO Warnaar |
1987 | |
Sarcoma-like mural nodules in cystic serous ovarian tumours
TJ Clarke |
Journal of clinical pathology | 1987 |
Cellular Biology and Pharmacology of the Placenta
RK Miller, HA Thiede |
1987 | |
Morphological Tumor Markers
G Seifer |
1987 | |
Immunological Approaches to the Diagnosis and Therapy of Breast Cancer
RL Ceriani |
1987 | |
Human carcinoma cell lines xenografted in athymic mice: biological and antigenic characteristics of an intraabdominal model
M Ripamonti, S Canevari, S Mnard, D Mezzanzanica, S Miotti, R Orlandi, F Rilke, E Tagliabue, MI Colnaghi |
Cancer Immunology, Immunotherapy | 1987 |
Immunohistological characterization of a monoclonal antibody (OV632) against epithelial ovarian carcinomas
G J Fleuren, E G Coerkamp, M Nap, L J vd Broek, S O Warnaar |
Virchows Archiv A Pathological Anatomy and Histopathology | 1987 |
Immunobiology of complete molar pregnancy and gestational trophoblastic tumor
RS Berkowitz, SA Umpierre, S Taylor-Emery, DP Goldstein, DJ Anderson |
Cancer and Metastasis Reviews | 1986 |
Antigen detection by the monoclonal antibodies CA 19-9 and CA 125 in normal and tumor tissue and patients' sera
M Dietel, H Arps, R Klapdor, S Mller-Hagen, M Sieck, L Hoffmann |
Journal of Cancer Research and Clinical Oncology | 1986 |
Non-human primate (baboon) anti-carcinoembryonic antigen antibody infusion in patients with metastatic adenocarcinoma: A Phase I study
MS Huberman, JJ Lokich, T Hill, A Kaldany, A Kassis, T Price, C Moore, S Davis, P Kasulis, AP Monaco, DE Haagensen |
Cancer Immunology, Immunotherapy | 1986 |
Evaluation of an Immunoradiometric Assay for the Detection of an Ovarian Tumour Marker, CA125, in Serum
MD Shelley, RG Fish |
Annals of Clinical Biochemistry | 1986 |
Monoclonal antibodies against human ovarian tumor associated antigen NB/70K: Preparation and use in a radioimmunoassay for measuring NB/70K in serum
S Knauf, J Kalwas, BF Helmkamp, LW Harwell, J Beecham, EdithM. |
Cancer Immunology, Immunotherapy | 1986 |
Ovarian Cancer
DS Alberts, EA Surwit |
1985 | |
Spezielle Gynäkologie und Geburtshilfe
E Burghardt |
1985 | |
Microenvironments in the Lymphoid System
GG Klaus |
1985 | |
Immune Complexes and Human Cancer
FA Salinas, MG Hanna |
1985 | |
Monoclonal Antibodies in Cancer
S Sell, RA Reisfeld |
1985 | |
Monoclonal Antibodies and Functional Cell Lines
RH Kennett, KB Bechtol, TJ McKearn |
1984 | |
Somatic Activation of rasK Gene in a Human Ovarian Carcinoma
LA Feig, RC Bast, RC Knapp, GM Cooper |
Science | 1984 |
Monoclonal antibodies to antigens associated with transitional cell carcinoma of the human urinary bladder: I. Determination of the selectivity of six antibodies by cell ELISA and immunofluorescence
H Koho, S Paulie, H Ben-Aissa, I Jnsdttir, Y Hansson, ML Lundblad, P Perlmann |
Cancer Immunology, Immunotherapy | 1984 |
Basic and Clinical Tumor Immunology
RB Herberman |
1983 | |
A Review of Intraperitoneal Therapy of Human Ovarian Carcinoma
RC Knapp, RC Knapp, ES John, RC Bast |
Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis | 1983 |
Human tumor-associated antigens identified by monoclonal antibodies
KE Hellstrm, I Hellstrm, JP Brown |
Springer Seminars in Immunopathology | 1982 |